{
  "title": "pmc_4854800",
  "content": "!DOCTYPE html   html lang \"en\"    head    meta charset \"UTF-8\" /   meta http-equiv \"X-UA-Compatible\" content \"IE edge\" /   meta name \"HandheldFriendly\" content \"True\" /   meta name \"MobileOptimized\" content \"320\" /   meta name \"viewport\" content \"width device-width, initial-scale 1.0\" /   link rel \"stylesheet\" href \"/static/assets/style-a68b4900.css\" /   script type \"module\" crossorigin \"\" src \"/static/assets/base_style-0a3f24ce.js\"  /script   link rel \"stylesheet\" href \"/static/assets/style-ef962842.css\" /   link rel \"stylesheet\" href \"/static/assets/style-3ade8b5c.css\" /   script type \"module\" crossorigin \"\" src \"/static/assets/article_style-d757a0dd.js\"  /script   style   media screen and (min-width: 64em) { div.pmc-wm { background: repeat-y; background-image: url(\"data:image/svg xml, 3Csvg xmlns 'http://www.w3.org/2000/svg' width '20' height '350' xmlns:xlink 'http://www.w3.org/1999/xlink' 3E 3Cdefs 3E 3Cfilter x '-.02' y '0' width '1.05' height '1' id 'c' 3E 3CfeFlood flood-color ' 23FFF'/ 3E 3CfeComposite in 'SourceGraphic'/ 3E 3C/filter 3E 3Ctext id 'b' font-family 'Helvetica' font-size '11pt' style 'opacity:1;fill: 23005ea2;stroke:none;text-anchor:middle' x '175' y '14' 3EAuthor Manuscript 3C/text 3E 3Cpath id 'a' style 'fill: 23005ea2' d 'M0 8h350v3H0z'/ 3E 3C/defs 3E 3Cuse xlink:href ' 23a' transform 'rotate(90 10 10)'/ 3E 3Cuse xlink:href ' 23b' transform 'rotate(90 10 10)' filter 'url( 23c)'/ 3E 3C/svg 3E\"); padding-left: 3rem; } }  /style   link rel \"apple-touch-icon\" sizes \"180x180\" href \"/static/img/favicons/apple-touch-icon.png\" /   link rel \"icon\" type \"image/png\" sizes \"48x48\" href \"/static/img/favicons/favicon-48x48.png\" /   link rel \"icon\" type \"image/png\" sizes \"32x32\" href \"/static/img/favicons/favicon-32x32.png\" /   link rel \"icon\" type \"image/png\" sizes \"16x16\" href \"/static/img/favicons/favicon-16x16.png\" /   link rel \"manifest\" href \"/static/img/favicons/site.webmanifest\" /   link rel \"mask-icon\" href \"/static/img/favicons/safari-pinned-tab.svg\" color \" 0071bc\" /   meta name \"msapplication-config\" content \"/static/img/favicons/browserconfig.xml\" /   meta name \"theme-color\" content \" ffffff\" /   title  DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation - PMC  /title   !-- Logging params: Pinger defaults --   meta name \"ncbi_app\" content \"cloudpmc-viewer\" /   meta name \"ncbi_db\" content \"pmc\" /   meta name \"ncbi_phid\" content \"67D7819D866BA25301819D0034C5CFB8.m_1\" /   meta name \"ncbi_pinger_stat_url\" content \"https://pmc.ncbi.nlm.nih.gov/stat\" /   !-- Logging params: Pinger custom --   meta name \"ncbi_pdid\" content \"article\" /   link rel \"preconnect\" href \"https://www.google-analytics.com\" /   link rel \"preconnect\" href \"https://cdn.ncbi.nlm.nih.gov\" /   !-- Include USWDS Init Script --   script src \"/static/assets/uswds-init.js\"  /script   meta name \"ncbi_domain\" content \"nihpa\"   meta name \"ncbi_type\" content \"fulltext\"   meta name \"ncbi_pcid\" content \"manuscript\"   link rel \"canonical\" href \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\"   meta name \"robots\" content \"INDEX,NOFOLLOW,NOARCHIVE\"   meta name \"citation_journal_title\" content \"European journal of pharmacology\"   meta name \"citation_title\" content \"DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation\"   meta name \"citation_author\" content \"Melody G Duvall\"   meta name \"citation_author_institution\" content \"Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women  x27;s Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts, 02115, USA.\"   meta name \"citation_author\" content \"Bruce D Levy\"   meta name \"citation_author_institution\" content \"Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women  x27;s Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts, 02115, USA.\"   meta name \"citation_publication_date\" content \"2015 Nov 3\"   meta name \"citation_volume\" content \"785\"   meta name \"citation_firstpage\" content \"144\"   meta name \"citation_doi\" content \"10.1016/j.ejphar.2015.11.001\"   meta name \"citation_pmid\" content \"26546247\"   meta name \"citation_abstract_html_url\" content \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\"   meta name \"citation_fulltext_html_url\" content \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\"   meta name \"citation_pdf_url\" content \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/pdf/nihms-737995.pdf\"   meta name \"description\" content \"Essential fatty acids can serve as important regulators of inflammation. A new window into mechanisms for the resolution of inflammation was opened with the identification and structural elucidation of mediators derived from these fatty acids with ...\"   meta name \"og:title\" content \"DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation\"   meta name \"og:type\" content \"article\"   meta name \"og:site_name\" content \"PubMed Central (PMC)\"   meta name \"og:description\" content \"Essential fatty acids can serve as important regulators of inflammation. A new window into mechanisms for the resolution of inflammation was opened with the identification and structural elucidation of mediators derived from these fatty acids with ...\"   meta name \"og:url\" content \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\"   meta name \"og:image\" content \"https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_ 0\"   meta name \"twitter:card\" content \"summary_large_image\"   meta name \"twitter:site\" content \" ncbi\"   /head   body    a class \"usa-skipnav \" href \" main-content\"  Skip to main content  /a   section class \"usa-banner \" aria-label \"Official website of the United States government\"    div class \"usa-accordion\"   header class \"usa-banner__header\"   div class \"usa-banner__inner\"   div class \"grid-col-auto\"   img aria-hidden \"true\" class \"usa-banner__header-flag\" src \"/static/img/us_flag.svg\" alt \"\" /   /div   div class \"grid-col-fill tablet:grid-col-auto\" aria-hidden \"true\"   p class \"usa-banner__header-text\"  An official website of the United States government  /p   span class \"usa-banner__header-action\" Here's how you know /span   /div   button type \"button\" class \"usa-accordion__button usa-banner__button \" aria-expanded \"false\" aria-controls \"gov-banner-default\" data-testid \"storybook-django-banner\"    span class \"usa-banner__button-text\" Here's how you know /span   /button   /div   /header   div class \"usa-banner__content usa-accordion__content\" id \"gov-banner-default\" hidden   div class \"grid-row grid-gap-lg\"   div class \"usa-banner__guidance tablet:grid-col-6\"   img class \"usa-banner__icon usa-media-block__img\" src \"/static/img/icon-dot-gov.svg\" alt \"\" aria-hidden \"true\" /   div class \"usa-media-block__body\"   p   strong Official websites use .gov /strong   br /  A  strong .gov /strong  website belongs to an official government organization in the United States.  /p   /div   /div   div class \"usa-banner__guidance tablet:grid-col-6\"   img class \"usa-banner__icon usa-media-block__img\" src \"/static/img/icon-https.svg\" alt \"\" aria-hidden \"true\" /   div class \"usa-media-block__body\"   p   strong Secure .gov websites use HTTPS /strong   br /  A  strong lock /strong  (  span class \"icon-lock\"   svg xmlns \"http://www.w3.org/2000/svg\" width \"52\" height \"64\" viewBox \"0 0 52 64\" class \"usa-banner__lock-image\" role \"graphics-symbol\" aria-labelledby \"banner-lock-description\" focusable \"false\"   title id \"banner-lock-title\" Lock /title   desc id \"banner-lock-description\"  Locked padlock icon  /desc   path fill \" 000000\" fill-rule \"evenodd\" d \"M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z\" /   /svg   /span ) or  strong https:// /strong  means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.  /p   /div   /div   /div   /div   /div   /section   div class \"usa-overlay\"   /div   header class \"usa-header usa-header--extended usa-header--wide\" data-testid \"header\" data-header    div class \"ncbi-header\"   div class \"ncbi-header__container\"   a class \"ncbi-header__logo-container\" href \"https://www.ncbi.nlm.nih.gov/\"   img alt \" NCBI home page \" class \"ncbi-header__logo-image\" src \"/static/img/ncbi-logos/nih-nlm-ncbi--white.svg\" /   /a   !-- Mobile menu hamburger button --   button type \"button\" class \"usa-menu-btn ncbi-header__hamburger-button \" aria-label \"Show menu\" data-testid \"navMenuButton\"    svg aria-hidden \"true\" class \"ncbi-hamburger-icon\" fill \"none\" focusable \"false\" height \"21\" viewBox \"0 0 31 21\" width \"31\" xmlns \"http://www.w3.org/2000/svg\"   path clip-rule \"evenodd\" d \"M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z\" fill \" F1F1F1\" fill-rule \"evenodd\" /   /svg   /button   !-- Desktop buttons--   div class \"ncbi-header__desktop-buttons\"   !-- Desktop search button --   button type \"button\" class \"usa-button usa-button--unstyled ncbi-header__desktop-button \" aria-expanded \"false\" aria-controls \"search-field-desktop-navigation\" aria-label \"Show search overlay\" data-testid \"toggleSearchPanelButton\" data-toggle-search-panel-button    svg class \"usa-icon \" role \"graphics-symbol\" aria-hidden \"true\"    use xlink:href \"/static/img/sprite.svg search\" /   /svg  Search  /button   !-- Desktop login dropdown --   div class \"ncbi-header__login-dropdown\"   button type \"button\" class \"usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button \" aria-expanded \"false\" aria-controls \"login-dropdown-menu\" aria-label \"Show login menu\" data-testid \"toggleLoginMenuDropdown\" data-desktop-login-button    svg class \"usa-icon \" role \"graphics-symbol\" aria-hidden \"true\"    use xlink:href \"/static/img/sprite.svg person\" /   /svg   span data-login-dropdown-text Log in /span   !-- Dropdown icon pointing up --   svg class \"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden\" role \"graphics-symbol\" aria-hidden \"true\" data-login-dropdown-up-arrow   use xlink:href \"/static/img/sprite.svg expand_less\" /   /svg   !-- Dropdown icon pointing down --   svg class \"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden\" role \"graphics-symbol\" aria-hidden \"true\" data-login-dropdown-down-arrow   use xlink:href \"/static/img/sprite.svg expand_more\" /   /svg   /button   !-- Login dropdown menu --   ul class \"usa-nav__submenu ncbi-header__login-dropdown-menu\" id \"login-dropdown-menu\" data-desktop-login-menu-dropdown hidden   li class \"usa-nav__submenu-item\"   !-- Uses custom style overrides to render external and document links. --   a href \"https://www.ncbi.nlm.nih.gov/myncbi/\" class \"usa-link \"   Dashboard  /a   /li   li class \"usa-nav__submenu-item\"   !-- Uses custom style overrides to render external and document links. --   a href \"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\" class \"usa-link \"   Publications  /a   /li   li class \"usa-nav__submenu-item\"   !-- Uses custom style overrides to render external and document links. --   a href \"https://www.ncbi.nlm.nih.gov/account/settings/\" class \"usa-link \"   Account settings  /a   /li   li class \"usa-nav__submenu-item\"   button type \"button\" class \"usa-button usa-button--outline ncbi-header__login-dropdown-logout-button \" data-testid \"desktopLogoutButton\" data-desktop-logout-button   Log out  /button   /li   /ul   /div   /div   /div   /div   !-- Search panel --   div class \"ncbi-search-panel ncbi--show-only-at-desktop\" data-testid \"searchPanel\" data-header-search-panel hidden   div class \"ncbi-search-panel__container\"   form action \"https://www.ncbi.nlm.nih.gov/search/all/\" aria-describedby \"search-field-desktop-navigation-help-text\" autocomplete \"off\" class \"usa-search usa-search--big ncbi-search-panel__form\" data-testid \"form\" method \"GET\" role \"search\"   label class \"usa-sr-only\" data-testid \"label\" for \"search-field-desktop-navigation\"  Search   /label   input class \"usa-input\" data-testid \"textInput\" id \"search-field-desktop-navigation\" name \"term\" placeholder \"Search NCBI\" type \"search\" value \"\" /   button type \"submit\" class \"usa-button \" data-testid \"button\"    span class \"usa-search__submit-text\"  Search NCBI  /span   /button   /form   /div   /div   nav aria-label \"Primary navigation\" class \"usa-nav\"   p class \"usa-sr-only\" id \"primary-navigation-sr-only-title\"  Primary site navigation  /p   !-- Mobile menu close button --   button type \"button\" class \"usa-nav__close ncbi-nav__close-button \" aria-label \"Close navigation menu\" data-testid \"navCloseButton\"    img src \"/static/img/usa-icons/close.svg\" alt \"Close\" /   /button   !-- Mobile search component --   form class \"usa-search usa-search--small ncbi--hide-at-desktop margin-top-6\" role \"search\"   label class \"usa-sr-only\" for \"search-field\"  Search  /label   input class \"usa-input\" id \"search-field-mobile-navigation\" type \"search\" placeholder \"Search NCBI\" name \"search\" /   button type \"submit\" class \"usa-button \"    !-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color --   img src \"data:image/svg xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8 PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg  \" class \"usa-search__submit-icon\" alt \"Search\" /   /button   /form   !-- Primary navigation menu items --   !-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop --   div class \"ncbi-nav__mobile-login-menu ncbi--hide-at-desktop\" data-mobile-login-menu hidden   p class \"ncbi-nav__mobile-login-menu-status\"  Logged in as:  strong class \"ncbi-nav__mobile-login-menu-email\" data-mobile-login-email-text  /strong   /p   ul class \"usa-nav__primary usa-accordion\"   li class \"usa-nav__primary-item\"   a href \"https://www.ncbi.nlm.nih.gov/myncbi/\" class \"usa-link \"   Dashboard  /a   /li   li class \"usa-nav__primary-item\"   a href \"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\" class \"usa-link \"   Publications  /a   /li   li class \"usa-nav__primary-item\"   a href \"https://www.ncbi.nlm.nih.gov/account/settings/\" class \"usa-link \"   Account settings  /a   /li   /ul   /div   button type \"button\" class \"usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop \" data-testid \"mobileLoginButton\" data-mobile-login-button   Log in  /button   /nav   /header   section class \"pmc-header pmc-header--basic\" aria-label \"PMC Header with search box\"   div class \"pmc-nav-container\"   div class \"pmc-header__bar\"   div class \"pmc-header__logo\"   a href \"/\" title \"Home\" aria-label \"PMC Home\"  /a   /div   button type \"button\" class \"usa-button usa-button--unstyled pmc-header__search__button\" aria-label \"Open search\" data-ga-category \"search\" data-ga-action \"PMC\" data-ga-label \"pmc_search_panel_mobile\"    svg class \"usa-icon width-4 height-4 pmc-icon__open\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg search\"  /use   /svg   svg class \"usa-icon width-4 height-4 pmc-icon__close\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg close\"  /use   /svg   /button   /div   div class \"pmc-header__search\"   form class \"usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form\" id \"pmc-search-form\" autocomplete \"off\" role \"search\"   label class \"usa-sr-only\" for \"pmc-search\" Search PMC Full-Text Archive /label   span class \"autoComplete_wrapper flex-1\"   input class \"usa-input width-full maxw-none\" required \"required\" placeholder \"Search PMC Full-Text Archive\" id \"pmc-search\" type \"search\" name \"term\" data-autocomplete-url \"https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/\"/   /span   button class \"usa-button\" type \"submit\" formaction \"https://www.ncbi.nlm.nih.gov/pmc/\" data-ga-category \"search\" data-ga-action \"PMC\" data-ga-label \"PMC_search_button\"    span class \"usa-search__submit-text\" Search in PMC /span   img src \"/static/img/usa-icons-bg/search--white.svg\" class \"usa-search__submit-icon\" alt \"Search\" /   /button   /form   div class \"display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44\"   ul class \"pmc-header__search__menu\"   li   a class \"usa-link\" href \"https://www.ncbi.nlm.nih.gov/pmc/advanced/\" data-ga-action \"featured_link\" data-ga-label \"advanced_search\"  Advanced Search  /a   /li   li   a class \"usa-link\" href \"/journals/\" data-ga-action \"featured_link\" data-ga-label \"journal list\"  Journal List  /a   /li   li   a class \"usa-link\" href \"/about/userguide/\" data-ga-action \"featured_link\" data-ga-label \"user guide\"  User Guide  /a   /li   /ul   button form \"pmc-search-form\" formaction \"https://pmc.ncbi.nlm.nih.gov/search/\" type \"submit\" class \"usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0\"   span class \"bg-green-label padding-05 text-white\" New /span  span class \"text-underline text-primary\" Try this search in PMC Beta Search /span   /button   /div   /div   /div   /section   div class \"usa-section padding-top-0 desktop:padding-top-6 pmc-article-section\" data-article-db \"pmc\" data-article-id \"4854800\"   div class \"grid-container pmc-actions-bar\" aria-label \"Actions bar\" role \"complementary\"   div class \"grid-row\"   div class \"grid-col-fill display-flex\"   div class \"display-flex\"   ul class \"usa-list usa-list--unstyled usa-list--horizontal\"   li class \"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"   button type \"button\" class \"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" aria-label \"Open resources\" data-extra-class \"is-visible-resources\" data-ga-category \"resources_accordion\" data-ga-action \"click\" data-ga-label \"mobile_icon\"    svg class \"usa-icon width-4 height-4\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg more_vert\"  /use   /svg   /button   /li   li class \"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"   a href \"https://doi.org/10.1016/j.ejphar.2015.11.001\" class \"usa-link display-flex usa-tooltip\" role \"button\" target \"_blank\" rel \"noreferrer noopener\" title \"View on publisher site\" data-position \"bottom\" aria-label \"View on publisher site\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"publisher_link_mobile\"    svg class \"usa-icon width-4 height-4\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg launch\"  /use   /svg   /a   /li   li class \"margin-right-2 mobile-lg:margin-right-4 display-flex\"   a href \"pdf/nihms-737995.pdf\" class \"usa-link display-flex usa-tooltip\" role \"button\" title \"Download PDF\" data-position \"bottom\" aria-label \"Download PDF\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"pdf_download_mobile\"    svg class \"usa-icon width-4 height-4\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg file_download\"  /use   /svg   /a   /li   li class \"margin-right-2 mobile-lg:margin-right-4 display-flex\"   button class \"usa-button usa-button--unstyled usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty\" title \"Add to Collections\" data-position \"bottom\" aria-label \"Save article in MyNCBI collections.\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"collections_button_mobile\" data-collections-open-dialog-enabled \"false\" data-collections-open-dialog-url \"https://account.ncbi.nlm.nih.gov/?back_url https 3A 2F 2Fpmc.ncbi.nlm.nih.gov 2Farticles 2FPMC4854800 2F 23open-collections-dialog\" data-in-collections \"false\"    svg class \"usa-icon width-4 height-4 usa-icon--bookmark-full\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/action-bookmark-full.svg icon\"  /use   /svg   svg class \"usa-icon width-4 height-4 usa-icon--bookmark-empty\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/action-bookmark-empty.svg icon\"  /use   /svg   /button   /li   li class \"margin-right-2 mobile-lg:margin-right-4 display-flex\"   button role \"button\" class \"usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex\" aria-label \"Open dialog with citation text in different styles\" title \"Cite\" data-position \"bottom\" data-ga-category \"actions\" data-ga-action \"open\" data-ga-label \"cite_mobile\" data-all-citations-url \"/resources/citations/4854800/\" data-citation-style \"nlm\" data-download-format-link \"/resources/citations/4854800/export/\"    svg class \"usa-icon width-4 height-4 usa-icon--bookmark-empty\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/sprite.svg format_quote\"  /use   /svg   /button   /li   li class \"pmc-permalink display-flex\"    button type \"button\" title \"Permalink\" data-position \"bottom\" class \"usa-button usa-button--unstyled display-flex usa-tooltip\" aria-label \"Show article permalink\" aria-expanded \"false\" aria-haspopup \"true\" data-ga-category \"actions\" data-ga-action \"open\" data-ga-label \"permalink_mobile\"    svg class \"usa-icon width-4 height-4\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg share\"  /use   /svg   /button   div class \"pmc-permalink__dropdown\" hidden   div class \"pmc-permalink__dropdown__container\"   h2 class \"usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs\" PERMALINK /h2   div class \"pmc-permalink__dropdown__content\"   input type \"text\" class \"usa-input\" value \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\" aria-label \"Article permalink\"   button class \"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title \"Copy article permalink\" data-ga-category \"save_share\" data-ga-action \"link\" data-ga-label \"copy_link\"   svg class \"usa-icon\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg content_copy\"  /use   /svg   span class \"margin-left-1\" Copy /span   /button   /div   /div   /div   /li   /ul   /div   button type \"button\" class \"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" aria-label \"Open article navigation\" data-extra-class \"is-visible-in-page\" data-ga-category \"actions\" data-ga-action \"open\" data-ga-label \"article_nav_mobile\"    svg class \"usa-icon width-4 height-4\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg list\"  /use   /svg   /button   /div   /div   /div   div class \"grid-container desktop:padding-left-6\"   div id \"article-container\" class \"grid-row grid-gap\"   div class \"grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content\"   div class \"grid-container padding-left-0 padding-right-0\"   div class \"grid-row desktop:margin-left-neg-6\"   div class \"grid-col-12\"   div class \"pmc-layout__disclaimer\" role \"complementary\" aria-label \"Disclaimer note\"  As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. br/  Learn more:  a class \"usa-link\" data-ga-category \"Link click\" data-ga-action \"Disclaimer\" data-ga-label \"New disclaimer box\" href \"/about/disclaimer/\" PMC Disclaimer /a     a class \"usa-link\" data-ga-category \"Link click\" data-ga-action \"PMC Copyright Notice\" data-ga-label \"New disclaimer box\" href \"/about/copyright/\"  PMC Copyright Notice  /a   /div   /div   /div   div class \"grid-row pmc-wm desktop:margin-left-neg-6\"   !-- Main content --   main id \"main-content\" class \"usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0\"    section class \"pmc-journal-banner text-center line-height-none\" aria-label \"Journal banner\"  img src \"https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nihpa.png\" alt \"NIHPA Author Manuscripts logo\" usemap \" pmc-banner-imagemap\" width \"500\" height \"75\"  map name \"pmc-banner-imagemap\"  area alt \"Link to NIHPA Author Manuscripts\" title \"Link to NIHPA Author Manuscripts\" shape \"default\" href \"https://www.hhs.gov/open/public-access-guiding-principles/index.html\" target \"_blank\" rel \"noopener noreferrer\"  /map  /section  article lang \"en\"  section aria-label \"Article citation and metadata\"  section class \"pmc-layout__citation font-secondary font-xs\"  div   div class \"display-inline-block\"  button type \"button\" class \"cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary\" aria-controls \"journal_context_menu\" Eur J Pharmacol /button  /div . Author manuscript; available in PMC: 2017 Aug 15. /div   div   em Published in final edited form as:  /em Eur J Pharmacol. 2015 Nov 3;785:144 155. doi:  a href \"https://doi.org/10.1016/j.ejphar.2015.11.001\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" 10.1016/j.ejphar.2015.11.001 /a   /div   nav id \"journal_context_menu\" hidden \"hidden\"  ul class \"menu-list font-family-ui\" role \"menu\"   li role \"presentation\"  a href \"https://www.ncbi.nlm.nih.gov/pmc/?term  22Eur 20J 20Pharmacol 22 5Bjour 5D\" class \"usa-link\" role \"menuitem\" Search in PMC /a  /li   li role \"presentation\"  a href \"https://pubmed.ncbi.nlm.nih.gov/?term  22Eur 20J 20Pharmacol 22 5Bjour 5D\" lang \"en\" class \"usa-link\" role \"menuitem\" Search in PubMed /a  /li   li role \"presentation\"  a href \"https://www.ncbi.nlm.nih.gov/nlmcatalog?term  22Eur 20J 20Pharmacol 22 5BTitle 20Abbreviation 5D\" class \"usa-link\" role \"menuitem\" View in NLM Catalog /a  /li   li role \"presentation\"  a href \"?term  22Eur 20J 20Pharmacol 22 5Bjour 5D\" class \"usa-link\" role \"menuitem\" data-add-to-search \"true\" Add to search /a  /li   /ul  /nav  /section  section class \"front-matter\"  div class \"ameta p font-secondary font-xs\"   hgroup  h1 DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation /h1  /hgroup  div class \"cg p\"   a href \"https://pubmed.ncbi.nlm.nih.gov/?term  22Duvall 20MG 22 5BAuthor 5D\" class \"usa-link\" aria-describedby \"id1\"  span class \"name western\" Melody G Duvall /span  /a  div hidden \"hidden\" id \"id1\"   h3  span class \"name western\" Melody G Duvall /span  /h3   div class \"p\"   sup 1 /sup Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts, 02115, USA. /div   div class \"p\" Find articles by  a href \"https://pubmed.ncbi.nlm.nih.gov/?term  22Duvall 20MG 22 5BAuthor 5D\" class \"usa-link\"  span class \"name western\" Melody G Duvall /span  /a   /div   /div   sup 1 /sup ,  a href \"https://pubmed.ncbi.nlm.nih.gov/?term  22Levy 20BD 22 5BAuthor 5D\" class \"usa-link\" aria-describedby \"id2\"  span class \"name western\" Bruce D Levy /span  /a  div hidden \"hidden\" id \"id2\"   h3  span class \"name western\" Bruce D Levy /span  /h3   div class \"p\"   sup 1 /sup Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts, 02115, USA. /div   div class \"p\" Find articles by  a href \"https://pubmed.ncbi.nlm.nih.gov/?term  22Levy 20BD 22 5BAuthor 5D\" class \"usa-link\"  span class \"name western\" Bruce D Levy /span  /a   /div   /div   sup 1 /sup   /div   ul class \"d-buttons inline-list\"   li  button class \"d-button\" aria-controls \"aip_a\" aria-expanded \"false\" Author information /button  /li   li  button class \"d-button\" aria-controls \"anp_a\" aria-expanded \"false\" Article notes /button  /li   li  button class \"d-button\" aria-controls \"clp_a\" aria-expanded \"false\" Copyright and License information /button  /li   /ul   div class \"d-panels font-secondary-light\"   div id \"aip_a\" class \"d-panel p\" style \"display: none\"   div class \"p\" id \"A1\"   sup 1 /sup Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts, 02115, USA. /div   div class \"author-notes p\"  div class \"fn\" id \"CR1\"   sup   /sup  p class \"display-inline\" Corresponding Author: Bruce D. Levy, MD,  span blevy partners.org /span  /p   /div  /div   /div   div id \"anp_a\" class \"d-panel p\" style \"display: none\"  div class \"notes p\"  section id \"historyarticle-meta1\" class \"history\"  p Issue date 2016 Aug 15. /p  /section  /div  /div   div id \"clp_a\" class \"d-panel p\" style \"display: none\"  div class \"p\"  a href \"/about/copyright/\" class \"usa-link\" PMC Copyright notice /a  /div  /div   /div   div PMCID: PMC4854800 NIHMSID: NIHMS737995 PMID:  a href \"https://pubmed.ncbi.nlm.nih.gov/26546247/\" class \"usa-link\" 26546247 /a   /div   div class \"ra xbox p\" role \"complementary\" aria-label \"Related or updated information about this article\"  div The publisher's version of this article is available at  a href \"https://doi.org/10.1016/j.ejphar.2015.11.001\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Eur J Pharmacol /a   /div  /div   /div  /section  /section  section aria-label \"Article content\"  section class \"body main-article-body\"  section class \"abstract\" id \"abstract1\"  h2 Abstract /h2   p id \"P1\" Essential fatty acids can serve as important regulators of inflammation. A new window into mechanisms for the resolution of inflammation was opened with the identification and structural elucidation of mediators derived from these fatty acids with pro-resolving capacity. Inflammation is necessary to ensure the continued health of the organism after an insult or injury; however, unrestrained inflammation can lead to injury  from within  and chronic changes that may prove both morbid and fatal. The resolution phase of inflammation, once thought to be a passive event, is now known to be a highly regulated, active, and complex program that terminates the inflammatory response once the threat has been contained. Specialized pro-resolving mediators (SPMs) are biosynthesized from omega-3 essential fatty acids to resolvins, protectins, and maresins and from omega-6 fatty acids to lipoxins. Through cell-specific actions mediated through select receptors, these SPMs are potent regulators of neutrophil infiltration, cytokine and chemokine production, and clearance of apoptotic neutrophils by macrophages, promoting a return to tissue homeostasis. This process appears to be defective in several common human lung diseases, such as asthma and COPD, which are characterized by chronic unrestrained inflammation and significant associated morbidity. Here, we highlight translational research in animal models of disease and with human subjects that sheds light on this rapidly evolving area of science and review the molecular and cellular components of the resolution of lung inflammation. /p   section id \"kwd-group1\" class \"kwd-group\"  p  strong Keywords: /strong  Fatty acids, resolution, inflammation, lung /p  /section  /section  section id \"S1\"  h2 class \"pmc_sec_title\" 1. Introduction /h2   p id \"P2\" The hallmarks of acute inflammation include specific cellular events, including increased permeability of the endothelium and epithelium, infiltration of polymorphonuclear leukocytes, inflammatory macrophages, and lymphocytes to sites of infection or injury, and subsequent tissue edema (Cotran, 2009). The cellular events of resolution oppose inflammation and in a process known as catabasis return the host tissues to a non-inflammatory state ( a href \" R105\" class \"usa-link\" aria-describedby \"R105\" Serhan et al., 2004 /a ). Barrier integrity is restored and the permeability of endothelium and epithelium is reduced; neutrophils cease trafficking to sites of inflammation; macrophages clear the inflammatory milieu by phagocytosis of microbes and apoptotic neutrophils in a process termed efferocytosis ( a href \" R95\" class \"usa-link\" aria-describedby \"R95\" Savill et al., 1989 /a ;  a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al., 2007 /a ); and neutrophils at the mucosal interface are released by CD55 from the apical surface of epithelial cells for luminal clearance ( a href \" R19\" class \"usa-link\" aria-describedby \"R19\" Campbell et al., 2007 /a ). As tissue leukocytes recede from sites of acute inflammation, levels of proinflammatory cytokines and chemokines also decrease. At this turning point, metabolism of polyunsaturated fatty acids switches from conversion to pro-inflammatory mediators, such as leukotrienes and prostaglandins, to pro-resolving mediators, such as lipoxins ( a href \" R67\" class \"usa-link\" aria-describedby \"R67\" Levy et al., 2001 /a ). These pro-resolving mediators act as agonists at specific receptors to contribute to the restoration of host tissues to a homeostatic state ( a href \" R100\" class \"usa-link\" aria-describedby \"R100\" Serhan, 2014 /a ). /p   p id \"P3\" Excessive acute inflammation and chronic unresolved inflammation have been linked to important and morbid human lung diseases, including acute respiratory distress syndrome (ARDS), asthma, cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Current research is determining whether the ungoverned inflammation in these diseases reflects a failure of the healthy resolution program in the lungs. This review will examine research in animal models of disease in which SPMs have been shown to increase survival and promote resolution of inflammation as well as several human diseases that are associated with dysregulation of SPM pathways, including SPMs generated from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). /p  /section  section id \"S2\"  h2 class \"pmc_sec_title\" 2. Polyunsaturated fatty acids are available during acute inflammation /h2   p id \"P4\" Polyunsaturated fatty acids (PUFAs) are known to be essential nutrients that are not produced by humans to any significant extent. The omega 6 PUFA arachidonic acid is incorporated into cellular phospholipids and on cellular activation is liberated by phospholipase A sub 2 /sub  enzymes for enzymatic conversion to prostaglandins, leukotrienes, or lipoxins ( a href \" R93\" class \"usa-link\" aria-describedby \"R93\" Samuelsson et al., 1987 /a ;  a href \" R98\" class \"usa-link\" aria-describedby \"R98\" Serhan, 2007 /a ). Omega 3 fatty acids are found primarily in dietary fish oils ( a href \" R17\" class \"usa-link\" aria-describedby \"R17\" Burr, 1929 /a ;  a href \" R18\" class \"usa-link\" aria-describedby \"R18\" Calder, 2013 /a ). The omega 3 PUFAs eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) are detectable in whole blood from healthy individuals and comprise a small proportion of total fatty acids. EPA levels in blood range from 0.5 to 2.8  of total fatty acids and DHA ranges from 1.3 to 5  ( a href \" R2\" class \"usa-link\" aria-describedby \"R2\" Albert et al., 2002 /a ;  a href \" R46\" class \"usa-link\" aria-describedby \"R46\" Gong et al., 1992 /a ;  a href \" R59\" class \"usa-link\" aria-describedby \"R59\" Kew et al., 2004 /a ;  a href \" R81\" class \"usa-link\" aria-describedby \"R81\" Newcomer et al., 2001 /a ;  a href \" R116\" class \"usa-link\" aria-describedby \"R116\" Wakai et al., 2005 /a ) varying based on differences in dietary intake. DHA and EPA have long been known to have beneficial health effects including anti-inflammatory, anti-thrombotic, and immuno-regulatory properties ( a href \" R35\" class \"usa-link\" aria-describedby \"R35\" De Caterina, 2011 /a ;  a href \" R53\" class \"usa-link\" aria-describedby \"R53\" Iigo et al., 1997 /a ). DHA and EPA are concentrated in neural tissues including brain and retina as well as in human milk, plasma, and sperm ( a href \" R11\" class \"usa-link\" aria-describedby \"R11\" Bazan, 2003 /a ;  a href \" R18\" class \"usa-link\" aria-describedby \"R18\" Calder, 2013 /a ;  a href \" R30\" class \"usa-link\" aria-describedby \"R30\" Crawford et al., 2013 /a ). The airway mucosa is also enriched with DHA in health ( a href \" R42\" class \"usa-link\" aria-describedby \"R42\" Freedman et al., 2004 /a ). Mechanisms for dietary enrichment of airway mucosal PUFA remain to be determined. These essential omega 3 PUFAs can serve important roles in regulating acute inflammation through their conversion to potent lipid derived pro-resolving mediators (reviewed in ( a href \" R100\" class \"usa-link\" aria-describedby \"R100\" Serhan, 2014 /a )). /p   p id \"P5\" DHA and EPA are now known to be available at sites of acute inflammation through several distinct mechanisms. In particular, circulating DHA and EPA in plasma can be detected in inflammatory exudates at the site of tissue injury within minutes of initial injury ( a href \" R57\" class \"usa-link\" aria-describedby \"R57\" Kasuga et al., 2008 /a ) ( a href \" F1\" class \"usa-link\" Fig. 1A /a ). DHA and EPA are carried via plasma edema into the inflammatory arena at the tissue level where they are made available for rapid enzymatic conversion into resolvins, protectins, and maresins that are bioactive for tissue inflammation and organ injury ( a href \" R99\" class \"usa-link\" aria-describedby \"R99\" Serhan, 2011 /a ). Additionally, on cell activation, DHA and EPA are rapidly released from cell membranes through the activity of select secretory phospholipase A sub 2 /sub  enzymes that hydrolyze phospholipids to release free fatty acids ( a href \" R80\" class \"usa-link\" aria-describedby \"R80\" Murakami et al., 2011 /a ) ( a href \" F1\" class \"usa-link\" Fig. 1B /a ). /p   figure class \"fig xbox font-sm\" id \"F1\"  h3 class \"obj_head\" Fig. 1. /h3   p class \"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"  a class \"tileshop\" target \"_blank\" href \"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title Click 20on 20image 20to 20zoom amp;p PMC3 amp;id 4854800_nihms-737995-f0001.jpg\"  img class \"graphic zoom-in\" src \"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3159/4854800/7bdc12a385e7/nihms-737995-f0001.jpg\" loading \"lazy\" height \"587\" width \"800\" alt \"Fig. 1\"  /a  /p   div class \"p text-right font-secondary\"  a href \"figure/F1/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div   figcaption  p EPA and DHA are available at sites of acute inflammation. A) The omega-3 fatty acids EPA and DHA circulate in plasma. On injury they move with edema into the tissue sites of acute inflammation where they are converted to exudate SPMs to interact with local immune cells. Shown is a cartoon representation of acute lung inflammation in the setting of allergic asthma. B) DHA and EPA can also be released from the cell membranes through the actions of secretory phospholipase A sub 2 /sub  (sPLA sub 2 /sub ). C) DHA (as LPC) is transported across the blood brain barrier via the transporter Mfsd2a. /p  /figcaption  /figure  p id \"P6\" DHA is highly enriched in brain phospholipids and is an essential component for brain growth; however, DHA cannot be synthesized in vivo and must be transported across the blood brain barrier. Recently, a new mechanism for DHA transport across the blood brain barrier was identified in mice where the orphan receptor Mfsd2a is engaged to transport DHA (in the form of lysophosphatidylcholine   LPC) across the blood brain barrier in a Na sup   /sup -dependent fashion ( a href \" R82\" class \"usa-link\" aria-describedby \"R82\" Nguyen et al., 2014 /a ) ( a href \" F2\" class \"usa-link\" Fig. 2C /a ). /p   figure class \"fig xbox font-sm\" id \"F2\"  h3 class \"obj_head\" Fig. 2. /h3   p class \"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"  a class \"tileshop\" target \"_blank\" href \"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title Click 20on 20image 20to 20zoom amp;p PMC3 amp;id 4854800_nihms-737995-f0002.jpg\"  img class \"graphic zoom-in\" src \"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3159/4854800/5caa69348889/nihms-737995-f0002.jpg\" loading \"lazy\" height \"571\" width \"800\" alt \"Fig. 2\"  /a  /p   div class \"p text-right font-secondary\"  a href \"figure/F2/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div   figcaption  p Biosynthesis of D-series resolvins, maresins, and protectins. Docosahexaenoic acid (DHA; C22:6n-3; grey box) is converted by 15-LOX to the intermediate 17S-hydroperoxy-DHA which is then further converted by neutrophil derived 5-LOX to the D-series resolvins, RvD1 through RvD4. DHA can also be converted via 15-LOX into a 16, 17-epoxy-protectin intermediate and then onto to protectin D1. DHA is converted via 12-LOX in macrophages to a 13S, 14S-epoxy-maresin and then through enzymatic hydrolysis to MaR1. /p  /figcaption  /figure  /section  section id \"S3\"  h2 class \"pmc_sec_title\" 3. DHA and EPA are enzymatically transformed to SPMs /h2   p id \"P7\" Essential PUFAs serve an important role in regulating the acute inflammatory response as substrates for enzymatic conversion to potent lipid-derived mediators ( a href \" R93\" class \"usa-link\" aria-describedby \"R93\" Samuelsson et al., 1987 /a ). During resolution of a self-limited experimental model of acute inflammation in vivo, liquid chromatography tandem mass spectrometry (LC-MS/MS)-based lipid mediator metabolomic profiling revealed that EPA and DHA are enzymatically converted into specific bioactive compounds that display protective anti-inflammatory and pro-resolving activities (reviewed in ( a href \" R100\" class \"usa-link\" aria-describedby \"R100\" Serhan, 2014 /a )). The biosynthetic pathways for conversion of DHA to the D-series resolvins, protectins, and maresins is shown in  a href \" F2\" class \"usa-link\" Fig. 2 /a  and the pathways for conversion of EPA to the E-series resolvins are shown in  a href \" F3\" class \"usa-link\" Fig. 3 /a . /p   figure class \"fig xbox font-sm\" id \"F3\"  h3 class \"obj_head\" Fig. 3. /h3   p class \"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"  a class \"tileshop\" target \"_blank\" href \"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title Click 20on 20image 20to 20zoom amp;p PMC3 amp;id 4854800_nihms-737995-f0003.jpg\"  img class \"graphic zoom-in\" src \"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3159/4854800/219843850feb/nihms-737995-f0003.jpg\" loading \"lazy\" height \"894\" width \"712\" alt \"Fig. 3\"  /a  /p   div class \"p text-right font-secondary\"  a href \"figure/F3/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div   figcaption  p Biosynthesis of E-series resolvins. Eicosapentaenoic acid (EPA; C20:5n-3; grey box) is converted via aspirin acetylated COX-2 or by cytochrome p450 in microbes to the intermediate 18R-hydroperoxy-EPE (18R-HEPE). The intermediate 18R-HEPE can be further transformed via neutrophil 5-LOX to an intermediate for subsequent enzymatic conversion to RvE1 or via reduction to RvE2. RvE3 is generated directly from 18R-HEPE via 12/15-LOX. /p  /figcaption  /figure  section id \"S4\"  h3 class \"pmc_sec_title\" 3.1. D-series Resolvins /h3   p id \"P8\" DHA (C22:6) is enzymatically converted to the D-series resolvins (RvD1-4) through trans-cellular biosynthesis ( a href \" F2\" class \"usa-link\" Fig. 2 /a ). During cell-cell interactions in airway inflammation, 15-lipoxygenase (15-LOX) in epithelial cells converts DHA to 17S-hydroperoxy-DHA, which can be subsequently converted by 5-LOX (in neutrophils) to RvD1 through RvD4 via epoxide-containing biosynthetic intermediates ( a href \" R51\" class \"usa-link\" aria-describedby \"R51\" Hong et al., 2003 /a ;  a href \" R107\" class \"usa-link\" aria-describedby \"R107\" Serhan et al., 2002 /a ) ( a href \" F2\" class \"usa-link\" Fig. 2A /a ). The aspirin triggered resolvins (AT-RvD1-4) are produced after initial conversion of DHA by aspirin-acetylated COX-2 in vascular endothelial cells to 17R-hydroxy-DHA, which can be transformed via neutrophil-derived 5-LOX to the epimeric forms of the resolvins ( a href \" R107\" class \"usa-link\" aria-describedby \"R107\" Serhan et al., 2002 /a ). The stereochemistry of some of the D-series resolvins has been established (RvD1 ( a href \" R111\" class \"usa-link\" aria-describedby \"R111\" Sun et al., 2007 /a ), RvD2 ( a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al., 2009 /a ), RvD3 ( a href \" R33\" class \"usa-link\" aria-describedby \"R33\" Dalli et al., 2013a /a ), and additional members (RvD4 through RvD6) have been detected. The D-series resolvins have been detected in blood from healthy individuals and increase with omega 3 fatty acid dietary supplementation ( a href \" R27\" class \"usa-link\" aria-describedby \"R27\" Colas et al., 2014 /a ;  a href \" R85\" class \"usa-link\" aria-describedby \"R85\" Oh et al., 2012 /a ;  a href \" R89\" class \"usa-link\" aria-describedby \"R89\" Psychogios et al., 2011 /a ). /p  /section  section id \"S5\"  h3 class \"pmc_sec_title\" 3.2. Protectins /h3   p id \"P9\" DHA can also be enzymatically converted through 15-LOX action via an epoxide-containing intermediate to the protectin family (also known as neuroprotectins in neural tissues) ( a href \" R51\" class \"usa-link\" aria-describedby \"R51\" Hong et al., 2003 /a ;  a href \" R106\" class \"usa-link\" aria-describedby \"R106\" Serhan et al., 2006 /a ). Protectin D1 is present in mouse inflammatory exudates, mouse lung, human blood, and human exhaled breath condensates in asthmatic and healthy individuals ( a href \" R51\" class \"usa-link\" aria-describedby \"R51\" Hong et al., 2003 /a ;  a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al., 2007 /a ;  a href \" R106\" class \"usa-link\" aria-describedby \"R106\" Serhan et al., 2006 /a ). /p  /section  section id \"S6\"  h3 class \"pmc_sec_title\" 3.3 Maresins /h3   p id \"P10\" Macrophage mediators in resolving inflammation, or maresins, are a third major family of DHA-derived SPMs. Maresins are primarily produced in macrophages ( a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al., 2009 /a ) wherein phagocytosis of apoptotic neutrophils generates SPMs ( a href \" R43\" class \"usa-link\" aria-describedby \"R43\" Freire-de-Lima et al., 2006 /a ;  a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al., 2007 /a ), as well as 14-hydroxy-DHA (14-HDHA) ( a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al., 2009 /a ). Maresin 1 (MaR1) is generated through conversion of 14-HDHA, via 12-LOX, through a 13,14-epoxide intermediate by human macrophages ( a href \" R34\" class \"usa-link\" aria-describedby \"R34\" Dalli et al., 2013b /a ). MaR1 is also generated during human platelet-neutrophil interaction via platelet 12-LOX conversion of DHA to 13S, 14S-epoxy-maresin followed by neutrophil conversion to MaR1 ( a href \" R1\" class \"usa-link\" aria-describedby \"R1\" Abdulnour et al., 2014 /a ). /p  /section  section id \"S7\"  h3 class \"pmc_sec_title\" 3.4 Sulfido Conjugates /h3   p id \"P11\" The DHA metabolome also includes sulfido-conjugates of maresin, protectin, and the D-series resolvins that are bioactive ( a href \" R31\" class \"usa-link\" aria-describedby \"R31\" Dalli et al., 2014 /a ;  a href \" R32\" class \"usa-link\" aria-describedby \"R32\" Dalli et al., 2015 /a ). These sulfido-conjugate compounds of SPMs are generated by conversion of DHA by activate phagocytes and are active in stimulating the resolution of acute inflammation and promoting tissue regeneration. /p  /section  section id \"S8\"  h3 class \"pmc_sec_title\" 3.5 E-series Resolvins /h3   p id \"P12\" EPA (C20:5) can be enzymatically converted into the E-series resolvins family of SPMs through trans-cellular mechanisms ( a href \" F3\" class \"usa-link\" Fig. 3 /a ). EPA is converted to 18R-hydroxyeicosapentaenoic acid (18R-HEPE) by vascular endothelial cells expressing COX-2, which is acetylated in the presence of aspirin during inflammation. 18R-HEPE is then released from endothelial cells and converted via neutrophil-derived 5-LOX through a common epoxy intermediate to RvE1 and RvE2 ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ;  a href \" R84\" class \"usa-link\" aria-describedby \"R84\" Ogawa et al., 2009 /a ;  a href \" R85\" class \"usa-link\" aria-describedby \"R85\" Oh et al., 2012 /a ;  a href \" R101\" class \"usa-link\" aria-describedby \"R101\" Serhan et al., 2000a /a ;  a href \" R114\" class \"usa-link\" aria-describedby \"R114\" Tjonahen et al., 2006 /a ). In the absence of aspirin, RvE1 biosynthesis can be initiated through cytochrome p450 enzymatic conversion of EPA ( a href \" R102\" class \"usa-link\" aria-describedby \"R102\" Serhan et al., 2000b /a ). RvE1 has been detected in plasma, sera, and sputum ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ;  a href \" R27\" class \"usa-link\" aria-describedby \"R27\" Colas et al., 2014 /a ;  a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al., 2012 /a ). RvE3 is distinct from the other E-series resolvins in its biosynthesis, as it is generated via the actions of 12/15-LOX derived from mouse eosinophils ( a href \" R55\" class \"usa-link\" aria-describedby \"R55\" Isobe et al., 2012 /a ) rather than neutrophil 5-LOX. /p  /section  /section  section id \"S9\"  h2 class \"pmc_sec_title\" 4. Cellular actions of SPMs /h2   p id \"P13\" Acute inflammation is essential for host defense and survival. Controlling and resolving inflammation to protect vital tissues and organs from collateral damage and further injury is equally as important. The acute inflammatory response resolves in an active way that engages specific cellular events. Neutrophils begin to die via induction of cytokines and T cells undergo activation-induced programmed cell death. SPMs induce the expression of CCR5 on T cells, which scavenges residual proinflammatory chemokines. Macrophages subsequently engulf apoptotic leukocytes clearing the tissue of inflammatory cells and mediators. Efferocytosis also leads to SPM production, which positively feeds back to limit neutrophil migration into the tissues and also enhances further macrophage phagocytosis of apoptotic neutrophils. /p   p id \"P14\" In addition to these innate immune effectors, SPMs have actions on multiple lymphocyte subsets. They enhance B cell differentiation into antibody-secreting cells ( a href \" R90\" class \"usa-link\" aria-describedby \"R90\" Ramon et al., 2012 /a ), direct NK cell-mediated apoptosis of neutrophils and eosinophils ( a href \" R10\" class \"usa-link\" aria-describedby \"R10\" Barnig et al., 2013 /a ) as well as NK cytotoxicity ( a href \" R48\" class \"usa-link\" aria-describedby \"R48\" Haworth et al., 2011 /a ), modulate pro-inflammatory cytokine production by innate lymphoid cells (ILCs) ( a href \" R10\" class \"usa-link\" aria-describedby \"R10\" Barnig et al., 2013 /a ) and engage regulatory T cells to restrict cytokine production by ILCs ( a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al., 2014 /a ). These findings uncover an interesting and pivotal role for SPMs at the bridge between innate and adaptive immunity during an inflammatory response. /p   p id \"P15\" SPMs are active in picogram to nanogram doses and have varied actions that promote control of inflammation, shorten the time interval to resolution, promote healing, and alleviate pain (reviewed in ( a href \" R100\" class \"usa-link\" aria-describedby \"R100\" Serhan, 2014 /a )). The SPMs display stereoselective and cell-type-specific actions, which are discussed below and shown in  a href \" T1\" class \"usa-link\" Table 1 /a . /p   section class \"tw xbox font-sm\" id \"T1\"  h3 class \"obj_head\" Table 1. /h3   div class \"caption p\"  p Cell-based actions of resolvins, protectins and maresins. /p  /div   div class \"tbl-box p\" tabindex \"0\"  table class \"content\" frame \"hsides\" rules \"groups\"   thead  tr   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" SPM /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Cell Type /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Action /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reference /th   /tr  /thead   tbody   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin E1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" T cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Increases CCR5 expression; Regulates Th17 cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R4\" class \"usa-link\" aria-describedby \"R4\" Ariel et al 2006 /a ;  a href \" R49\" class \"usa-link\" aria-describedby \"R49\" Haworth et al 2008 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits trans-migration and promotes clearance /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R19\" class \"usa-link\" aria-describedby \"R19\" Campbell et al 2007 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances phagocytosis of apoptotic neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al 2007 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" NK Cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Promotes clearance of eosinophils and neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R48\" class \"usa-link\" aria-describedby \"R48\" Haworth et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Dendritic Cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits IL-23 release; Reduces migration and IL-12 production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R49\" class \"usa-link\" aria-describedby \"R49\" Haworth et al 2008 /a ;  a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al 2005 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Platelets /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces activation and aggregation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R36\" class \"usa-link\" aria-describedby \"R36\" Dona et al 2008 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Vascular smooth muscle /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Confers a protective phenotype switch by decreasing PDGF-stimulated migration /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R50\" class \"usa-link\" aria-describedby \"R50\" Ho et al 2010 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin D1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits trans-migration; Stimulates rapid shape change and halts chemotaxis; br Blocks adhesion molecules /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R111\" class \"usa-link\" aria-describedby \"R111\" Sun et al 2007 /a ; Kasuga 2008; br  a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al 2010 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances phagocytosis of apoptotic neutrophils; Enhances allergen clearance /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al 2010 /a ;  a href \" R92\" class \"usa-link\" aria-describedby \"R92\" Rogerio et al 2012 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" B cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Promotes IgM and IgG production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R90\" class \"usa-link\" aria-describedby \"R90\" Ramon et al 2012 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin D2 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces recruitment by altering adhesion receptor expression /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al 2009 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances phagocytosis of apoptotic neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al 2009 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Endothelial cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces leukocyte: endothelial interactions through NO production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al 2009 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protectin D1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" T cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Blocks T cell migration; Increases CCR5 expression; Promotes T cell apoptosis; br Inhibits TNF-α and IFN-γ production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R5\" class \"usa-link\" aria-describedby \"R5\" Ariel et al 2005 /a ;  a href \" R4\" class \"usa-link\" aria-describedby \"R4\" Ariel et al 2006 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits trans-endothelial migration /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al 2007 /a ;  a href \" R104\" class \"usa-link\" aria-describedby \"R104\" Serhan et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Promotes efferocytosis of apoptotic neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al 2007 /a ;  a href \" R104\" class \"usa-link\" aria-describedby \"R104\" Serhan et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Epithelial cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protects against oxidative-stress induced apoptosis (retinal pigment epithelium) /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R79\" class \"usa-link\" aria-describedby \"R79\" Mukherjee et al 2004 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Glial cells /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces cytokine production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R51\" class \"usa-link\" aria-describedby \"R51\" Hong et al 2003 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Maresin 1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Stimulates phagocytosis of apoptotic neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al 2009 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Platelet-neutrophil aggregates /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases lung neutrophils, edema, tissue hypoxia, and prophlogistic mediators /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R1\" class \"usa-link\" aria-describedby \"R1\" Abdulnour et al 2014 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Innate lymphoid cells (type 2) /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces expression of IL-5 and IL-13; increases amphiregulin /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al 2014 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Regulatory T cells (Tregs) /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Augments Treg generation leading to ILC2 effects /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al 2014 /a   /td   /tr   /tbody   /table  /div   div class \"p text-right font-secondary\"  a href \"table/T1/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div  /section  section id \"S10\"  h3 class \"pmc_sec_title\" 4.1. D-series Resolvins /h3   p id \"P16\" RvD1 has been shown to prevent transendothelial migration of neutrophils in a murine model of peritonitis ( a href \" R111\" class \"usa-link\" aria-describedby \"R111\" Sun et al., 2007 /a ) and to block integrin adhesion molecules on human neutrophils ( a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al., 2010 /a ). RvD1 also promotes macrophage engulfment and phagocytosis of apoptotic neutrophils ( a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al., 2010 /a ). RvD1 can influence the humoral immune response by increasing production of IgM and IgG from activated B cells ( a href \" R90\" class \"usa-link\" aria-describedby \"R90\" Ramon et al., 2012 /a ). RvD1 also enhances macrophage phagocytosis and clearance of allergen in a murine model of allergic airways disease ( a href \" R92\" class \"usa-link\" aria-describedby \"R92\" Rogerio et al., 2012 /a ). /p   p id \"P17\" RvD2 increases survival in a mouse model of sepsis ( a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al., 2009 /a ). In this model, RvD2 decreases endothelial-leukocyte interactions via nitric oxide production as well as modifying adhesion receptors on leukocytes ( a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al., 2009 /a ). In addition, RvD2 decreases local and systemic bacterial burden, blunts cytokine production and neutrophil recruitment, and increases peritoneal mononuclear cell and macrophage phagocytosis ( a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al., 2009 /a ), all of which contribute to regulation of excessive inflammation. /p  /section  section id \"S11\"  h3 class \"pmc_sec_title\" 4.2. Protectins /h3   p id \"P18\" Protectin D1 is produced from DHA by T helper type 2-skewed PBMCs. Protectin D1 promotes human T cell apoptosis via lipid raft clustering and blocks T cell migration in vivo ( a href \" R5\" class \"usa-link\" aria-describedby \"R5\" Ariel et al., 2005 /a ). Protectin D1 promotes upregulation of CCR5 expression on apoptotic T cells leading to termination of chemokine signaling during the resolution phase of inflammation ( a href \" R4\" class \"usa-link\" aria-describedby \"R4\" Ariel et al., 2006 /a ). Protectin D1 also inhibits tumor necrosis factor alpha (TNF-[.Delta]) and interferon-gamma (IFN-[.theta1]) secretion from T cells ( a href \" R5\" class \"usa-link\" aria-describedby \"R5\" Ariel et al., 2005 /a ). Protectin D1 is active in human retinal pigment epithelial cells to protect against oxidative stress-induced apoptosis ( a href \" R79\" class \"usa-link\" aria-describedby \"R79\" Mukherjee et al., 2004 /a ) and in glial cells to block cytokine production ( a href \" R51\" class \"usa-link\" aria-describedby \"R51\" Hong et al., 2003 /a ). Finally, like the D-series and E-series resolvins, protectin D1 has also been described to inhibit transendothelial migration of neutrophils and enhance macrophage efferocytosis of apoptotic neutrophils ( a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al., 2007 /a ;  a href \" R104\" class \"usa-link\" aria-describedby \"R104\" Serhan et al., 2011 /a ). /p  /section  section id \"S12\"  h3 class \"pmc_sec_title\" 4.3. Maresins /h3   p id \"P19\" During the resolution phase of murine peritonitis, maresins are a potent stimulus for macrophage uptake and phagocytosis of apoptotic neutrophils ( a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al., 2009 /a ). MaR1 acts directly on planaria tissue to promote regeneration and in mice MaR1 reduces neuropathic pain ( a href \" R103\" class \"usa-link\" aria-describedby \"R103\" Serhan et al., 2012 /a ). MaR1 reduces lung inflammation and ILC type 2 (ILC2) production of the type 2 cytokines IL-5 and IL-13 ( a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al., 2014 /a ). Regulation of ILC2s is selective as MaR1-mediated inhibition of type 2 cytokines was accompanied by increased production of amphiregulin, which is important in tissue repair ( a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al., 2014 /a ). MaR1 also induces regulatory T cell (Treg)-based suppressive activity for ILC2 and Th2 cells ( a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al., 2014 /a ). /p  /section  section id \"S13\"  h3 class \"pmc_sec_title\" 4.4. E-series Resolvins /h3   p id \"P20\" In a mouse model of peritonitis, apoptotic T cells upregulated CCR5 expression in the presence of RvE1 ( a href \" R4\" class \"usa-link\" aria-describedby \"R4\" Ariel et al., 2006 /a ). RvE1 also acts at the mucosal surface to reduce transendothelial migration of neutrophils as well as promote luminal clearance of neutrophils by apical CD55 expression at mucosal sites of acute inflammation ( a href \" R19\" class \"usa-link\" aria-describedby \"R19\" Campbell et al., 2007 /a ). RvE1 has activity that promotes a reduction in neutrophils by regulating tissue infiltration, increasing macrophage ingestion of apoptotic neutrophils, and enhancing lymphatic clearance of phagocytes ( a href \" R96\" class \"usa-link\" aria-describedby \"R96\" Schwab et al., 2007 /a ). RvE1 dramatically reduces dermal inflammation, peritonitis, dendritic cell migration, and IL-12 production ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ) and blocks platelet activation and aggregation ( a href \" R36\" class \"usa-link\" aria-describedby \"R36\" Dona et al., 2008 /a ). RvE1 modulates vascular smooth muscle cells towards a more protective phenotype not associated with peripheral arterial disease and atherosclerosis ( a href \" R50\" class \"usa-link\" aria-describedby \"R50\" Ho et al., 2010 /a ). RvE1 promotes NK cell mediated clearance of eosinophils and antigen specific T cells ( a href \" R48\" class \"usa-link\" aria-describedby \"R48\" Haworth et al., 2011 /a ) and regulates pro-inflammatory cytokine production by dendritic cells and Th17 cells in allergic inflammation ( a href \" R49\" class \"usa-link\" aria-describedby \"R49\" Haworth et al., 2008 /a ). /p  /section  /section  section id \"S14\"  h2 class \"pmc_sec_title\" 5. SPMs act through specific receptors ( a href \" F4\" class \"usa-link\" Fig. 4 /a ) /h2   figure class \"fig xbox font-sm\" id \"F4\"  h3 class \"obj_head\" Fig. 4. /h3   p class \"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"  a class \"tileshop\" target \"_blank\" href \"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title Click 20on 20image 20to 20zoom amp;p PMC3 amp;id 4854800_nihms-737995-f0004.jpg\"  img class \"graphic zoom-in\" src \"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3159/4854800/330b53bd10c0/nihms-737995-f0004.jpg\" loading \"lazy\" height \"430\" width \"800\" alt \"Fig. 4\"  /a  /p   div class \"p text-right font-secondary\"  a href \"figure/F4/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div   figcaption  p Cellular targets and receptors for resolvins, protectins, and maresins. SPMs signal through specific 7-transmembrane G-protein coupled receptors. Lipoxin A4 (LXA sub 4 /sub ) and the D-series resolvins, in particular RvD1 are agonists for the ALX/FPR2 receptor that is present on a wide variety of leukocytes and other cells. RvE1 and RvE2 are agonists for the CMKLR1/ERV receptor, which is widely expressed on immune cells, and antagonists at the BLT1 receptor. The D-series resolvins are also agonists at the DRV1 and DRV2 receptors. The receptors for protectins and maresins have yet to be molecularly characterized. SPMs signal through these specific receptors to exert influence on leukocytes including halting neutrophil trafficking, promoting macrophage phagocytosis of apoptotic cells and microbes, and blocking further pro-inflammatory cytokine and chemokine production. /p  /figcaption  /figure  section id \"S15\"  h3 class \"pmc_sec_title\" 5.1. ALX/FPR2 Receptor /h3   p id \"P21\" The ALX/FRP2 receptor is present on human neutrophils, eosinophils, airway epithelium, monocytes, macrophages, T cells, synovial fibroblasts, and intestinal epithelial cells ( a href \" R15\" class \"usa-link\" aria-describedby \"R15\" Bonnans et al., 2006 /a ;  a href \" R24\" class \"usa-link\" aria-describedby \"R24\" Chiang et al., 2006 /a ;  a href \" R39\" class \"usa-link\" aria-describedby \"R39\" Fiore et al., 1994 /a ;  a href \" R71\" class \"usa-link\" aria-describedby \"R71\" Maddox et al., 1997 /a ) as well as human NK cells and ILCs ( a href \" R10\" class \"usa-link\" aria-describedby \"R10\" Barnig et al., 2013 /a ). Orthologs of the ALX receptor are expressed in mice ( a href \" R113\" class \"usa-link\" aria-describedby \"R113\" Takano et al., 1997 /a ) and rats ( a href \" R25\" class \"usa-link\" aria-describedby \"R25\" Chiang et al., 2003 /a ) with preserved structure and function. The ALX receptor is a 7-transmembrane G-protein coupled receptor that interacts with and transmits intracellular signals from LXA sub 4 /sub , 15-epi-LXA sub 4 /sub , RvD1, aspirin-triggered RvD1, and the corticosteroid-induced protein annexin A1 ( a href \" R24\" class \"usa-link\" aria-describedby \"R24\" Chiang et al., 2006 /a ;  a href \" R39\" class \"usa-link\" aria-describedby \"R39\" Fiore et al., 1994 /a ;  a href \" R63\" class \"usa-link\" aria-describedby \"R63\" Krishnamoorthy et al., 2012 /a ;  a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al., 2010 /a ). ALX receptor expression on cells is regulated by inflammatory mediators, transcription factors, and epigenetic mechanisms. LXA sub 4 /sub  itself increases ALX expression by activating its promoter in a positive-feedback fashion ( a href \" R109\" class \"usa-link\" aria-describedby \"R109\" Simiele et al., 2012 /a ). Intriguingly, single-nucleotide polymorphisms in the ALX receptor promoter decrease its activity and are associated with increased cardiovascular risk ( a href \" R109\" class \"usa-link\" aria-describedby \"R109\" Simiele et al., 2012 /a ). Additionally, in severe asthma there is a deficit in generation of LXA sub 4 /sub  and granulocytes have decreased expression of surface ALX ( a href \" R69\" class \"usa-link\" aria-describedby \"R69\" Levy et al., 2012 /a ), suggesting an association with defective signaling through ALX and chronic lung inflammation. /p  /section  section id \"S16\"  h3 class \"pmc_sec_title\" 5.2. ERV (CMKLR1) Receptor /h3   p id \"P22\" The chemokine receptor-like 1 (CMKLR1; also known as ChemR23 and now E-series resolvin (ERV) receptor) is expressed in brain, kidney, cardiovascular, GI, and myeloid tissues ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ) and in particular on NK cells, ILCs, macrophages, dendritic cells, and epithelial cells ( a href \" R10\" class \"usa-link\" aria-describedby \"R10\" Barnig et al., 2013 /a ;  a href \" R19\" class \"usa-link\" aria-describedby \"R19\" Campbell et al., 2007 /a ;  a href \" R20\" class \"usa-link\" aria-describedby \"R20\" Cash et al., 2008 /a ;  a href \" R37\" class \"usa-link\" aria-describedby \"R37\" Du and Leung, 2009 /a ;  a href \" R86\" class \"usa-link\" aria-describedby \"R86\" Parolini et al., 2007 /a ). The ERV receptor is also a 7-transmembrane G-protein coupled receptor that interacts with and transmits intracellular signals from the peptide mediator chemerin as well as RvE1. RvE2 binds to human neutrophils with strong affinity and likely shares receptors with RvE1 ( a href \" R85\" class \"usa-link\" aria-describedby \"R85\" Oh et al., 2012 /a ). /p   p id \"P23\" ERV is expressed in the lung by both leukocytes and structural cells and signaling through ERV plays pivotal roles in the regulation of innate and adaptive immune cell activation in the lung. In particular, ERV may play a significant role in anti-viral immunity. ERV knock out mice have increased mortality, delayed viral clearance, and increased neutrophilic infiltration and worse lung function compared to controls in a murine model of viral pneumonia ( a href \" R14\" class \"usa-link\" aria-describedby \"R14\" Bondue et al., 2011 /a ). /p  /section  section id \"S17\"  h3 class \"pmc_sec_title\" 5.3. BLT1 Receptor /h3   p id \"P24\" The leukotriene B sub 4 /sub  receptor 1 (BLT1) is expressed on human neutrophils, eosinophils, monocytes, macrophages, mast cells, dendritic cells, and T cells ( a href \" R123\" class \"usa-link\" aria-describedby \"R123\" Yokomizo et al., 1997 /a ). RvE1 and RvE2 are antagonists at the BLT1 receptor, and have counterregulatory effects that lead to inhibition of neutrophil chemotaxis, calcium mobilization, and NF-kB activation ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ;  a href \" R7\" class \"usa-link\" aria-describedby \"R7\" Arita et al., 2007 /a ). /p  /section  section id \"S18\"  h3 class \"pmc_sec_title\" 5.4. DRV1 Receptor /h3   p id \"P25\" The G-protein coupled receptor 32 (GPR32; now known as the RvD1 receptor DRV1) is expressed on human neutrophils, lymphocytes, macrophages, and monocytes as well as vascular tissues ( a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al., 2010 /a ). RvD1, its aspirin triggered epimer AT-RvD1, RvD3, and RvD5 have all been shown to bind and signal through the DRV1 receptor ( a href \" R23\" class \"usa-link\" aria-describedby \"R23\" Chiang et al., 2012 /a ;  a href \" R33\" class \"usa-link\" aria-describedby \"R33\" Dalli et al., 2013a /a ;  a href \" R63\" class \"usa-link\" aria-describedby \"R63\" Krishnamoorthy et al., 2012 /a ;  a href \" R64\" class \"usa-link\" aria-describedby \"R64\" Krishnamoorthy et al., 2010 /a ;  a href \" R111\" class \"usa-link\" aria-describedby \"R111\" Sun et al., 2007 /a ). It appears that RvD1 differentially interacts with the DRV1 receptor during periods of homeostasis and the ALX receptor during the resolution phase of inflammation ( a href \" R63\" class \"usa-link\" aria-describedby \"R63\" Krishnamoorthy et al., 2012 /a ). /p  /section  section id \"S19\"  h3 class \"pmc_sec_title\" 5.5. DRV2 Receptor /h3   p id \"P26\" The G-protein coupled receptor 18 (GPR18; known now as the RvD2 receptor DRV2) is expressed on human and murine neutrophils, monocytes, and macrophages ( a href \" R22\" class \"usa-link\" aria-describedby \"R22\" Chiang et al., 2015 /a ). RvD2 binds to and signals through the DRV2 receptor to limit neutrophil infiltration, enhance phagocyte clearance of bacteria, and promote tissue resolution in a murine model of acute inflammation ( a href \" R22\" class \"usa-link\" aria-describedby \"R22\" Chiang et al., 2015 /a ). /p  /section  section id \"S20\"  h3 class \"pmc_sec_title\" 5.6. Other Receptors /h3   p id \"P27\" The molecular identification of the receptors through which protectin D1 signals has not yet been elucidated. Protectin D1 activity is cell-type specific, with a structure activity relationship suggestive of the presence of one or more receptors. Protectin D1 binds to neutrophils at high- and low-affinity binding sites as well as retinal epithelial cells ( a href \" R72\" class \"usa-link\" aria-describedby \"R72\" Marcheselli et al., 2010 /a ). The molecular identification of the receptors through which MaR1 signals has also not yet been elucidated; however, MaR1 can block the transient receptor potential V1 (TRPV1) signaling in primary sensory neurons thus reducing inflammatory and neuropathic pain in vivo in mice ( a href \" R103\" class \"usa-link\" aria-describedby \"R103\" Serhan et al., 2012 /a ). Studies are ongoing to further define the receptors through with the maresins exert their effects. /p  /section  /section  section id \"S21\"  h2 class \"pmc_sec_title\" 6. Human lung diseases are associated with decreased SPMs /h2   p id \"P28\" In humans, the actions of the resolvins, protectins, and maresins in vivo are just beginning to be investigated. RvD1, RvD2, and RvE1 can be detected in samples of peripheral venous blood from healthy individuals and their levels are modified by omega-3 fatty acid dietary supplementation ( a href \" R27\" class \"usa-link\" aria-describedby \"R27\" Colas et al., 2014 /a ;  a href \" R74\" class \"usa-link\" aria-describedby \"R74\" Mas et al., 2012 /a ;  a href \" R89\" class \"usa-link\" aria-describedby \"R89\" Psychogios et al., 2011 /a ). A recent study has described the upregulation of RvD1 and RvD2 in the plasma of patients recently diagnosed with pulmonary tuberculosis ( a href \" R41\" class \"usa-link\" aria-describedby \"R41\" Frediani et al., 2014 /a ). Importantly, RvE1 has also been detected in human milk ( a href \" R118\" class \"usa-link\" aria-describedby \"R118\" Weiss et al., 2013 /a ). This conveyance of SPMs from mother to child is strong suggestive evidence of their protective activities. SPMs are also detectable in serum and CSF from patients with multiple sclerosis ( a href \" R88\" class \"usa-link\" aria-describedby \"R88\" Pruss et al., 2013 /a ), plasma of patients with IgA nephropathy ( a href \" R124\" class \"usa-link\" aria-describedby \"R124\" Zivkovic et al., 2012 /a ), and in sputum from adults with cystic fibrosis ( a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al., 2012 /a ). Protectin D1 is present in serum and cerebrospinal fluid of patients with multiple sclerosis ( a href \" R88\" class \"usa-link\" aria-describedby \"R88\" Pruss et al., 2013 /a ), exhaled breath condensates from asthmatics ( a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al., 2007 /a ) and embryonic stem cells ( a href \" R121\" class \"usa-link\" aria-describedby \"R121\" Yanes et al., 2010 /a ). Finally, MaR1 has been detected in synovial fluid of patients with rheumatoid arthritis ( a href \" R45\" class \"usa-link\" aria-describedby \"R45\" Giera et al., 2012 /a ). /p   p id \"P29\" Common lung diseases such as asthma and COPD are characterized in part by unrestrained and chronic inflammation that fails to resolve. Several studies, which we review in this section and  a href \" T2\" class \"usa-link\" Table 2 /a , have identified deficiencies in levels of SPMs in the setting of common human inflammatory lung diseases, suggesting that an insufficiency in the activity of these SPMs in the resolution phase of acute inflammation may perpetuate the chronic inflammation and underlie the pathobiology of these diseases. /p   section class \"tw xbox font-sm\" id \"T2\"  h3 class \"obj_head\" Table 2. /h3   div class \"caption p\"  p Human lung diseases associated with decreased levels of SPMs /p  /div   div class \"tbl-box p\" tabindex \"0\"  table class \"content\" frame \"hsides\" rules \"groups\"   thead  tr   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" SPM /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Disease /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Finding /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reference /th   /tr  /thead   tbody   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin E1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Cystic Fibrosis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased RvE1 in CF patients with lower lung function /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al 2012 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protectin D1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Asthma Exacerbation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased PD1 in uncontrolled asthma br Decreased PD1 in eosinophils in severe asthma /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al 2007 /a   br   a href \" R76\" class \"usa-link\" aria-describedby \"R76\" Miyata et al 2013 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Lipoxin A4 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Severe Asthma /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased LXA sub 4 /sub  biosynthesis in severe asthma (blood, sputum, BAL); Lower LXA sub 4 /sub  levels in exhaled breath condensates correlates with worse lung function /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R66\" class \"usa-link\" aria-describedby \"R66\" Levy et al 2005 /a ;  a href \" R115\" class \"usa-link\" aria-describedby \"R115\" Vachier et al 2005 /a ; br  a href \" R21\" class \"usa-link\" aria-describedby \"R21\" Celik et al 2007 /a ;  a href \" R87\" class \"usa-link\" aria-describedby \"R87\" Planaguma et al 2008 /a ;  a href \" R12\" class \"usa-link\" aria-describedby \"R12\" Bhavsar et al 2010 /a ; We et al 2010;  a href \" R44\" class \"usa-link\" aria-describedby \"R44\" Fritscher et al 2012 /a ;  a href \" R58\" class \"usa-link\" aria-describedby \"R58\" Kazani et al 2013 /a . /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Asthma Exacerbation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased LXA sub 4 /sub  in exhaled breath condensates during exacerbation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R47\" class \"usa-link\" aria-describedby \"R47\" Hasan et al 2012 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Exercise-induced Asthma /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased LXA sub 4 /sub  in plasma of children with exercise induced bronchospasm /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R112\" class \"usa-link\" aria-describedby \"R112\" Tahan et al 2008 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Aspirin-intolerant asthma /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased lipoxins in aspirin-intolerant asthmatics compared to aspirin tolerant asthmatics /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R94\" class \"usa-link\" aria-describedby \"R94\" Sanak et al 2000 /a ;  a href \" R21\" class \"usa-link\" aria-describedby \"R21\" Celik et al 2007 /a ; br  a href \" R120\" class \"usa-link\" aria-describedby \"R120\" Yamaguchi et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" COPD /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduced LXA sub 4 /sub  detected in exhaled breath condensates; serum amyloid A opposes LXA sub 4 /sub  at ALX /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R44\" class \"usa-link\" aria-describedby \"R44\" Fritscher et al 2012 /a ; br  a href \" R16\" class \"usa-link\" aria-describedby \"R16\" Bozinovski et al 2012 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Cystic Fibrosis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased LXA sub 4 /sub  production and defective lipoxin activity /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R56\" class \"usa-link\" aria-describedby \"R56\" Karp et al 2004 /a ;  a href \" R26\" class \"usa-link\" aria-describedby \"R26\" Chiron et al 2008 /a ; br  a href \" R75\" class \"usa-link\" aria-describedby \"R75\" Mattoscio et al 2010 /a ;  a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al 2012 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Pleural Effusions /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" LXA sub 4 /sub  present in exudative effusions and correlates with neutrophils /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R67\" class \"usa-link\" aria-describedby \"R67\" Levy et al 2001 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Lung Transplant /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" LXA sub 4 /sub  present in BAL fluid during rejection /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R70\" class \"usa-link\" aria-describedby \"R70\" Levy et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Scleroderma /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreased LXA sub 4 /sub  levels in BAL of patients with scleroderma lung disease /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R61\" class \"usa-link\" aria-describedby \"R61\" Kowal-Bielecka et al 2005 /a   /td   /tr   /tbody   /table  /div   div class \"p text-right font-secondary\"  a href \"table/T2/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div  /section  p id \"P30\" Severe asthmatic patients have decreased levels of arachidonic acid (i.e., omega-6 PUFA) dervied LXA sub 4 /sub  in blood, induced sputum, bronchoalveolar lavage fluid, and exhaled breath condensates that in some cases has correlated with severity of disease (i.e., FEV1) ( a href \" R12\" class \"usa-link\" aria-describedby \"R12\" Bhavsar et al., 2010 /a ;  a href \" R58\" class \"usa-link\" aria-describedby \"R58\" Kazani et al., 2013 /a ) ( a href \" R21\" class \"usa-link\" aria-describedby \"R21\" Celik et al., 2007 /a ;  a href \" R44\" class \"usa-link\" aria-describedby \"R44\" Fritscher et al., 2012 /a ;  a href \" R66\" class \"usa-link\" aria-describedby \"R66\" Levy et al., 2005 /a ;  a href \" R87\" class \"usa-link\" aria-describedby \"R87\" Planaguma et al., 2008 /a ;  a href \" R115\" class \"usa-link\" aria-describedby \"R115\" Vachier et al., 2005 /a ). LXA sub 4 /sub  is reduced in the exhaled breath condensates of children with status asthmaticus in the pediatric intensive care unit compared to controls ( a href \" R47\" class \"usa-link\" aria-describedby \"R47\" Hasan et al., 2012 /a ). Children with exercise-induced asthma have lower levels of LXA sub 4 /sub  in plasma after exercise challenge compared to those asthmatics not triggered by exertion ( a href \" R112\" class \"usa-link\" aria-describedby \"R112\" Tahan et al., 2008 /a ). Asthmatic individuals who are aspirin-intolerant have a more frequent and severe respiratory symptoms and a lower biosynthetic capacity to generate lipoxins compared to aspirin-tolerant asthmatic patients or controls, which may contribute to their more severe clinical phenotype ( a href \" R21\" class \"usa-link\" aria-describedby \"R21\" Celik et al., 2007 /a ;  a href \" R94\" class \"usa-link\" aria-describedby \"R94\" Sanak et al., 2000 /a ;  a href \" R120\" class \"usa-link\" aria-describedby \"R120\" Yamaguchi et al., 2011 /a ). In addition to asthmatic individuals, moderate to severe COPD patients also have reduced levels of LXA sub 4 /sub  in exhaled breath condensates ( a href \" R44\" class \"usa-link\" aria-describedby \"R44\" Fritscher et al., 2012 /a ). During exacerbations in glucocorticoid-resistant COPD patients, serum amyloid A levels are markedly increased and because serum amyloid A can pirate ALX/FPR2 receptors to promote inflammation, it opposes the counter-regulatory mechanisms of LXA sub 4 /sub  at the ALX receptor, which leads to steroid-refractory inflammation in pre-clinical murine models of airway inflammation ( a href \" R16\" class \"usa-link\" aria-describedby \"R16\" Bozinovski et al., 2012 /a ). /p   p id \"P31\" LXA sub 4 /sub  is present in exudative pleural effusions from human subjects with pleural disease and is associated with pleural exudates that are rich in neutrophils ( a href \" R67\" class \"usa-link\" aria-describedby \"R67\" Levy et al., 2001 /a ). Endogenous levels of LXA sub 4 /sub  in BAL fluid from human lung transplant recipients correlates with the severity of both airway and vascular rejection, suggesting a role for SPMs in regulating immune-mediated mechanisms of organ rejection ( a href \" R70\" class \"usa-link\" aria-describedby \"R70\" Levy et al., 2011 /a ). /p   p id \"P32\" In health, the airway mucosa is enriched with DHA. Of interest, mucosal levels of DHA decrease in asthma and cystic fibrosis ( a href \" R42\" class \"usa-link\" aria-describedby \"R42\" Freedman et al., 2004 /a ), which would adversely impact the generation of DHA-derived SPMs such as D-series resolvins, maresins, and protectins. Levels of EPA-derived RvE1 in respiratory secretions from adults with CF correlated with better lung function (i.e., FEV1) compared to those patients with undetectable levels of RvE1 ( a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al., 2012 /a ). Lipoxin levels in airway secretions ( a href \" R56\" class \"usa-link\" aria-describedby \"R56\" Karp et al., 2004 /a ;  a href \" R122\" class \"usa-link\" aria-describedby \"R122\" Yang et al., 2012 /a ) and platelets ( a href \" R75\" class \"usa-link\" aria-describedby \"R75\" Mattoscio et al., 2010 /a ) from patients with CF are significantly suppressed compared with controls, and can be increased by antibiotic therapy ( a href \" R26\" class \"usa-link\" aria-describedby \"R26\" Chiron et al., 2008 /a ). In a mouse model of CF, exogenous administration of a lipoxin analog suppresses neutrophilic inflammation, decreases pulmonary bacterial burden and attenuates disease severity ( a href \" R56\" class \"usa-link\" aria-describedby \"R56\" Karp et al., 2004 /a ). /p   p id \"P33\" Protectin D1 is an anti-inflammatory and pro-resolving molecule synthesized by human eosinophils; however, levels of protectin D1 are significantly lower in exhaled breath condensates from subjects with asthma exacerbations ( a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al., 2007 /a ), and eosinophils from patients with severe asthma have decreased protectin D1 production, even in presence of exogenous DHA ( a href \" R76\" class \"usa-link\" aria-describedby \"R76\" Miyata et al., 2013 /a ). /p   p id \"P34\" Patients with scleroderma lung disease have an upregulation of pro-inflammatory molecules such as leukotrienes in the lungs that are not balanced by a concomitant upregulation of anti-inflammatory or pro-resolving molecules such as LXA sub 4 /sub  ( a href \" R61\" class \"usa-link\" aria-describedby \"R61\" Kowal-Bielecka et al., 2005 /a ). /p   p id \"P35\" Additional studies assessing the presence and activity of SPMs in other human pulmonary diseases such as viral infection, acute respiratory distress syndrome, interstitial lung disease, idiopathic fibrosis, lung cancer and tuberculosis as well as diseases of the pulmonary vasculature such as pulmonary hypertension are warranted. /p  /section  section id \"S22\"  h2 class \"pmc_sec_title\" 7. SPMs in animal models of disease /h2   section id \"S23\"  h3 class \"pmc_sec_title\" 7.1. Allergic asthma /h3   p id \"P36\" In mouse models of allergic asthma/airway inflammation, SPMs display potent immunomodulatory actions ( a href \" T3\" class \"usa-link\" Table 3 /a ). In acute and chronic allergen-driven models, RvE1 promotes the resolution of inflammatory airway responses by inhibiting airway eosinophil and lymphocyte recruitment, suppressing the production of IL-6, IL-13, and IL-23, promoting LXA sub 4 /sub  and IFN-γ production, and decreasing airway hyperresponsiveness to inhaled methacholine ( a href \" R40\" class \"usa-link\" aria-describedby \"R40\" Flesher et al., 2014 /a ;  a href \" R49\" class \"usa-link\" aria-describedby \"R49\" Haworth et al., 2008 /a ). When administered prior to allergen challenge, RvE1 also has anti-inflammatory effects, including decreasing airway eosinophilia and lymphocyte recruitment and decreasing type 2 cytokine secretion ( a href \" R3\" class \"usa-link\" aria-describedby \"R3\" Aoki et al., 2008 /a ). RvD1 markedly decreases airway eosinophilia and mucus metaplasia, shortens the resolution interval for lung eosinophilia, significantly enhances macrophage phagocytosis of allergen from the airways, and potently regulates NF-kB activity ( a href \" R92\" class \"usa-link\" aria-describedby \"R92\" Rogerio et al., 2012 /a ). /p   section class \"tw xbox font-sm\" id \"T3\"  h4 class \"obj_head\" Table 3. /h4   div class \"caption p\"  p Actions in vivo for SPMs in animal models of disease /p  /div   div class \"tbl-box p\" tabindex \"0\"  table class \"content\" frame \"hsides\" rules \"groups\"   thead  tr   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" SPM /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Disease Model /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" In vivo action /th   th align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reference /th   /tr  /thead   tbody   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin E1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Pneumonia /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances bacterial clearance; Decreases lung neutrophils; Improves survival /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R97\" class \"usa-link\" aria-describedby \"R97\" Seki et al 2010 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Allergic Airway Inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances T cells and eosinophil clearance; Abrogates airway hyperresponsiveness; br Improves mucous metaplasia; Prevents Th2 cytokine release; br Enhances IFN-γ production; Suppresses macrophage cytokine production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R49\" class \"usa-link\" aria-describedby \"R49\" Haworth et al 2008 /a ;  a href \" R3\" class \"usa-link\" aria-describedby \"R3\" Aoki et al 2008 /a ;  a href \" R40\" class \"usa-link\" aria-describedby \"R40\" Flesher et al 2014 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Acid-induced acute lung injury /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases neutrophil trafficking to lung; Attenuates pro-inflammatory mediators /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R97\" class \"usa-link\" aria-describedby \"R97\" Seki et al 2010 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Colitis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases neutrophil recruitment; Down-regulates pro-inflammatory gene expression; br Improves survival /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R8\" class \"usa-link\" aria-describedby \"R8\" Arita et al 2005b /a ; br  a href \" R54\" class \"usa-link\" aria-describedby \"R54\" Ishida et al 2010 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Peritonitis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits neutrophil recruitment; Promotes lymphatic removal of phagocytes; br Regulates chemokine/cytokine production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al 2005a /a ; br  a href \" R9\" class \"usa-link\" aria-describedby \"R9\" Bannenberg et al 2005 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Retinopathy /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protects against pathological neovascularlization /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R28\" class \"usa-link\" aria-describedby \"R28\" Connor et al 2007 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Heart ischemia /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protects against reperfusion injury after hypoxia /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R60\" class \"usa-link\" aria-describedby \"R60\" Keyes et al 2010 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Solid organ transplant /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Preserves organ function; prolongs survival of allograft /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R70\" class \"usa-link\" aria-describedby \"R70\" Levy et al 2011 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin D1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Acute lung injury (acid-induced) sup  a href \" TFN1\" class \"usa-link\"   /a  /sup   /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases PMNs; Reduces pro-inflammatory cytokines; Improves barrier integrity; br Reduces airway resistance /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R38\" class \"usa-link\" aria-describedby \"R38\" Eickmeier et al 2013 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Acute lung injury (LPS-induced) /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases PMN recruitment; reduces TNF-α and IL-6 production; Reduces mortality /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R117\" class \"usa-link\" aria-describedby \"R117\" Wang et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Allergic airway inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases airway eosinophilia and mucus metaplasia; Enhances macrophage phagocytosis of allergen from airways /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R92\" class \"usa-link\" aria-describedby \"R92\" Rogerio et al 2012 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Secondary lung injury /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces second organ injury in ischemia/reperfusion models by inhibiting neutrophil migration /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R57\" class \"usa-link\" aria-describedby \"R57\" Kasuga et al 2008 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Cigarette induced lung inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Promotes M2 macrophages and neutrophil efferocytosis; br Accelerates resolution of inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R52\" class \"usa-link\" aria-describedby \"R52\" Hsiao et al 2013 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Septic Shock /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Suppresses release of inflammatory cytokines /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R80\" class \"usa-link\" aria-describedby \"R80\" Murakami et al 2011 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Alzheimer's disease /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Stimulates phagocytosis of amyloid-β by macrophages /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R77\" class \"usa-link\" aria-describedby \"R77\" Mizwicki et al 2013 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Resolvin D2 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Sepsis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces inflammatory cytokine release; Enhances bacterial clearance; Improves survival /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R110\" class \"usa-link\" aria-describedby \"R110\" Spite et al 2009 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Secondary lung injury /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces second organ injury in ischemia/reperfusion models by inhibiting neutrophil migration /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R22\" class \"usa-link\" aria-describedby \"R22\" Chiang et al 2015 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Burn wound /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Prevents secondary thrombosis and necrosis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R13\" class \"usa-link\" aria-describedby \"R13\" Bohr et al 2013 /a ;  a href \" R65\" class \"usa-link\" aria-describedby \"R65\" Kurihara et al 2013 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Protectin D1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Influenza (H1N1) infection /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Inhibits viral replication and reduces severity of disease /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R78\" class \"usa-link\" aria-describedby \"R78\" Morita et al 2013 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Allergic airway inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Enhances eosinophil and T cell clearance from lung /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al 2007 /a   /td   /tr   tr  td colspan \"4\" align \"left\" valign \"top\" rowspan \"1\"  hr  /td  /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Maresin 1 /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" ARDS /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Decreases lung neutrophils, edema, tissue hypoxia, and inflammatory mediators; Dependent on platelet/neutrophil interactions /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R1\" class \"usa-link\" aria-describedby \"R1\" Abdulnour et al 2014 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Allergic airway inflammation /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Restrains airway inflammation through Treg suppression of ILC2 cytokine production /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al 2014 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Peritonitis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Reduces neutrophil recruitment /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al 2009 /a   /td   /tr   tr   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"  /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Colitis /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\" Promotes macrophage M2 phenotype; Decreases inflammatory cytokines /td   td align \"left\" valign \"top\" rowspan \"1\" colspan \"1\"   a href \" R73\" class \"usa-link\" aria-describedby \"R73\" Marcon et al 2013 /a   /td   /tr   /tbody   /table  /div   div class \"p text-right font-secondary\"  a href \"table/T3/\" class \"usa-link\" target \"_blank\" rel \"noopener noreferrer\" Open in a new tab /a  /div   div class \"tw-foot p\"  div class \"fn\" id \"TFN1\"   sup   /sup  p class \"display-inline\" id \"P50\" AT-RvD1 /p   /div  /div  /section  p id \"P37\" When protectin D1 is administered before aeroallergen challenge in a murine asthma model, airway eosinophil and T cell recruitment is decreased, airway mucous and levels of pro-inflammatory mediators (including IL-13, cysteinyl leukotrienes and PGD sub 2 /sub ) are decreased, and airway hyperresponsiveness to inhaled methacholine is dampened ( a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al., 2007 /a ). When protectin D1 is given later, after aeroallergen challenge, the resolution phase of inflammation is markedly accelerated ( a href \" R68\" class \"usa-link\" aria-describedby \"R68\" Levy et al., 2007 /a ). MaR1 decreases ILC2 cytokine production and augments the generation of regulatory T cells for anti-inflammatory and pro-resolving actions, respectively ( a href \" R62\" class \"usa-link\" aria-describedby \"R62\" Krishnamoorthy et al., 2014 /a ). /p  /section  section id \"S24\"  h3 class \"pmc_sec_title\" 7.2. Pneumonia/Acute Lung Injury /h3   p id \"P38\" In mouse models of pneumonia and acute lung injury, SPMs also display protective actions ( a href \" T3\" class \"usa-link\" Table 3 /a ). In a model of aspiration pneumonia where mice receive intratracheal hydrochloric acid followed by Escherichia coli, RvE1 was important in resolving sterile and infectious lung inflammation ( a href \" R97\" class \"usa-link\" aria-describedby \"R97\" Seki et al., 2010 /a ). Animals who received RvE1 had significantly decreased lung levels of pro-inflammatory cytokines, including IL-1[.Epsilon], enhanced bacterial clearance, decreased lung neutrophil trafficking, and improved survival ( a href \" R97\" class \"usa-link\" aria-describedby \"R97\" Seki et al., 2010 /a ). /p   p id \"P39\" In a mouse model of LPS-induced acute lung injury, pretreatment of animals with RvD1 prior to LPS exposure is protective ( a href \" R117\" class \"usa-link\" aria-describedby \"R117\" Wang et al., 2011 /a ). RvD1 exposure decreases mortality, improves lung pathological changes, inhibits LPS-induced increases in neutrophil and mononuclear leukocytes recruitment, and inhibits TNF-α and IL-6 production in the BAL fluid ( a href \" R117\" class \"usa-link\" aria-describedby \"R117\" Wang et al., 2011 /a ). The RvD1 epimer AT-RvD1 is protective in an acid-injury model of acute lung injury. AT-RvD1 reduces BAL fluid neutrophils by  75  and inhibits neutrophil-platelet interactions by downregulating both P-selectin and its ligand CD24 ( a href \" R38\" class \"usa-link\" aria-describedby \"R38\" Eickmeier et al., 2013 /a ). Animals treated with AT-RvD1 had improved epithelial and endothelial barrier integrity and decreased airway resistance associated with increased BAL fluid levels of epinephrine ( a href \" R38\" class \"usa-link\" aria-describedby \"R38\" Eickmeier et al., 2013 /a ). AT-RvD1 also significantly decreased levels of BAL fluid pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α ( a href \" R38\" class \"usa-link\" aria-describedby \"R38\" Eickmeier et al., 2013 /a ). Second organ lung injury following reperfusion after ischemia is mediated in part by activated neutrophils that have difficulty navigating the pulmonary capillary bed, leading to local release of several potentially injurious molecules (e.g., proteases, reactive oxygen species and lipases). In murine hind-limb ischemia/reperfusion models, RvD1 analogues and RvD2 provide significant protection against secondary lung damage by controlling leukocyte activation and infiltration by approximately 50  ( a href \" R22\" class \"usa-link\" aria-describedby \"R22\" Chiang et al., 2015 /a ;  a href \" R57\" class \"usa-link\" aria-describedby \"R57\" Kasuga et al., 2008 /a ). /p   p id \"P40\" A mouse model of lethal influenza infection has shown that protectin D1 is a strong inhibitor of viral replication and leads to improved survival in those animals with severe disease ( a href \" R78\" class \"usa-link\" aria-describedby \"R78\" Morita et al., 2013 /a ). In a murine model of ARDS, early MaR1 production occurs in the vascular bed and is dependent on platelet-neutrophil interactions ( a href \" R1\" class \"usa-link\" aria-describedby \"R1\" Abdulnour et al., 2014 /a ). MaR1 production is associated with lung protective effects, including decreased neutrophil trafficking to lung, decreased production of inflammatory mediators, and reduced lung edema and tissue hypoxia ( a href \" R1\" class \"usa-link\" aria-describedby \"R1\" Abdulnour et al., 2014 /a ). /p  /section  section id \"S25\"  h3 class \"pmc_sec_title\" 7.3. Other models of disease /h3   p id \"P41\" In mouse models of peritonitis, RvE1 ( a href \" R6\" class \"usa-link\" aria-describedby \"R6\" Arita et al., 2005a /a ;  a href \" R9\" class \"usa-link\" aria-describedby \"R9\" Bannenberg et al., 2005 /a ), RvD1 ( a href \" R83\" class \"usa-link\" aria-describedby \"R83\" Norling et al., 2012 /a ;  a href \" R91\" class \"usa-link\" aria-describedby \"R91\" Recchiuti et al., 2011 /a ), and MaR1 ( a href \" R108\" class \"usa-link\" aria-describedby \"R108\" Serhan et al., 2009 /a ) have all been demonstrated to limit recruitment of neutrophils to site of inflammation, promote lymphatic removal of phagocytes, inhibit pro-inflammatory cytokine production and generally accelerate the resolution of inflammation. In a murine model of colitis, maresin 1 decreases inflammatory cytokines and promotes the M2 phenotype of macrophages ( a href \" R73\" class \"usa-link\" aria-describedby \"R73\" Marcon et al., 2013 /a ). /p   p id \"P42\" RvD1 (Murakami 2011) and RvD2 (Spite 2009) both reduce the release of pro-inflammatory cytokines and reducing neutrophil trafficking to sites of inflammation in models of septic shock and RvD2 protects against death (Spite 2009). In murine models of significant trauma from burns, RvD2 administered after a burn prevents secondary thrombosis and necrosis of tissue ( a href \" R13\" class \"usa-link\" aria-describedby \"R13\" Bohr et al., 2013 /a ) and improves survival ( a href \" R65\" class \"usa-link\" aria-describedby \"R65\" Kurihara et al., 2013 /a ). /p   p id \"P43\" RvE1 improves survival in models of colitis ( a href \" R8\" class \"usa-link\" aria-describedby \"R8\" Arita et al., 2005b /a ;  a href \" R54\" class \"usa-link\" aria-describedby \"R54\" Ishida et al., 2010 /a ), protects against neovascularization in a model of retinopathy ( a href \" R28\" class \"usa-link\" aria-describedby \"R28\" Connor et al., 2007 /a ), protects against reperfusion injury in a model of heart ischemia ( a href \" R60\" class \"usa-link\" aria-describedby \"R60\" Keyes et al., 2010 /a ), and leads to prolonged survival of allograft in a model of solid organ transplant ( a href \" R70\" class \"usa-link\" aria-describedby \"R70\" Levy et al., 2011 /a ). /p   p id \"P44\" In a mouse model of cigarette exposure RvD1 promotes differentiation of alternatively activated (M2) macrophages and neutrophil efferocytosis and accelerates the resolution of lung inflammation ( a href \" R52\" class \"usa-link\" aria-describedby \"R52\" Hsiao et al., 2013 /a ). RvD1 also improves macrophage phagocytosis of amyloid beta protein in a murine model of Alzheimer's disease ( a href \" R77\" class \"usa-link\" aria-describedby \"R77\" Mizwicki et al., 2013 /a ). /p  /section  /section  section id \"S26\"  h2 class \"pmc_sec_title\" 8. Conclusions /h2   p id \"P45\" In order to maintain health, the body must respond to a wide array of insults including injury, infection, and noxious stimuli. In particular, the lung is exposed to this milieu of agents potentially through each breath. The host needs to respond to respiratory pathogens and allergens as well as toxins and irritants by mounting an acute inflammatory response to resolve the insult in a timely manner and restore homeostasis. If there is a failure of catabasis to resolve the acute immune response, then overly exuberant acute inflammation or conversion to chronic inflammation may ensue. The pathobiology of several common lung diseases, such as asthma, COPD, and cystic fibrosis, is linked to a chronic inflammatory state that fails to resolve. Similarly, unrestrained acute lung inflammation, as in acute respiratory distress syndrome, may also result from impaired resolution pathways. /p   p id \"P46\" The omega-3 fatty acids DHA and EPA and the omega-6 fatty acid arachidonic acid are available at sites of acute inflammation where they are converted into bioactive SPMs. These SPMs are comprised of several distinct families, including the omega-6 PUFA derived lipoxins, and the omega-3 PUFA derived D-series resolvins, E-series resolvins, protectins, and maresins. The SPMs act at subnanogram doses on specific receptors on diverse cells of the immune system, including neutrophils, macrophages, endothelial and epithelial cells, and lymphocytes. The actions of SPMs direct key features of inflammation resolution including inhibition of neutrophil migration, enhancement of macrophage phagocytosis of apoptotic neutrophils, and suppression of pro-inflammatory cytokines and chemokines. There are several reports in preclinical animal models of disease that demonstrate important roles for SPMs in modulating pathobiology and promoting a return to homeostasis after infection or injury leading to improved outcomes, including survival. Common and important human diseases are associated with decreased levels of SPMs including uncontrolled asthma, COPD, and cystic fibrosis. Of great interest, a recent clinical trial of SPMs in humans showed that topical 15-epi-LXA sub 4 /sub  significantly reduced skin inflammation and symptoms in patients with infantile eczema with efficacy that was at least equivalent to the current clinical gold standard therapy topical steroids ( a href \" R119\" class \"usa-link\" aria-describedby \"R119\" Wu et al., 2013 /a ), supporting the therapeutic potential of SPMs. Further study of human diseases in the context of inflammation resolution is likely to inform potential new avenues for therapeutic intervention in several common, morbid, and sometimes fatal diseases. /p  /section  section id \"S27\" class \"ack\"  h2 class \"pmc_sec_title\" Acknowledgements /h2   p This work was funded in part by US National Institutes of Health grants R01-HL122531, U01-HL108712, U10-HL109172, U24-AI118656 and P01-GM095467. /p  /section  section id \"fn-group1\" class \"fn-group\"  h2 class \"pmc_sec_title\" Footnotes /h2   div class \"fn-group p font-secondary-light font-sm\"   div class \"fn p\" id \"FN1\"  p id \"P47\"  strong Publisher's Disclaimer: /strong  This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. /p  /div   div class \"fn p\" id \"FN2\"   p id \"P48\" Conflict Of Interest /p   p id \"P49\" B.D.L. is an inventor on patents assigned to Brigham and Women's Hospital; some of these patents (those pertaining to Rvs) are licensed to Resolvyx Pharmaceuticals. The interests of B.D.L. were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. M.G.D. has no conflict of interest to disclose. /p   /div   /div  /section  section id \"ref-list1\" class \"ref-list\"  h2 class \"pmc_sec_title\" References /h2   section id \"ref-list1_sec2\"  ol class \"ref-list font-sm\"   li id \"R1\"   cite Abdulnour RE, Dalli J, Colby JK, Krishnamoorthy N, Timmons JY, Tan SH, Colas RA, Petasis NA, Serhan CN, Levy BD. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:16526 16531. doi: 10.1073/pnas.1407123111. /cite  [ a href \"https://doi.org/10.1073/pnas.1407123111\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4246348/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/25369934/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Maresin 201 20biosynthesis 20during 20platelet-neutrophil 20interactions 20is 20organ-protective. amp;author RE 20Abdulnour amp;author J 20Dalli amp;author JK 20Colby amp;author N 20Krishnamoorthy amp;author JY 20Timmons amp;volume 111 amp;publication_year 2014 amp;pages 16526-16531 amp;pmid 25369934 amp;doi 10.1073/pnas.1407123111 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R2\"   cite Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113 1118. doi: 10.1056/NEJMoa012918. /cite  [ a href \"https://doi.org/10.1056/NEJMoa012918\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/11948270/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal N 20Engl 20J 20Med amp;title Blood 20levels 20of 20long-chain 20n-3 20fatty 20acids 20and 20the 20risk 20of 20sudden 20death. amp;author CM 20Albert amp;author H 20Campos amp;author MJ 20Stampfer amp;author PM 20Ridker amp;author JE 20Manson amp;volume 346 amp;publication_year 2002 amp;pages 1113-1118 amp;pmid 11948270 amp;doi 10.1056/NEJMoa012918 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R3\"   cite Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochemical and biophysical research communications. 2008;367:509 515. doi: 10.1016/j.bbrc.2008.01.012. /cite  [ a href \"https://doi.org/10.1016/j.bbrc.2008.01.012\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18190790/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Biochemical 20and 20biophysical 20research 20communications amp;title Resolvin 20E1 20dampens 20airway 20inflammation 20and 20hyperresponsiveness 20in 20a 20murine 20model 20of 20asthma. amp;author H 20Aoki amp;author T 20Hisada amp;author T 20Ishizuka amp;author M 20Utsugi amp;author T 20Kawata amp;volume 367 amp;publication_year 2008 amp;pages 509-515 amp;pmid 18190790 amp;doi 10.1016/j.bbrc.2008.01.012 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R4\"   cite Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nature immunology. 2006;7:1209 1216. doi: 10.1038/ni1392. /cite  [ a href \"https://doi.org/10.1038/ni1392\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC1797066/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17013391/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20immunology amp;title Apoptotic 20neutrophils 20and 20T 20cells 20sequester 20chemokines 20during 20immune 20response 20resolution 20through 20modulation 20of 20CCR5 20expression. amp;author A 20Ariel amp;author G 20Fredman amp;author YP 20Sun amp;author A 20Kantarci amp;author TE 20Van 20Dyke amp;volume 7 amp;publication_year 2006 amp;pages 1209-1216 amp;pmid 17013391 amp;doi 10.1038/ni1392 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R5\"   cite Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, Gotlinger KH, Serhan CN. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. The Journal of biological chemistry. 2005;280:43079 43086. doi: 10.1074/jbc.M509796200. /cite  [ a href \"https://doi.org/10.1074/jbc.M509796200\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16216871/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title The 20docosatriene 20protectin 20D1 20is 20produced 20by 20TH2 20skewing 20and 20promotes 20human 20T 20cell 20apoptosis 20via 20lipid 20raft 20clustering. amp;author A 20Ariel amp;author PL 20Li amp;author W 20Wang amp;author WX 20Tang amp;author G 20Fredman amp;volume 280 amp;publication_year 2005 amp;pages 43079-43086 amp;pmid 16216871 amp;doi 10.1074/jbc.M509796200 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R6\"   cite Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. The Journal of experimental medicine. 2005a;201:713 722. doi: 10.1084/jem.20042031. /cite  [ a href \"https://doi.org/10.1084/jem.20042031\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2212834/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15753205/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Stereochemical 20assignment, 20antiinflammatory 20properties, 20and 20receptor 20for 20the 20omega-3 20lipid 20mediator 20resolvin 20E1. amp;author M 20Arita amp;author F 20Bianchini amp;author J 20Aliberti amp;author A 20Sher amp;author N 20Chiang amp;volume 201 amp;publication_year 2005a amp;pages 713-722 amp;pmid 15753205 amp;doi 10.1084/jem.20042031 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R7\"   cite Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Journal of immunology. 2007;178:3912 3917. doi: 10.4049/jimmunol.178.6.3912. /cite  [ a href \"https://doi.org/10.4049/jimmunol.178.6.3912\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17339491/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Resolvin 20E1 20selectively 20interacts 20with 20leukotriene 20B4 20receptor 20BLT1 20and 20ChemR23 20to 20regulate 20inflammation. amp;author M 20Arita amp;author T 20Ohira amp;author YP 20Sun amp;author S 20Elangovan amp;author N 20Chiang amp;volume 178 amp;publication_year 2007 amp;pages 3912-3917 amp;pmid 17339491 amp;doi 10.4049/jimmunol.178.6.3912 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R8\"   cite Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proceedings of the National Academy of Sciences of the United States of America. 2005b;102:7671 7676. doi: 10.1073/pnas.0409271102. /cite  [ a href \"https://doi.org/10.1073/pnas.0409271102\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC1103706/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15890784/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Resolvin 20E1, 20an 20endogenous 20lipid 20mediator 20derived 20from 20omega-3 20eicosapentaenoic 20acid, 20protects 20against 202,4,6-trinitrobenzene 20sulfonic 20acid-induced 20colitis. amp;author M 20Arita amp;author M 20Yoshida amp;author S 20Hong amp;author E 20Tjonahen amp;author JN 20Glickman amp;volume 102 amp;publication_year 2005b amp;pages 7671-7676 amp;pmid 15890784 amp;doi 10.1073/pnas.0409271102 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R9\"   cite Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. Journal of immunology. 2005;174:4345 4355. doi: 10.4049/jimmunol.174.7.4345. /cite  [ a href \"https://doi.org/10.4049/jimmunol.174.7.4345\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15778399/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Molecular 20circuits 20of 20resolution: 20formation 20and 20actions 20of 20resolvins 20and 20protectins. amp;author GL 20Bannenberg amp;author N 20Chiang amp;author A 20Ariel amp;author M 20Arita amp;author E 20Tjonahen amp;volume 174 amp;publication_year 2005 amp;pages 4345-4355 amp;pmid 15778399 amp;doi 10.4049/jimmunol.174.7.4345 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R10\"   cite Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Science translational medicine. 2013;5:174ra126. doi: 10.1126/scitranslmed.3004812. /cite  [ a href \"https://doi.org/10.1126/scitranslmed.3004812\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3823369/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23447017/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Science 20translational 20medicine amp;title Lipoxin 20A4 20regulates 20natural 20killer 20cell 20and 20type 202 20innate 20lymphoid 20cell 20activation 20in 20asthma. amp;author C 20Barnig amp;author M 20Cernadas amp;author S 20Dutile amp;author X 20Liu amp;author MA 20Perrella amp;volume 5 amp;publication_year 2013 amp;pages 174ra126 amp;pmid 23447017 amp;doi 10.1126/scitranslmed.3004812 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R11\"   cite Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res. 2003;44:2221 2233. doi: 10.1194/jlr.R300013-JLR200. /cite  [ a href \"https://doi.org/10.1194/jlr.R300013-JLR200\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/13130128/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal J 20Lipid 20Res amp;title Synaptic 20lipid 20signaling: 20significance 20of 20polyunsaturated 20fatty 20acids 20and 20platelet-activating 20factor. amp;author NG 20Bazan amp;volume 44 amp;publication_year 2003 amp;pages 2221-2233 amp;pmid 13130128 amp;doi 10.1194/jlr.R300013-JLR200 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R12\"   cite Bhavsar PK, Levy BD, Hew MJ, Pfeffer MA, Kazani S, Israel E, Chung KF. Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respiratory research. 2010;11:71. doi: 10.1186/1465-9921-11-71. /cite  [ a href \"https://doi.org/10.1186/1465-9921-11-71\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2894769/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20529300/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Respiratory 20research amp;title Corticosteroid 20suppression 20of 20lipoxin 20A4 20and 20leukotriene 20B4 20from 20alveolar 20macrophages 20in 20severe 20asthma. amp;author PK 20Bhavsar amp;author BD 20Levy amp;author MJ 20Hew amp;author MA 20Pfeffer amp;author S 20Kazani amp;volume 11 amp;publication_year 2010 amp;pages 71 amp;pmid 20529300 amp;doi 10.1186/1465-9921-11-71 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R13\"   cite Bohr S, Patel SJ, Sarin D, Irimia D, Yarmush ML, Berthiaume F. Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2013;21:35 43. doi: 10.1111/j.1524-475X.2012.00853.x. /cite  [ a href \"https://doi.org/10.1111/j.1524-475X.2012.00853.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3746505/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23110665/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Wound 20repair 20and 20regeneration 20: 20official 20publication 20of 20the 20Wound 20Healing 20Society 20 5Band 5D 20the 20European 20Tissue 20Repair 20Society amp;title Resolvin 20D2 20prevents 20secondary 20thrombosis 20and 20necrosis 20in 20a 20mouse 20burn 20wound 20model. amp;author S 20Bohr amp;author SJ 20Patel amp;author D 20Sarin amp;author D 20Irimia amp;author ML 20Yarmush amp;volume 21 amp;publication_year 2013 amp;pages 35-43 amp;pmid 23110665 amp;doi 10.1111/j.1524-475X.2012.00853.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R14\"   cite Bondue B, Vosters O, de Nadai P, Glineur S, De Henau O, Luangsay S, Van Gool F, Communi D, De Vuyst P, Desmecht D, Parmentier M. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS pathogens. 2011;7:e1002358. doi: 10.1371/journal.ppat.1002358. /cite  [ a href \"https://doi.org/10.1371/journal.ppat.1002358\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3207933/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22072972/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal PLoS 20pathogens amp;title ChemR23 20dampens 20lung 20inflammation 20and 20enhances 20anti-viral 20immunity 20in 20a 20mouse 20model 20of 20acute 20viral 20pneumonia. amp;author B 20Bondue amp;author O 20Vosters amp;author P 20de 20Nadai amp;author S 20Glineur amp;author O 20De 20Henau amp;volume 7 amp;publication_year 2011 amp;pages e1002358 amp;pmid 22072972 amp;doi 10.1371/journal.ppat.1002358 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R15\"   cite Bonnans C, Fukunaga K, Levy MA, Levy BD. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. The American journal of pathology. 2006;168:1064 1072. doi: 10.2353/ajpath.2006.051056. /cite  [ a href \"https://doi.org/10.2353/ajpath.2006.051056\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC1606555/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16565483/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20American 20journal 20of 20pathology amp;title Lipoxin 20A(4) 20regulates 20bronchial 20epithelial 20cell 20responses 20to 20acid 20injury. amp;author C 20Bonnans amp;author K 20Fukunaga amp;author MA 20Levy amp;author BD 20Levy amp;volume 168 amp;publication_year 2006 amp;pages 1064-1072 amp;pmid 16565483 amp;doi 10.2353/ajpath.2006.051056 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R16\"   cite Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, Merritt AS, Wark PA, Hutchinson A, Irving LB, Levy BD, Anderson GP. Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:935 940fff. doi: 10.1073/pnas.1109382109. /cite  [ a href \"https://doi.org/10.1073/pnas.1109382109\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3271884/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22215599/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Serum 20amyloid 20A 20opposes 20lipoxin 20A(4) 20to 20mediate 20glucocorticoid 20refractory 20lung 20inflammation 20in 20chronic 20obstructive 20pulmonary 20disease. amp;author S 20Bozinovski amp;author M 20Uddin amp;author R 20Vlahos amp;author M 20Thompson amp;author JL 20McQualter amp;volume 109 amp;publication_year 2012 amp;pages 935-940fff amp;pmid 22215599 amp;doi 10.1073/pnas.1109382109 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R17\"   cite Burr GB, MM A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 1929;82:345 367. doi: 10.1111/j.1753-4887.1973.tb06008.x. /cite  [ a href \"https://doi.org/10.1111/j.1753-4887.1973.tb06008.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/4586201/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal J. 20Biol. 20Chem amp;title A 20new 20deficiency 20disease 20produced 20by 20the 20rigid 20exclusion 20of 20fat 20from 20the 20diet. amp;author GB 20Burr amp;author  20MM amp;volume 82 amp;publication_year 1929 amp;pages 345-367 amp;pmid 4586201 amp;doi 10.1111/j.1753-4887.1973.tb06008.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R18\"   cite Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75:645 662. doi: 10.1111/j.1365-2125.2012.04374.x. /cite  [ a href \"https://doi.org/10.1111/j.1365-2125.2012.04374.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3575932/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22765297/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Br 20J 20Clin 20Pharmacol amp;title Omega-3 20polyunsaturated 20fatty 20acids 20and 20inflammatory 20processes: 20nutrition 20or 20pharmacology? amp;author PC 20Calder amp;volume 75 amp;publication_year 2013 amp;pages 645-662 amp;pmid 22765297 amp;doi 10.1111/j.1365-2125.2012.04374.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R19\"   cite Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan SP. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2007;21:3162 3170. doi: 10.1096/fj.07-8473com. /cite  [ a href \"https://doi.org/10.1096/fj.07-8473com\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17496159/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Resolvin 20E1 20promotes 20mucosal 20surface 20clearance 20of 20neutrophils: 20a 20new 20paradigm 20for 20inflammatory 20resolution. amp;author EL 20Campbell amp;author NA 20Louis amp;author SE 20Tomassetti amp;author GO 20Canny amp;author M 20Arita amp;volume 21 amp;publication_year 2007 amp;pages 3162-3170 amp;pmid 17496159 amp;doi 10.1096/fj.07-8473com amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R20\"   cite Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. The Journal of experimental medicine. 2008;205:767 775. doi: 10.1084/jem.20071601. /cite  [ a href \"https://doi.org/10.1084/jem.20071601\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2292217/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18391062/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Synthetic 20chemerin-derived 20peptides 20suppress 20inflammation 20through 20ChemR23. amp;author JL 20Cash amp;author R 20Hart amp;author A 20Russ amp;author JP 20Dixon amp;author WH 20Colledge amp;volume 205 amp;publication_year 2008 amp;pages 767-775 amp;pmid 18391062 amp;doi 10.1084/jem.20071601 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R21\"   cite Celik GE, Erkekol FO, Misirligil Z, Melli M. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2007;37:1494 1501. doi: 10.1111/j.1365-2222.2007.02806.x. /cite  [ a href \"https://doi.org/10.1111/j.1365-2222.2007.02806.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17883729/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Clinical 20and 20experimental 20allergy 20: 20journal 20of 20the 20British 20Society 20for 20Allergy 20and 20Clinical 20Immunology amp;title Lipoxin 20A4 20levels 20in 20asthma: 20relation 20with 20disease 20severity 20and 20aspirin 20sensitivity. amp;author GE 20Celik amp;author FO 20Erkekol amp;author Z 20Misirligil amp;author M 20Melli amp;volume 37 amp;publication_year 2007 amp;pages 1494-1501 amp;pmid 17883729 amp;doi 10.1111/j.1365-2222.2007.02806.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R22\"   cite Chiang N, Dalli J, Colas RA, Serhan CN. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. The Journal of experimental medicine. 2015;212:1203 1217. doi: 10.1084/jem.20150225. /cite  [ a href \"https://doi.org/10.1084/jem.20150225\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4516788/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/26195725/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Identification 20of 20resolvin 20D2 20receptor 20mediating 20resolution 20of 20infections 20and 20organ 20protection. amp;author N 20Chiang amp;author J 20Dalli amp;author RA 20Colas amp;author CN 20Serhan amp;volume 212 amp;publication_year 2015 amp;pages 1203-1217 amp;pmid 26195725 amp;doi 10.1084/jem.20150225 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R23\"   cite Chiang N, Fredman G, Backhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524 528. doi: 10.1038/nature11042. /cite  [ a href \"https://doi.org/10.1038/nature11042\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3340015/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22538616/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title Infection 20regulates 20pro-resolving 20mediators 20that 20lower 20antibiotic 20requirements. amp;author N 20Chiang amp;author G 20Fredman amp;author F 20Backhed amp;author SF 20Oh amp;author T 20Vickery amp;volume 484 amp;publication_year 2012 amp;pages 524-528 amp;pmid 22538616 amp;doi 10.1038/nature11042 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R24\"   cite Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacological reviews. 2006;58:463 487. doi: 10.1124/pr.58.3.4. /cite  [ a href \"https://doi.org/10.1124/pr.58.3.4\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16968948/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Pharmacological 20reviews amp;title The 20lipoxin 20receptor 20ALX: 20potent 20ligand-specific 20and 20stereoselective 20actions 20in 20vivo. amp;author N 20Chiang amp;author CN 20Serhan amp;author SE 20Dahlen amp;author JM 20Drazen amp;author DW 20Hay amp;volume 58 amp;publication_year 2006 amp;pages 463-487 amp;pmid 16968948 amp;doi 10.1124/pr.58.3.4 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R25\"   cite Chiang N, Takano T, Arita M, Watanabe S, Serhan CN. A novel rat lipoxin A4 receptor that is conserved in structure and function. British journal of pharmacology. 2003;139:89 98. doi: 10.1038/sj.bjp.0705220. /cite  [ a href \"https://doi.org/10.1038/sj.bjp.0705220\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC1573822/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/12746227/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal British 20journal 20of 20pharmacology amp;title A 20novel 20rat 20lipoxin 20A4 20receptor 20that 20is 20conserved 20in 20structure 20and 20function. amp;author N 20Chiang amp;author T 20Takano amp;author M 20Arita amp;author S 20Watanabe amp;author CN 20Serhan amp;volume 139 amp;publication_year 2003 amp;pages 89-98 amp;pmid 12746227 amp;doi 10.1038/sj.bjp.0705220 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R26\"   cite Chiron R, Grumbach YY, Quynh NV, Verriere V, Urbach V. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2008;7:463 468. doi: 10.1016/j.jcf.2008.04.002. /cite  [ a href \"https://doi.org/10.1016/j.jcf.2008.04.002\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18541460/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20cystic 20fibrosis 20: 20official 20journal 20of 20the 20European 20Cystic 20Fibrosis 20Society amp;title Lipoxin 20A(4) 20and 20interleukin-8 20levels 20in 20cystic 20fibrosis 20sputum 20after 20antibiotherapy. amp;author R 20Chiron amp;author YY 20Grumbach amp;author NV 20Quynh amp;author V 20Verriere amp;author V 20Urbach amp;volume 7 amp;publication_year 2008 amp;pages 463-468 amp;pmid 18541460 amp;doi 10.1016/j.jcf.2008.04.002 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R27\"   cite Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. American journal of physiology. Cell physiology. 2014;307:C39 54. doi: 10.1152/ajpcell.00024.2014. /cite  [ a href \"https://doi.org/10.1152/ajpcell.00024.2014\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4080182/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/24696140/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Cell 20physiology amp;title Identification 20and 20signature 20profiles 20for 20pro-resolving 20and 20inflammatory 20lipid 20mediators 20in 20human 20tissue. 20American 20journal 20of 20physiology. amp;author RA 20Colas amp;author M 20Shinohara amp;author J 20Dalli amp;author N 20Chiang amp;author CN 20Serhan amp;volume 307 amp;publication_year 2014 amp;pages C39-54 amp;pmid 24696140 amp;doi 10.1152/ajpcell.00024.2014 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R28\"   cite Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N, Jr., Serhan CN, Smith LE. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature medicine. 2007;13:868 873. doi: 10.1038/nm1591. /cite  [ a href \"https://doi.org/10.1038/nm1591\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4491412/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17589522/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20medicine amp;title Increased 20dietary 20intake 20of 20omega-3-polyunsaturated 20fatty 20acids 20reduces 20pathological 20retinal 20angiogenesis. amp;author KM 20Connor amp;author JP 20SanGiovanni amp;author C 20Lofqvist amp;author CM 20Aderman amp;author J 20Chen amp;volume 13 amp;publication_year 2007 amp;pages 868-873 amp;pmid 17589522 amp;doi 10.1038/nm1591 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R29\"   cite Cotran RVK, Collins T. Robbins Pathologic Basis of Disease. Saunders; Philadelphia: 2009.  /cite  [ a href \"https://scholar.google.com/scholar_lookup?title Robbins 20Pathologic 20Basis 20of 20Disease amp;author RVK 20Cotran amp;author T 20Collins amp;publication_year 2009 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R30\"   cite Crawford MA, Broadhurst CL, Guest M, Nagar A, Wang Y, Ghebremeskel K, Schmidt WF. A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution. Prostaglandins, leukotrienes, and essential fatty acids. 2013;88:5 13. doi: 10.1016/j.plefa.2012.08.005. /cite  [ a href \"https://doi.org/10.1016/j.plefa.2012.08.005\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23206328/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Prostaglandins, 20leukotrienes, 20and 20essential 20fatty 20acids amp;title A 20quantum 20theory 20for 20the 20irreplaceable 20role 20of 20docosahexaenoic 20acid 20in 20neural 20cell 20signalling 20throughout 20evolution. amp;author MA 20Crawford amp;author CL 20Broadhurst amp;author M 20Guest amp;author A 20Nagar amp;author Y 20Wang amp;volume 88 amp;publication_year 2013 amp;pages 5-13 amp;pmid 23206328 amp;doi 10.1016/j.plefa.2012.08.005 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R31\"   cite Dalli J, Chiang N, Serhan CN. Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:E4753 4761. doi: 10.1073/pnas.1415006111. /cite  [ a href \"https://doi.org/10.1073/pnas.1415006111\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4226123/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/25324525/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Identification 20of 2014-series 20sulfido-conjugated 20mediators 20that 20promote 20resolution 20of 20infection 20and 20organ 20protection. amp;author J 20Dalli amp;author N 20Chiang amp;author CN 20Serhan amp;volume 111 amp;publication_year 2014 amp;pages E4753-4761 amp;pmid 25324525 amp;doi 10.1073/pnas.1415006111 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R32\"   cite Dalli J, Ramon S, Norris PC, Colas RA, Serhan CN. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2015;29:2120 2136. doi: 10.1096/fj.14-268441. /cite  [ a href \"https://doi.org/10.1096/fj.14-268441\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4415017/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/25713027/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Novel 20proresolving 20and 20tissue-regenerative 20resolvin 20and 20protectin 20sulfido-conjugated 20pathways. amp;author J 20Dalli amp;author S 20Ramon amp;author PC 20Norris amp;author RA 20Colas amp;author CN 20Serhan amp;volume 29 amp;publication_year 2015 amp;pages 2120-2136 amp;pmid 25713027 amp;doi 10.1096/fj.14-268441 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R33\"   cite Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, Petasis NA, Serhan CN. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chemistry  amp; biology. 2013a;20:188 201. doi: 10.1016/j.chembiol.2012.11.010. /cite  [ a href \"https://doi.org/10.1016/j.chembiol.2012.11.010\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3583372/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23438748/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Chemistry 20 amp; 20biology amp;title Resolvin 20D3 20and 20aspirin-triggered 20resolvin 20D3 20are 20potent 20immunoresolvents. amp;author J 20Dalli amp;author JW 20Winkler amp;author RA 20Colas amp;author H 20Arnardottir amp;author CY 20Cheng amp;volume 20 amp;publication_year 2013a amp;pages 188-201 amp;pmid 23438748 amp;doi 10.1016/j.chembiol.2012.11.010 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R34\"   cite Dalli J, Zhu M, Vlasenko NA, Deng B, Haeggstrom JZ, Petasis NA, Serhan CN. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2013b;27:2573 2583. doi: 10.1096/fj.13-227728. /cite  [ a href \"https://doi.org/10.1096/fj.13-227728\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3688739/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23504711/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title The 20novel 2013S,14S-epoxy-maresin 20is 20converted 20by 20human 20macrophages 20to 20maresin 201 20(MaR1), 20inhibits 20leukotriene 20A4 20hydrolase 20(LTA4H), 20and 20shifts 20macrophage 20phenotype. amp;author J 20Dalli amp;author M 20Zhu amp;author NA 20Vlasenko amp;author B 20Deng amp;author JZ 20Haeggstrom amp;volume 27 amp;publication_year 2013b amp;pages 2573-2583 amp;pmid 23504711 amp;doi 10.1096/fj.13-227728 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R35\"   cite De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364:2439 2450. doi: 10.1056/NEJMra1008153. /cite  [ a href \"https://doi.org/10.1056/NEJMra1008153\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21696310/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal N 20Engl 20J 20Med amp;title n-3 20fatty 20acids 20in 20cardiovascular 20disease. amp;author R 20De 20Caterina amp;volume 364 amp;publication_year 2011 amp;pages 2439-2450 amp;pmid 21696310 amp;doi 10.1056/NEJMra1008153 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R36\"   cite Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 2008;112:848 855. doi: 10.1182/blood-2007-11-122598. /cite  [ a href \"https://doi.org/10.1182/blood-2007-11-122598\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2481548/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18480426/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Blood amp;title Resolvin 20E1, 20an 20EPA-derived 20mediator 20in 20whole 20blood, 20selectively 20counterregulates 20leukocytes 20and 20platelets. amp;author M 20Dona amp;author G 20Fredman amp;author JM 20Schwab amp;author N 20Chiang amp;author M 20Arita amp;volume 112 amp;publication_year 2008 amp;pages 848-855 amp;pmid 18480426 amp;doi 10.1182/blood-2007-11-122598 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R37\"   cite Du XY, Leung LL. Proteolytic regulatory mechanism of chemerin bioactivity. Acta biochimica et biophysica Sinica. 2009;41:973 979. doi: 10.1093/abbs/gmp091. /cite  [ a href \"https://doi.org/10.1093/abbs/gmp091\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2788413/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20011981/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Acta 20biochimica 20et 20biophysica 20Sinica amp;title Proteolytic 20regulatory 20mechanism 20of 20chemerin 20bioactivity. amp;author XY 20Du amp;author LL 20Leung amp;volume 41 amp;publication_year 2009 amp;pages 973-979 amp;pmid 20011981 amp;doi 10.1093/abbs/gmp091 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R38\"   cite Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal immunology. 2013;6:256 266. doi: 10.1038/mi.2012.66. /cite  [ a href \"https://doi.org/10.1038/mi.2012.66\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3511650/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22785226/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Mucosal 20immunology amp;title Aspirin-triggered 20resolvin 20D1 20reduces 20mucosal 20inflammation 20and 20promotes 20resolution 20in 20a 20murine 20model 20of 20acute 20lung 20injury. amp;author O 20Eickmeier amp;author H 20Seki amp;author O 20Haworth amp;author JN 20Hilberath amp;author F 20Gao amp;volume 6 amp;publication_year 2013 amp;pages 256-266 amp;pmid 22785226 amp;doi 10.1038/mi.2012.66 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R39\"   cite Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. The Journal of experimental medicine. 1994;180:253 260. doi: 10.1084/jem.180.1.253. /cite  [ a href \"https://doi.org/10.1084/jem.180.1.253\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2191537/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/8006586/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Identification 20of 20a 20human 20cDNA 20encoding 20a 20functional 20high 20affinity 20lipoxin 20A4 20receptor. amp;author S 20Fiore amp;author JF 20Maddox amp;author HD 20Perez amp;author CN 20Serhan amp;volume 180 amp;publication_year 1994 amp;pages 253-260 amp;pmid 8006586 amp;doi 10.1084/jem.180.1.253 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R40\"   cite Flesher RP, Herbert C, Kumar RK. Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma. Clin Sci (Lond) 2014;126:805 814. doi: 10.1042/CS20130623. /cite  [ a href \"https://doi.org/10.1042/CS20130623\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/24344649/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Clin 20Sci 20(Lond) amp;title Resolvin 20E1 20promotes 20resolution 20of 20inflammation 20in 20a 20mouse 20model 20of 20an 20acute 20exacerbation 20of 20allergic 20asthma. amp;author RP 20Flesher amp;author C 20Herbert amp;author RK 20Kumar amp;volume 126 amp;publication_year 2014 amp;pages 805-814 amp;pmid 24344649 amp;doi 10.1042/CS20130623 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R41\"   cite Frediani JK, Jones DP, Tukvadze N, Uppal K, Sanikidze E, Kipiani M, Tran VT, Hebbar G, Walker DI, Kempker RR, Kurani SS, Colas RA, Dalli J, Tangpricha V, Serhan CN, Blumberg HM, Ziegler TR. Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study. PloS one. 2014;9:e108854. doi: 10.1371/journal.pone.0108854. /cite  [ a href \"https://doi.org/10.1371/journal.pone.0108854\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4198093/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/25329995/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal PloS 20one amp;title Plasma 20metabolomics 20in 20human 20pulmonary 20tuberculosis 20disease: 20a 20pilot 20study. amp;author JK 20Frediani amp;author DP 20Jones amp;author N 20Tukvadze amp;author K 20Uppal amp;author E 20Sanikidze amp;volume 9 amp;publication_year 2014 amp;pages e108854 amp;pmid 25329995 amp;doi 10.1371/journal.pone.0108854 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R42\"   cite Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004;350:560 569. doi: 10.1056/NEJMoa021218. /cite  [ a href \"https://doi.org/10.1056/NEJMoa021218\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/14762183/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal N 20Engl 20J 20Med amp;title Association 20of 20cystic 20fibrosis 20with 20abnormalities 20in 20fatty 20acid 20metabolism. amp;author SD 20Freedman amp;author PG 20Blanco amp;author MM 20Zaman amp;author JC 20Shea amp;author M 20Ollero amp;volume 350 amp;publication_year 2004 amp;pages 560-569 amp;pmid 14762183 amp;doi 10.1056/NEJMoa021218 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R43\"   cite Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. The Journal of biological chemistry. 2006;281:38376 38384. doi: 10.1074/jbc.M605146200. /cite  [ a href \"https://doi.org/10.1074/jbc.M605146200\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17056601/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title Apoptotic 20cells, 20through 20transforming 20growth 20factor-beta, 20coordinately 20induce 20anti-inflammatory 20and 20suppress 20pro-inflammatory 20eicosanoid 20and 20NO 20synthesis 20in 20murine 20macrophages. amp;author CG 20Freire-de-Lima amp;author YQ 20Xiao amp;author SJ 20Gardai amp;author DL 20Bratton amp;author WP 20Schiemann amp;volume 281 amp;publication_year 2006 amp;pages 38376-38384 amp;pmid 17056601 amp;doi 10.1074/jbc.M605146200 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R44\"   cite Fritscher LG, Post M, Rodrigues MT, Silverman F, Balter M, Chapman KR, Zamel N. Profile of eicosanoids in breath condensate in asthma and COPD. Journal of breath research. 2012;6:026001. doi: 10.1088/1752-7155/6/2/026001. /cite  [ a href \"https://doi.org/10.1088/1752-7155/6/2/026001\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22451217/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20breath 20research amp;title Profile 20of 20eicosanoids 20in 20breath 20condensate 20in 20asthma 20and 20COPD. amp;author LG 20Fritscher amp;author M 20Post amp;author MT 20Rodrigues amp;author F 20Silverman amp;author M 20Balter amp;volume 6 amp;publication_year 2012 amp;pages 026001 amp;pmid 22451217 amp;doi 10.1088/1752-7155/6/2/026001 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R45\"   cite Giera M, Ioan-Facsinay A, Toes R, Gao F, Dalli J, Deelder AM, Serhan CN, Mayboroda OA. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochimica et biophysica acta. 2012;1821:1415 1424. doi: 10.1016/j.bbalip.2012.07.011. /cite  [ a href \"https://doi.org/10.1016/j.bbalip.2012.07.011\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3433634/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22841830/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Biochimica 20et 20biophysica 20acta amp;title Lipid 20and 20lipid 20mediator 20profiling 20of 20human 20synovial 20fluid 20in 20rheumatoid 20arthritis 20patients 20by 20means 20of 20LC-MS/MS. amp;author M 20Giera amp;author A 20Ioan-Facsinay amp;author R 20Toes amp;author F 20Gao amp;author J 20Dalli amp;volume 1821 amp;publication_year 2012 amp;pages 1415-1424 amp;pmid 22841830 amp;doi 10.1016/j.bbalip.2012.07.011 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R46\"   cite Gong J, Rosner B, Rees DG, Berson EL, Weigel-DiFranco CA, Schaefer EJ. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1992;33:2596 2602. /cite  [ a href \"https://pubmed.ncbi.nlm.nih.gov/1386350/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Invest 20Ophthalmol 20Vis 20Sci amp;title Plasma 20docosahexaenoic 20acid 20levels 20in 20various 20genetic 20forms 20of 20retinitis 20pigmentosa. amp;author J 20Gong amp;author B 20Rosner amp;author DG 20Rees amp;author EL 20Berson amp;author CA 20Weigel-DiFranco amp;volume 33 amp;publication_year 1992 amp;pages 2596-2602 amp;pmid 1386350 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R47\"   cite Hasan RA, O'Brien E, Mancuso P. Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2012;13:141 145. doi: 10.1097/PCC.0b013e3182231644. /cite  [ a href \"https://doi.org/10.1097/PCC.0b013e3182231644\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4078922/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21666533/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Pediatric 20critical 20care 20medicine 20: 20a 20journal 20of 20the 20Society 20of 20Critical 20Care 20Medicine 20and 20the 20World 20Federation 20of 20Pediatric 20Intensive 20and 20Critical 20Care 20Societies amp;title Lipoxin 20A(4) 20and 208-isoprostane 20in 20the 20exhaled 20breath 20condensate 20of 20children 20hospitalized 20for 20status 20asthmaticus. amp;author RA 20Hasan amp;author E 20O'Brien amp;author P 20Mancuso amp;volume 13 amp;publication_year 2012 amp;pages 141-145 amp;pmid 21666533 amp;doi 10.1097/PCC.0b013e3182231644 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R48\"   cite Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. Journal of immunology. 2011;186:6129 6135. doi: 10.4049/jimmunol.1004007. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1004007\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3823382/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21515793/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title NK 20cells 20are 20effectors 20for 20resolvin 20E1 20in 20the 20timely 20resolution 20of 20allergic 20airway 20inflammation. amp;author O 20Haworth amp;author M 20Cernadas amp;author BD 20Levy amp;volume 186 amp;publication_year 2011 amp;pages 6129-6135 amp;pmid 21515793 amp;doi 10.4049/jimmunol.1004007 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R49\"   cite Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nature immunology. 2008;9:873 879. doi: 10.1038/ni.1627. /cite  [ a href \"https://doi.org/10.1038/ni.1627\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2784998/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18568027/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20immunology amp;title Resolvin 20E1 20regulates 20interleukin 2023, 20interferon-gamma 20and 20lipoxin 20A4 20to 20promote 20the 20resolution 20of 20allergic 20airway 20inflammation. amp;author O 20Haworth amp;author M 20Cernadas amp;author R 20Yang amp;author CN 20Serhan amp;author BD 20Levy amp;volume 9 amp;publication_year 2008 amp;pages 873-879 amp;pmid 18568027 amp;doi 10.1038/ni.1627 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R50\"   cite Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. The American journal of pathology. 2010;177:2116 2123. doi: 10.2353/ajpath.2010.091082. /cite  [ a href \"https://doi.org/10.2353/ajpath.2010.091082\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2947304/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20709806/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20American 20journal 20of 20pathology amp;title Aspirin-triggered 20lipoxin 20and 20resolvin 20E1 20modulate 20vascular 20smooth 20muscle 20phenotype 20and 20correlate 20with 20peripheral 20atherosclerosis. amp;author KJ 20Ho amp;author M 20Spite amp;author CD 20Owens amp;author H 20Lancero amp;author AH 20Kroemer amp;volume 177 amp;publication_year 2010 amp;pages 2116-2123 amp;pmid 20709806 amp;doi 10.2353/ajpath.2010.091082 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R51\"   cite Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. The Journal of biological chemistry. 2003;278:14677 14687. doi: 10.1074/jbc.M300218200. /cite  [ a href \"https://doi.org/10.1074/jbc.M300218200\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/12590139/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title Novel 20docosatrienes 20and 2017S-resolvins 20generated 20from 20docosahexaenoic 20acid 20in 20murine 20brain, 20human 20blood, 20and 20glial 20cells. 20Autacoids 20in 20anti-inflammation. amp;author S 20Hong amp;author K 20Gronert amp;author PR 20Devchand amp;author RL 20Moussignac amp;author CN 20Serhan amp;volume 278 amp;publication_year 2003 amp;pages 14677-14687 amp;pmid 12590139 amp;doi 10.1074/jbc.M300218200 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R52\"   cite Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PloS one. 2013;8:e58258. doi: 10.1371/journal.pone.0058258. /cite  [ a href \"https://doi.org/10.1371/journal.pone.0058258\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3590122/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23484005/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal PloS 20one amp;title A 20novel 20anti-inflammatory 20and 20pro-resolving 20role 20for 20resolvin 20D1 20in 20acute 20cigarette 20smoke-induced 20lung 20inflammation. amp;author HM 20Hsiao amp;author RE 20Sapinoro amp;author TH 20Thatcher amp;author A 20Croasdell amp;author EP 20Levy amp;volume 8 amp;publication_year 2013 amp;pages e58258 amp;pmid 23484005 amp;doi 10.1371/journal.pone.0058258 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R53\"   cite Iigo M, Nakagawa T, Ishikawa C, Iwahori Y, Asamoto M, Yazawa K, Araki E, Tsuda H. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer. 1997;75:650 655. doi: 10.1038/bjc.1997.116. /cite  [ a href \"https://doi.org/10.1038/bjc.1997.116\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2063338/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/9043019/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Br 20J 20Cancer amp;title Inhibitory 20effects 20of 20docosahexaenoic 20acid 20on 20colon 20carcinoma 2026 20metastasis 20to 20the 20lung. amp;author M 20Iigo amp;author T 20Nakagawa amp;author C 20Ishikawa amp;author Y 20Iwahori amp;author M 20Asamoto amp;volume 75 amp;publication_year 1997 amp;pages 650-655 amp;pmid 9043019 amp;doi 10.1038/bjc.1997.116 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R54\"   cite Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kutsumi H, Inokuchi H, Serhan CN, Blumberg RS, Azuma T. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflammatory bowel diseases. 2010;16:87 95. doi: 10.1002/ibd.21029. /cite  [ a href \"https://doi.org/10.1002/ibd.21029\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3070396/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19572372/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Inflammatory 20bowel 20diseases amp;title Resolvin 20E1, 20an 20endogenous 20lipid 20mediator 20derived 20from 20eicosapentaenoic 20acid, 20prevents 20dextran 20sulfate 20sodium-induced 20colitis. amp;author T 20Ishida amp;author M 20Yoshida amp;author M 20Arita amp;author Y 20Nishitani amp;author S 20Nishiumi amp;volume 16 amp;publication_year 2010 amp;pages 87-95 amp;pmid 19572372 amp;doi 10.1002/ibd.21029 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R55\"   cite Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D, Inoue M, Arai H. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. The Journal of biological chemistry. 2012;287:10525 10534. doi: 10.1074/jbc.M112.340612. /cite  [ a href \"https://doi.org/10.1074/jbc.M112.340612\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3322993/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22275352/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title Identification 20and 20structure 20determination 20of 20novel 20anti-inflammatory 20mediator 20resolvin 20E3, 2017,18-dihydroxyeicosapentaenoic 20acid. amp;author Y 20Isobe amp;author M 20Arita amp;author S 20Matsueda amp;author R 20Iwamoto amp;author T 20Fujihara amp;volume 287 amp;publication_year 2012 amp;pages 10525-10534 amp;pmid 22275352 amp;doi 10.1074/jbc.M112.340612 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R56\"   cite Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, Petasis NA. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nature immunology. 2004;5:388 392. doi: 10.1038/ni1056. /cite  [ a href \"https://doi.org/10.1038/ni1056\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15034576/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20immunology amp;title Defective 20lipoxin-mediated 20anti-inflammatory 20activity 20in 20the 20cystic 20fibrosis 20airway. amp;author CL 20Karp amp;author LM 20Flick amp;author KW 20Park amp;author S 20Softic amp;author TM 20Greer amp;volume 5 amp;publication_year 2004 amp;pages 388-392 amp;pmid 15034576 amp;doi 10.1038/ni1056 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R57\"   cite Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, Toner M, Serhan CN. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. Journal of immunology. 2008;181:8677 8687. doi: 10.4049/jimmunol.181.12.8677. /cite  [ a href \"https://doi.org/10.4049/jimmunol.181.12.8677\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2664686/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19050288/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Rapid 20appearance 20of 20resolvin 20precursors 20in 20inflammatory 20exudates: 20novel 20mechanisms 20in 20resolution. amp;author K 20Kasuga amp;author R 20Yang amp;author TF 20Porter amp;author N 20Agrawal amp;author NA 20Petasis amp;volume 181 amp;publication_year 2008 amp;pages 8677-8687 amp;pmid 19050288 amp;doi 10.4049/jimmunol.181.12.8677 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R58\"   cite Kazani S, Planaguma A, Ono E, Bonini M, Zahid M, Marigowda G, Wechsler ME, Levy BD, Israel E. Exhaled breath condensate eicosanoid levels associate with asthma and its severity. The Journal of allergy and clinical immunology. 2013;132:547 553. doi: 10.1016/j.jaci.2013.01.058. /cite  [ a href \"https://doi.org/10.1016/j.jaci.2013.01.058\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3759610/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23608729/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20allergy 20and 20clinical 20immunology amp;title Exhaled 20breath 20condensate 20eicosanoid 20levels 20associate 20with 20asthma 20and 20its 20severity. amp;author S 20Kazani amp;author A 20Planaguma amp;author E 20Ono amp;author M 20Bonini amp;author M 20Zahid amp;volume 132 amp;publication_year 2013 amp;pages 547-553 amp;pmid 23608729 amp;doi 10.1016/j.jaci.2013.01.058 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R59\"   cite Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004;79:674 681. doi: 10.1093/ajcn/79.4.674. /cite  [ a href \"https://doi.org/10.1093/ajcn/79.4.674\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15051614/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Am 20J 20Clin 20Nutr amp;title Effects 20of 20oils 20rich 20in 20eicosapentaenoic 20and 20docosahexaenoic 20acids 20on 20immune 20cell 20composition 20and 20function 20in 20healthy 20humans. amp;author S 20Kew amp;author MD 20Mesa amp;author S 20Tricon amp;author R 20Buckley amp;author AM 20Minihane amp;volume 79 amp;publication_year 2004 amp;pages 674-681 amp;pmid 15051614 amp;doi 10.1093/ajcn/79.4.674 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R60\"   cite Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, Birnbaum Y. Resolvin E1 protects the rat heart against reperfusion injury. American journal of physiology. Heart and circulatory physiology. 2010;299:H153 164. doi: 10.1152/ajpheart.01057.2009. /cite  [ a href \"https://doi.org/10.1152/ajpheart.01057.2009\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20435846/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Heart 20and 20circulatory 20physiology amp;title Resolvin 20E1 20protects 20the 20rat 20heart 20against 20reperfusion 20injury. 20American 20journal 20of 20physiology. amp;author KT 20Keyes amp;author Y 20Ye amp;author Y 20Lin amp;author C 20Zhang amp;author JR 20Perez-Polo amp;volume 299 amp;publication_year 2010 amp;pages H153-164 amp;pmid 20435846 amp;doi 10.1152/ajpheart.01057.2009 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R61\"   cite Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis and rheumatism. 2005;52:3783 3791. doi: 10.1002/art.21432. /cite  [ a href \"https://doi.org/10.1002/art.21432\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16320329/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Arthritis 20and 20rheumatism amp;title Cyclooxygenase- 20and 20lipoxygenase-derived 20eicosanoids 20in 20bronchoalveolar 20lavage 20fluid 20from 20patients 20with 20scleroderma 20lung 20disease: 20an 20imbalance 20between 20proinflammatory 20and 20antiinflammatory 20lipid 20mediators. amp;author O 20Kowal-Bielecka amp;author K 20Kowal amp;author O 20Distler amp;author J 20Rojewska amp;author A 20Bodzenta-Lukaszyk amp;volume 52 amp;publication_year 2005 amp;pages 3783-3791 amp;pmid 16320329 amp;doi 10.1002/art.21432 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R62\"   cite Krishnamoorthy N, Burkett PR, Dalli J, Abdulnour RE, Colas R, Ramon S, Phipps RP, Petasis NA, Kuchroo VK, Serhan CN, Levy BD. Cutting Edge: Maresin-1 Engages Regulatory T Cells To Limit Type 2 Innate Lymphoid Cell Activation and Promote Resolution of Lung Inflammation. Journal of immunology. 2014 doi: 10.4049/jimmunol.1402534. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1402534\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4297713/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/25539814/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Cutting 20Edge: 20Maresin-1 20Engages 20Regulatory 20T 20Cells 20To 20Limit 20Type 202 20Innate 20Lymphoid 20Cell 20Activation 20and 20Promote 20Resolution 20of 20Lung 20Inflammation. amp;author N 20Krishnamoorthy amp;author PR 20Burkett amp;author J 20Dalli amp;author RE 20Abdulnour amp;author R 20Colas amp;publication_year 2014 amp;pmid 25539814 amp;doi 10.4049/jimmunol.1402534 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R63\"   cite Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. The American journal of pathology. 2012;180:2018 2027. doi: 10.1016/j.ajpath.2012.01.028. /cite  [ a href \"https://doi.org/10.1016/j.ajpath.2012.01.028\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3349829/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22449948/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20American 20journal 20of 20pathology amp;title Resolvin 20D1 20receptor 20stereoselectivity 20and 20regulation 20of 20inflammation 20and 20proresolving 20microRNAs. amp;author S 20Krishnamoorthy amp;author A 20Recchiuti amp;author N 20Chiang amp;author G 20Fredman amp;author CN 20Serhan amp;volume 180 amp;publication_year 2012 amp;pages 2018-2027 amp;pmid 22449948 amp;doi 10.1016/j.ajpath.2012.01.028 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R64\"   cite Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:1660 1665. doi: 10.1073/pnas.0907342107. /cite  [ a href \"https://doi.org/10.1073/pnas.0907342107\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2824371/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20080636/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Resolvin 20D1 20binds 20human 20phagocytes 20with 20evidence 20for 20proresolving 20receptors. amp;author S 20Krishnamoorthy amp;author A 20Recchiuti amp;author N 20Chiang amp;author S 20Yacoubian amp;author CH 20Lee amp;volume 107 amp;publication_year 2010 amp;pages 1660-1665 amp;pmid 20080636 amp;doi 10.1073/pnas.0907342107 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R65\"   cite Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, Tompkins RG, Fagan SP, Irimia D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2013;27:2270 2281. doi: 10.1096/fj.12-219519. /cite  [ a href \"https://doi.org/10.1096/fj.12-219519\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3659356/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23430978/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Resolvin 20D2 20restores 20neutrophil 20directionality 20and 20improves 20survival 20after 20burns. amp;author T 20Kurihara amp;author CN 20Jones amp;author YM 20Yu amp;author AJ 20Fischman amp;author S 20Watada amp;volume 27 amp;publication_year 2013 amp;pages 2270-2281 amp;pmid 23430978 amp;doi 10.1096/fj.12-219519 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R66\"   cite Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E, Severe Asthma Research Program, N.H.L., Blood, I. Diminished lipoxin biosynthesis in severe asthma. American journal of respiratory and critical care medicine. 2005;172:824 830. doi: 10.1164/rccm.200410-1413OC. /cite  [ a href \"https://doi.org/10.1164/rccm.200410-1413OC\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2718403/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15961693/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal American 20journal 20of 20respiratory 20and 20critical 20care 20medicine amp;title Diminished 20lipoxin 20biosynthesis 20in 20severe 20asthma. amp;author BD 20Levy amp;author C 20Bonnans amp;author ES 20Silverman amp;author LJ 20Palmer amp;author G 20Marigowda amp;volume 172 amp;publication_year 2005 amp;pages 824-830 amp;pmid 15961693 amp;doi 10.1164/rccm.200410-1413OC amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R67\"   cite Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nature immunology. 2001;2:612 619. doi: 10.1038/89759. /cite  [ a href \"https://doi.org/10.1038/89759\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/11429545/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20immunology amp;title Lipid 20mediator 20class 20switching 20during 20acute 20inflammation: 20signals 20in 20resolution. amp;author BD 20Levy amp;author CB 20Clish amp;author B 20Schmidt amp;author K 20Gronert amp;author CN 20Serhan amp;volume 2 amp;publication_year 2001 amp;pages 612-619 amp;pmid 11429545 amp;doi 10.1038/89759 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R68\"   cite Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S, Israel E, Haley KJ, Serhan CN. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. Journal of immunology. 2007;178:496 502. doi: 10.4049/jimmunol.178.1.496. /cite  [ a href \"https://doi.org/10.4049/jimmunol.178.1.496\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3005704/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17182589/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Protectin 20D1 20is 20generated 20in 20asthma 20and 20dampens 20airway 20inflammation 20and 20hyperresponsiveness. amp;author BD 20Levy amp;author P 20Kohli amp;author K 20Gotlinger amp;author O 20Haworth amp;author S 20Hong amp;volume 178 amp;publication_year 2007 amp;pages 496-502 amp;pmid 17182589 amp;doi 10.4049/jimmunol.178.1.496 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R69\"   cite Levy BD, Vachier I, Serhan CN. Resolution of inflammation in asthma. Clinics in chest medicine. 2012;33:559 570. doi: 10.1016/j.ccm.2012.06.006. /cite  [ a href \"https://doi.org/10.1016/j.ccm.2012.06.006\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3431599/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22929102/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Clinics 20in 20chest 20medicine amp;title Resolution 20of 20inflammation 20in 20asthma. amp;author BD 20Levy amp;author I 20Vachier amp;author CN 20Serhan amp;volume 33 amp;publication_year 2012 amp;pages 559-570 amp;pmid 22929102 amp;doi 10.1016/j.ccm.2012.06.006 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R70\"   cite Levy BD, Zhang QY, Bonnans C, Primo V, Reilly JJ, Perkins DL, Liang Y, Amin Arnaout M, Nikolic B, Serhan CN. The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins, leukotrienes, and essential fatty acids. 2011;84:43 50. doi: 10.1016/j.plefa.2010.09.002. /cite  [ a href \"https://doi.org/10.1016/j.plefa.2010.09.002\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3019284/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20869861/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Prostaglandins, 20leukotrienes, 20and 20essential 20fatty 20acids amp;title The 20endogenous 20pro-resolving 20mediators 20lipoxin 20A4 20and 20resolvin 20E1 20preserve 20organ 20function 20in 20allograft 20rejection. amp;author BD 20Levy amp;author QY 20Zhang amp;author C 20Bonnans amp;author V 20Primo amp;author JJ 20Reilly amp;volume 84 amp;publication_year 2011 amp;pages 43-50 amp;pmid 20869861 amp;doi 10.1016/j.plefa.2010.09.002 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R71\"   cite Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. The Journal of biological chemistry. 1997;272:6972 6978. doi: 10.1074/jbc.272.11.6972. /cite  [ a href \"https://doi.org/10.1074/jbc.272.11.6972\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/9054386/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title Lipoxin 20A4 20stable 20analogs 20are 20potent 20mimetics 20that 20stimulate 20human 20monocytes 20and 20THP-1 20cells 20via 20a 20G-protein-linked 20lipoxin 20A4 20receptor. amp;author JF 20Maddox amp;author M 20Hachicha amp;author T 20Takano amp;author NA 20Petasis amp;author VV 20Fokin amp;volume 272 amp;publication_year 1997 amp;pages 6972-6978 amp;pmid 9054386 amp;doi 10.1074/jbc.272.11.6972 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R72\"   cite Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, Sheets K, Winkler JW, Petasis NA, Serhan CN, Bazan NG. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins, leukotrienes, and essential fatty acids. 2010;82:27 34. doi: 10.1016/j.plefa.2009.10.010. /cite  [ a href \"https://doi.org/10.1016/j.plefa.2009.10.010\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2822836/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19931440/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Prostaglandins, 20leukotrienes, 20and 20essential 20fatty 20acids amp;title Neuroprotectin 20D1/protectin 20D1 20stereoselective 20and 20specific 20binding 20with 20human 20retinal 20pigment 20epithelial 20cells 20and 20neutrophils. amp;author VL 20Marcheselli amp;author PK 20Mukherjee amp;author M 20Arita amp;author S 20Hong amp;author R 20Antony amp;volume 82 amp;publication_year 2010 amp;pages 27-34 amp;pmid 19931440 amp;doi 10.1016/j.plefa.2009.10.010 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R73\"   cite Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. Journal of immunology. 2013;191:4288 4298. doi: 10.4049/jimmunol.1202743. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1202743\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/24038091/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Maresin 201, 20a 20proresolving 20lipid 20mediator 20derived 20from 20omega-3 20polyunsaturated 20fatty 20acids, 20exerts 20protective 20actions 20in 20murine 20models 20of 20colitis. amp;author R 20Marcon amp;author AF 20Bento amp;author RC 20Dutra amp;author MA 20Bicca amp;author DF 20Leite amp;volume 191 amp;publication_year 2013 amp;pages 4288-4298 amp;pmid 24038091 amp;doi 10.4049/jimmunol.1202743 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R74\"   cite Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clinical chemistry. 2012;58:1476 1484. doi: 10.1373/clinchem.2012.190199. /cite  [ a href \"https://doi.org/10.1373/clinchem.2012.190199\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22912397/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Clinical 20chemistry amp;title Resolvins 20D1, 20D2, 20and 20other 20mediators 20of 20self-limited 20resolution 20of 20inflammation 20in 20human 20blood 20following 20n-3 20fatty 20acid 20supplementation. amp;author E 20Mas amp;author KD 20Croft amp;author P 20Zahra amp;author A 20Barden amp;author TA 20Mori amp;volume 58 amp;publication_year 2012 amp;pages 1476-1484 amp;pmid 22912397 amp;doi 10.1373/clinchem.2012.190199 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R75\"   cite Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, Pandolfi A, Di Silvestre S, Manarini S, Martelli N, Rocca B, Petrucci G, Angelini DF, Battistini L, Robuffo I, Pensabene T, Pieroni L, Furnari ML, Pardo F, Quattrucci S, Lancellotti S, Davi G, Romano M. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2010;24:3970 3980. doi: 10.1096/fj.10-159921. /cite  [ a href \"https://doi.org/10.1096/fj.10-159921\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20530751/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Cystic 20fibrosis 20transmembrane 20conductance 20regulator 20(CFTR) 20expression 20in 20human 20platelets: 20impact 20on 20mediators 20and 20mechanisms 20of 20the 20inflammatory 20response. amp;author D 20Mattoscio amp;author V 20Evangelista amp;author R 20De 20Cristofaro amp;author A 20Recchiuti amp;author A 20Pandolfi amp;volume 24 amp;publication_year 2010 amp;pages 3970-3980 amp;pmid 20530751 amp;doi 10.1096/fj.10-159921 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R76\"   cite Miyata J, Fukunaga K, Iwamoto R, Isobe Y, Niimi K, Takamiya R, Takihara T, Tomomatsu K, Suzuki Y, Oguma T, Sayama K, Arai H, Betsuyaku T, Arita M, Asano K. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. The Journal of allergy and clinical immunology. 2013;131:353 360. e351 352. doi: 10.1016/j.jaci.2012.07.048. /cite  [ a href \"https://doi.org/10.1016/j.jaci.2012.07.048\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23006546/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20allergy 20and 20clinical 20immunology amp;title Dysregulated 20synthesis 20of 20protectin 20D1 20in 20eosinophils 20from 20patients 20with 20severe 20asthma. amp;author J 20Miyata amp;author K 20Fukunaga amp;author R 20Iwamoto amp;author Y 20Isobe amp;author K 20Niimi amp;volume 131 amp;publication_year 2013 amp;pages 353-360 amp;pmid 23006546 amp;doi 10.1016/j.jaci.2012.07.048 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R77\"   cite Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB. 1alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer's disease patients. Journal of Alzheimer's disease : JAD. 2013;34:155 170. doi: 10.3233/JAD-121735. /cite  [ a href \"https://doi.org/10.3233/JAD-121735\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4040018/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23186989/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20Alzheimer's 20disease 20: 20JAD amp;title 1alpha,25-dihydroxyvitamin 20D3 20and 20resolvin 20D1 20retune 20the 20balance 20between 20amyloid-beta 20phagocytosis 20and 20inflammation 20in 20Alzheimer's 20disease 20patients. amp;author MT 20Mizwicki amp;author G 20Liu amp;author M 20Fiala amp;author L 20Magpantay amp;author J 20Sayre amp;volume 34 amp;publication_year 2013 amp;pages 155-170 amp;pmid 23186989 amp;doi 10.3233/JAD-121735 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R78\"   cite Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell. 2013;153:112 125. doi: 10.1016/j.cell.2013.02.027. /cite  [ a href \"https://doi.org/10.1016/j.cell.2013.02.027\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23477864/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Cell amp;title The 20lipid 20mediator 20protectin 20D1 20inhibits 20influenza 20virus 20replication 20and 20improves 20severe 20influenza. amp;author M 20Morita amp;author K 20Kuba amp;author A 20Ichikawa amp;author M 20Nakayama amp;author J 20Katahira amp;volume 153 amp;publication_year 2013 amp;pages 112-125 amp;pmid 23477864 amp;doi 10.1016/j.cell.2013.02.027 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R79\"   cite Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:8491 8496. doi: 10.1073/pnas.0402531101. /cite  [ a href \"https://doi.org/10.1073/pnas.0402531101\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC420421/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15152078/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Proceedings 20of 20the 20National 20Academy 20of 20Sciences 20of 20the 20United 20States 20of 20America amp;title Neuroprotectin 20D1: 20a 20docosahexaenoic 20acid-derived 20docosatriene 20protects 20human 20retinal 20pigment 20epithelial 20cells 20from 20oxidative 20stress. amp;author PK 20Mukherjee amp;author VL 20Marcheselli amp;author CN 20Serhan amp;author NG 20Bazan amp;volume 101 amp;publication_year 2004 amp;pages 8491-8496 amp;pmid 15152078 amp;doi 10.1073/pnas.0402531101 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R80\"   cite Murakami M, Taketomi Y, Sato H, Yamamoto K. Secreted phospholipase A2 revisited. J Biochem. 2011;150:233 255. doi: 10.1093/jb/mvr088. /cite  [ a href \"https://doi.org/10.1093/jb/mvr088\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21746768/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal J 20Biochem amp;title Secreted 20phospholipase 20A2 20revisited. amp;author M 20Murakami amp;author Y 20Taketomi amp;author H 20Sato amp;author K 20Yamamoto amp;volume 150 amp;publication_year 2011 amp;pages 233-255 amp;pmid 21746768 amp;doi 10.1093/jb/mvr088 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R81\"   cite Newcomer LM, King IB, Wicklund KG, Stanford JL. The association of fatty acids with prostate cancer risk. Prostate. 2001;47:262 268. doi: 10.1002/pros.1070. /cite  [ a href \"https://doi.org/10.1002/pros.1070\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/11398173/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Prostate amp;title The 20association 20of 20fatty 20acids 20with 20prostate 20cancer 20risk. amp;author LM 20Newcomer amp;author IB 20King amp;author KG 20Wicklund amp;author JL 20Stanford amp;volume 47 amp;publication_year 2001 amp;pages 262-268 amp;pmid 11398173 amp;doi 10.1002/pros.1070 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R82\"   cite Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL, Silver DL. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509:503 506. doi: 10.1038/nature13241. /cite  [ a href \"https://doi.org/10.1038/nature13241\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/24828044/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title Mfsd2a 20is 20a 20transporter 20for 20the 20essential 20omega-3 20fatty 20acid 20docosahexaenoic 20acid. amp;author LN 20Nguyen amp;author D 20Ma amp;author G 20Shui amp;author P 20Wong amp;author A 20Cazenave-Gassiot amp;volume 509 amp;publication_year 2014 amp;pages 503-506 amp;pmid 24828044 amp;doi 10.1038/nature13241 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R83\"   cite Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arteriosclerosis, thrombosis, and vascular biology. 2012;32:1970 1978. doi: 10.1161/ATVBAHA.112.249508. /cite  [ a href \"https://doi.org/10.1161/ATVBAHA.112.249508\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3401489/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22499990/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Arteriosclerosis, 20thrombosis, 20and 20vascular 20biology amp;title Resolvin 20D1 20limits 20polymorphonuclear 20leukocyte 20recruitment 20to 20inflammatory 20loci: 20receptor-dependent 20actions. amp;author LV 20Norling amp;author J 20Dalli amp;author RJ 20Flower amp;author CN 20Serhan amp;author M 20Perretti amp;volume 32 amp;publication_year 2012 amp;pages 1970-1978 amp;pmid 22499990 amp;doi 10.1161/ATVBAHA.112.249508 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R84\"   cite Ogawa S, Urabe D, Yokokura Y, Arai H, Arita M, Inoue M. Total synthesis and bioactivity of resolvin E2. Org Lett. 2009;11:3602 3605. doi: 10.1021/ol901350g. /cite  [ a href \"https://doi.org/10.1021/ol901350g\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19637859/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Org 20Lett amp;title Total 20synthesis 20and 20bioactivity 20of 20resolvin 20E2. amp;author S 20Ogawa amp;author D 20Urabe amp;author Y 20Yokokura amp;author H 20Arai amp;author M 20Arita amp;volume 11 amp;publication_year 2009 amp;pages 3602-3605 amp;pmid 19637859 amp;doi 10.1021/ol901350g amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R85\"   cite Oh SF, Dona M, Fredman G, Krishnamoorthy S, Irimia D, Serhan CN. Resolvin E2 formation and impact in inflammation resolution. Journal of immunology. 2012;188:4527 4534. doi: 10.4049/jimmunol.1103652. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1103652\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3331964/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22450811/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Resolvin 20E2 20formation 20and 20impact 20in 20inflammation 20resolution. amp;author SF 20Oh amp;author M 20Dona amp;author G 20Fredman amp;author S 20Krishnamoorthy amp;author D 20Irimia amp;volume 188 amp;publication_year 2012 amp;pages 4527-4534 amp;pmid 22450811 amp;doi 10.4049/jimmunol.1103652 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R86\"   cite Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007;109:3625 3632. doi: 10.1182/blood-2006-08-038844. /cite  [ a href \"https://doi.org/10.1182/blood-2006-08-038844\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17202316/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Blood amp;title The 20role 20of 20chemerin 20in 20the 20colocalization 20of 20NK 20and 20dendritic 20cell 20subsets 20into 20inflamed 20tissues. amp;author S 20Parolini amp;author A 20Santoro amp;author E 20Marcenaro amp;author W 20Luini amp;author L 20Massardi amp;volume 109 amp;publication_year 2007 amp;pages 3625-3632 amp;pmid 17202316 amp;doi 10.1182/blood-2006-08-038844 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R87\"   cite Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. American journal of respiratory and critical care medicine. 2008;178:574 582. doi: 10.1164/rccm.200801-061OC. /cite  [ a href \"https://doi.org/10.1164/rccm.200801-061OC\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2542432/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18583575/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal American 20journal 20of 20respiratory 20and 20critical 20care 20medicine amp;title Airway 20lipoxin 20A4 20generation 20and 20lipoxin 20A4 20receptor 20expression 20are 20decreased 20in 20severe 20asthma. amp;author A 20Planaguma amp;author S 20Kazani amp;author G 20Marigowda amp;author O 20Haworth amp;author TJ 20Mariani amp;volume 178 amp;publication_year 2008 amp;pages 574-582 amp;pmid 18583575 amp;doi 10.1164/rccm.200801-061OC amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R88\"   cite Pruss H, Rosche B, Sullivan AB, Brommer B, Wengert O, Gronert K, Schwab JM. Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PloS one. 2013;8:e55859. doi: 10.1371/journal.pone.0055859. /cite  [ a href \"https://doi.org/10.1371/journal.pone.0055859\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3568070/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23409068/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal PloS 20one amp;title Proresolution 20lipid 20mediators 20in 20multiple 20sclerosis 20- 20differential, 20disease 20severity-dependent 20synthesis 20- 20a 20clinical 20pilot 20trial. amp;author H 20Pruss amp;author B 20Rosche amp;author AB 20Sullivan amp;author B 20Brommer amp;author O 20Wengert amp;volume 8 amp;publication_year 2013 amp;pages e55859 amp;pmid 23409068 amp;doi 10.1371/journal.pone.0055859 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R89\"   cite Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS. The human serum metabolome. PloS one. 2011;6:e16957. doi: 10.1371/journal.pone.0016957. /cite  [ a href \"https://doi.org/10.1371/journal.pone.0016957\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3040193/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21359215/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal PloS 20one amp;title The 20human 20serum 20metabolome. amp;author N 20Psychogios amp;author DD 20Hau amp;author J 20Peng amp;author AC 20Guo amp;author R 20Mandal amp;volume 6 amp;publication_year 2011 amp;pages e16957 amp;pmid 21359215 amp;doi 10.1371/journal.pone.0016957 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R90\"   cite Ramon S, Gao F, Serhan CN, Phipps RP. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. Journal of immunology. 2012;189:1036 1042. doi: 10.4049/jimmunol.1103483. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1103483\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3392531/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22711890/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Specialized 20proresolving 20mediators 20enhance 20human 20B 20cell 20differentiation 20to 20antibody-secreting 20cells. amp;author S 20Ramon amp;author F 20Gao amp;author CN 20Serhan amp;author RP 20Phipps amp;volume 189 amp;publication_year 2012 amp;pages 1036-1042 amp;pmid 22711890 amp;doi 10.4049/jimmunol.1103483 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R91\"   cite Recchiuti A, Krishnamoorthy S, Fredman G, Chiang N, Serhan CN. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011;25:544 560. doi: 10.1096/fj.10-169599. /cite  [ a href \"https://doi.org/10.1096/fj.10-169599\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3023392/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20956612/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title MicroRNAs 20in 20resolution 20of 20acute 20inflammation: 20identification 20of 20novel 20resolvin 20D1-miRNA 20circuits. amp;author A 20Recchiuti amp;author S 20Krishnamoorthy amp;author G 20Fredman amp;author N 20Chiang amp;author CN 20Serhan amp;volume 25 amp;publication_year 2011 amp;pages 544-560 amp;pmid 20956612 amp;doi 10.1096/fj.10-169599 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R92\"   cite Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R, Serhan CN, Levy BD. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. Journal of immunology. 2012;189:1983 1991. doi: 10.4049/jimmunol.1101665. /cite  [ a href \"https://doi.org/10.4049/jimmunol.1101665\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3534750/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22802419/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Resolvin 20D1 20and 20aspirin-triggered 20resolvin 20D1 20promote 20resolution 20of 20allergic 20airways 20responses. amp;author AP 20Rogerio amp;author O 20Haworth amp;author R 20Croze amp;author SF 20Oh amp;author M 20Uddin amp;volume 189 amp;publication_year 2012 amp;pages 1983-1991 amp;pmid 22802419 amp;doi 10.4049/jimmunol.1101665 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R93\"   cite Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237:1171 1176. doi: 10.1126/science.2820055. /cite  [ a href \"https://doi.org/10.1126/science.2820055\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/2820055/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Science amp;title Leukotrienes 20and 20lipoxins: 20structures, 20biosynthesis, 20and 20biological 20effects. amp;author B 20Samuelsson amp;author SE 20Dahlen amp;author JA 20Lindgren amp;author CA 20Rouzer amp;author CN 20Serhan amp;volume 237 amp;publication_year 1987 amp;pages 1171-1176 amp;pmid 2820055 amp;doi 10.1126/science.2820055 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R94\"   cite Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L, Serhan CN, Szczeklik A. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. The European respiratory journal. 2000;16:44 49. doi: 10.1034/j.1399-3003.2000.16a08.x. /cite  [ a href \"https://doi.org/10.1034/j.1399-3003.2000.16a08.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/10933083/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20European 20respiratory 20journal amp;title Aspirin-tolerant 20asthmatics 20generate 20more 20lipoxins 20than 20aspirin-intolerant 20asthmatics. amp;author M 20Sanak amp;author BD 20Levy amp;author CB 20Clish amp;author N 20Chiang amp;author K 20Gronert amp;volume 16 amp;publication_year 2000 amp;pages 44-49 amp;pmid 10933083 amp;doi 10.1034/j.1399-3003.2000.16a08.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R95\"   cite Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. The Journal of clinical investigation. 1989;83:865 875. doi: 10.1172/JCI113970. /cite  [ a href \"https://doi.org/10.1172/JCI113970\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC303760/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/2921324/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20clinical 20investigation amp;title Macrophage 20phagocytosis 20of 20aging 20neutrophils 20in 20inflammation. 20Programmed 20cell 20death 20in 20the 20neutrophil 20leads 20to 20its 20recognition 20by 20macrophages. amp;author JS 20Savill amp;author AH 20Wyllie amp;author JE 20Henson amp;author MJ 20Walport amp;author PM 20Henson amp;volume 83 amp;publication_year 1989 amp;pages 865-875 amp;pmid 2921324 amp;doi 10.1172/JCI113970 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R96\"   cite Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869 874. doi: 10.1038/nature05877. /cite  [ a href \"https://doi.org/10.1038/nature05877\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2757086/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17568749/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title Resolvin 20E1 20and 20protectin 20D1 20activate 20inflammation-resolution 20programmes. amp;author JM 20Schwab amp;author N 20Chiang amp;author M 20Arita amp;author CN 20Serhan amp;volume 447 amp;publication_year 2007 amp;pages 869-874 amp;pmid 17568749 amp;doi 10.1038/nature05877 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R97\"   cite Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. Journal of immunology. 2010;184:836 843. doi: 10.4049/jimmunol.0901809. /cite  [ a href \"https://doi.org/10.4049/jimmunol.0901809\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3000830/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20007539/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title The 20anti-inflammatory 20and 20proresolving 20mediator 20resolvin 20E1 20protects 20mice 20from 20bacterial 20pneumonia 20and 20acute 20lung 20injury. amp;author H 20Seki amp;author K 20Fukunaga amp;author M 20Arita amp;author H 20Arai amp;author H 20Nakanishi amp;volume 184 amp;publication_year 2010 amp;pages 836-843 amp;pmid 20007539 amp;doi 10.4049/jimmunol.0901809 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R98\"   cite Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual review of immunology. 2007;25:101 137. doi: 10.1146/annurev.immunol.25.022106.141647. /cite  [ a href \"https://doi.org/10.1146/annurev.immunol.25.022106.141647\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17090225/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Annual 20review 20of 20immunology amp;title Resolution 20phase 20of 20inflammation: 20novel 20endogenous 20anti-inflammatory 20and 20proresolving 20lipid 20mediators 20and 20pathways. amp;author CN 20Serhan amp;volume 25 amp;publication_year 2007 amp;pages 101-137 amp;pmid 17090225 amp;doi 10.1146/annurev.immunol.25.022106.141647 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R99\"   cite Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011;25:1441 1448. doi: 10.1096/fj.11-0502ufm. /cite  [ a href \"https://doi.org/10.1096/fj.11-0502ufm\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3228345/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21532053/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title The 20resolution 20of 20inflammation: 20the 20devil 20in 20the 20flask 20and 20in 20the 20details. amp;author CN 20Serhan amp;volume 25 amp;publication_year 2011 amp;pages 1441-1448 amp;pmid 21532053 amp;doi 10.1096/fj.11-0502ufm amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R100\"   cite Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92 101. doi: 10.1038/nature13479. /cite  [ a href \"https://doi.org/10.1038/nature13479\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC4263681/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/24899309/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title Pro-resolving 20lipid 20mediators 20are 20leads 20for 20resolution 20physiology. amp;author CN 20Serhan amp;volume 510 amp;publication_year 2014 amp;pages 92-101 amp;pmid 24899309 amp;doi 10.1038/nature13479 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R101\"   cite Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. The Journal of experimental medicine. 2000a;192:1197 1204. doi: 10.1084/jem.192.8.1197. /cite  [ a href \"https://doi.org/10.1084/jem.192.8.1197\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2195872/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/11034610/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Novel 20functional 20sets 20of 20lipid-derived 20mediators 20with 20antiinflammatory 20actions 20generated 20from 20omega-3 20fatty 20acids 20via 20cyclooxygenase 202-nonsteroidal 20antiinflammatory 20drugs 20and 20transcellular 20processing. amp;author CN 20Serhan amp;author CB 20Clish amp;author J 20Brannon amp;author SP 20Colgan amp;author N 20Chiang amp;volume 192 amp;publication_year 2000a amp;pages 1197-1204 amp;pmid 11034610 amp;doi 10.1084/jem.192.8.1197 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R102\"   cite Serhan CN, Clish CB, Brannon J, Colgan SP, Gronert K, Chiang N. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. J Physiol Pharmacol. 2000b;51:643 654. /cite  [ a href \"https://pubmed.ncbi.nlm.nih.gov/11192938/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal J 20Physiol 20Pharmacol amp;title Anti-microinflammatory 20lipid 20signals 20generated 20from 20dietary 20N-3 20fatty 20acids 20via 20cyclooxygenase-2 20and 20transcellular 20processing: 20a 20novel 20mechanism 20for 20NSAID 20and 20N-3 20PUFA 20therapeutic 20actions. amp;author CN 20Serhan amp;author CB 20Clish amp;author J 20Brannon amp;author SP 20Colgan amp;author K 20Gronert amp;volume 51 amp;publication_year 2000b amp;pages 643-654 amp;pmid 11192938 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R103\"   cite Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, Xu ZZ, Ji RR, Zhu M, Petasis NA. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012;26:1755 1765. doi: 10.1096/fj.11-201442. /cite  [ a href \"https://doi.org/10.1096/fj.11-201442\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3316905/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22253477/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Macrophage 20proresolving 20mediator 20maresin 201 20stimulates 20tissue 20regeneration 20and 20controls 20pain. amp;author CN 20Serhan amp;author J 20Dalli amp;author S 20Karamnov amp;author A 20Choi amp;author CK 20Park amp;volume 26 amp;publication_year 2012 amp;pages 1755-1765 amp;pmid 22253477 amp;doi 10.1096/fj.11-201442 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R104\"   cite Serhan CN, Fredman G, Yang R, Karamnov S, Belayev LS, Bazan NG, Zhu M, Winkler JW, Petasis NA. Novel proresolving aspirin-triggered DHA pathway. Chemistry  amp; biology. 2011;18:976 987. doi: 10.1016/j.chembiol.2011.06.008. /cite  [ a href \"https://doi.org/10.1016/j.chembiol.2011.06.008\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3164791/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21867913/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Chemistry 20 amp; 20biology amp;title Novel 20proresolving 20aspirin-triggered 20DHA 20pathway. amp;author CN 20Serhan amp;author G 20Fredman amp;author R 20Yang amp;author S 20Karamnov amp;author LS 20Belayev amp;volume 18 amp;publication_year 2011 amp;pages 976-987 amp;pmid 21867913 amp;doi 10.1016/j.chembiol.2011.06.008 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R105\"   cite Serhan CN, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins  amp; other lipid mediators. 2004;73:155 172. doi: 10.1016/j.prostaglandins.2004.03.005. /cite  [ a href \"https://doi.org/10.1016/j.prostaglandins.2004.03.005\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15290791/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Prostaglandins 20 amp; 20other 20lipid 20mediators amp;title Resolvins, 20docosatrienes, 20and 20neuroprotectins, 20novel 20omega-3-derived 20mediators, 20and 20their 20aspirin-triggered 20endogenous 20epimers: 20an 20overview 20of 20their 20protective 20roles 20in 20catabasis. amp;author CN 20Serhan amp;author K 20Gotlinger amp;author S 20Hong amp;author M 20Arita amp;volume 73 amp;publication_year 2004 amp;pages 155-172 amp;pmid 15290791 amp;doi 10.1016/j.prostaglandins.2004.03.005 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R106\"   cite Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. Journal of immunology. 2006;176:1848 1859. doi: 10.4049/jimmunol.176.3.1848. /cite  [ a href \"https://doi.org/10.4049/jimmunol.176.3.1848\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16424216/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Journal 20of 20immunology amp;title Anti-inflammatory 20actions 20of 20neuroprotectin 20D1/protectin 20D1 20and 20its 20natural 20stereoisomers: 20assignments 20of 20dihydroxy-containing 20docosatrienes. amp;author CN 20Serhan amp;author K 20Gotlinger amp;author S 20Hong amp;author Y 20Lu amp;author J 20Siegelman amp;volume 176 amp;publication_year 2006 amp;pages 1848-1859 amp;pmid 16424216 amp;doi 10.4049/jimmunol.176.3.1848 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R107\"   cite Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. The Journal of experimental medicine. 2002;196:1025 1037. doi: 10.1084/jem.20020760. /cite  [ a href \"https://doi.org/10.1084/jem.20020760\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2194036/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/12391014/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Resolvins: 20a 20family 20of 20bioactive 20products 20of 20omega-3 20fatty 20acid 20transformation 20circuits 20initiated 20by 20aspirin 20treatment 20that 20counter 20proinflammation 20signals. amp;author CN 20Serhan amp;author S 20Hong amp;author K 20Gronert amp;author SP 20Colgan amp;author PR 20Devchand amp;volume 196 amp;publication_year 2002 amp;pages 1025-1037 amp;pmid 12391014 amp;doi 10.1084/jem.20020760 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R108\"   cite Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. The Journal of experimental medicine. 2009;206:15 23. doi: 10.1084/jem.20081880. /cite  [ a href \"https://doi.org/10.1084/jem.20081880\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2626672/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19103881/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Maresins: 20novel 20macrophage 20mediators 20with 20potent 20antiinflammatory 20and 20proresolving 20actions. amp;author CN 20Serhan amp;author R 20Yang amp;author K 20Martinod amp;author K 20Kasuga amp;author PS 20Pillai amp;volume 206 amp;publication_year 2009 amp;pages 15-23 amp;pmid 19103881 amp;doi 10.1084/jem.20081880 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R109\"   cite Simiele F, Recchiuti A, Mattoscio D, De Luca A, Cianci E, Franchi S, Gatta V, Parolari A, Werba JP, Camera M, Favaloro B, Romano M. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012;26:1323 1333. doi: 10.1096/fj.11-198069. /cite  [ a href \"https://doi.org/10.1096/fj.11-198069\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22131270/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal FASEB 20journal 20: 20official 20publication 20of 20the 20Federation 20of 20American 20Societies 20for 20Experimental 20Biology amp;title Transcriptional 20regulation 20of 20the 20human 20FPR2/ALX 20gene: 20evidence 20of 20a 20heritable 20genetic 20variant 20that 20impairs 20promoter 20activity. amp;author F 20Simiele amp;author A 20Recchiuti amp;author D 20Mattoscio amp;author A 20De 20Luca amp;author E 20Cianci amp;volume 26 amp;publication_year 2012 amp;pages 1323-1333 amp;pmid 22131270 amp;doi 10.1096/fj.11-198069 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R110\"   cite Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009;461:1287 1291. doi: 10.1038/nature08541. /cite  [ a href \"https://doi.org/10.1038/nature08541\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2779525/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/19865173/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title Resolvin 20D2 20is 20a 20potent 20regulator 20of 20leukocytes 20and 20controls 20microbial 20sepsis. amp;author M 20Spite amp;author LV 20Norling amp;author L 20Summers amp;author R 20Yang amp;author D 20Cooper amp;volume 461 amp;publication_year 2009 amp;pages 1287-1291 amp;pmid 19865173 amp;doi 10.1038/nature08541 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R111\"   cite Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. The Journal of biological chemistry. 2007;282:9323 9334. doi: 10.1074/jbc.M609212200. /cite  [ a href \"https://doi.org/10.1074/jbc.M609212200\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17244615/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20biological 20chemistry amp;title Resolvin 20D1 20and 20its 20aspirin-triggered 2017R 20epimer. 20Stereochemical 20assignments, 20anti-inflammatory 20properties, 20and 20enzymatic 20inactivation. amp;author YP 20Sun amp;author SF 20Oh amp;author J 20Uddin amp;author R 20Yang amp;author K 20Gotlinger amp;volume 282 amp;publication_year 2007 amp;pages 9323-9334 amp;pmid 17244615 amp;doi 10.1074/jbc.M609212200 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R112\"   cite Tahan F, Saraymen R, Gumus H. The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma. The Journal of asthma : official journal of the Association for the Care of Asthma. 2008;45:161 164. doi: 10.1080/02770900701847068. /cite  [ a href \"https://doi.org/10.1080/02770900701847068\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/18350409/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20asthma 20: 20official 20journal 20of 20the 20Association 20for 20the 20Care 20of 20Asthma amp;title The 20role 20of 20lipoxin 20A4 20in 20exercise-induced 20bronchoconstriction 20in 20asthma. amp;author F 20Tahan amp;author R 20Saraymen amp;author H 20Gumus amp;volume 45 amp;publication_year 2008 amp;pages 161-164 amp;pmid 18350409 amp;doi 10.1080/02770900701847068 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R113\"   cite Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN. Aspirin-triggered 15-epilipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. The Journal of experimental medicine. 1997;185:1693 1704. doi: 10.1084/jem.185.9.1693. /cite  [ a href \"https://doi.org/10.1084/jem.185.9.1693\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2196289/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/9151906/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20experimental 20medicine amp;title Aspirin-triggered 2015-epilipoxin 20A4 20(LXA4) 20and 20LXA4 20stable 20analogues 20are 20potent 20inhibitors 20of 20acute 20inflammation: 20evidence 20for 20anti-inflammatory 20receptors. amp;author T 20Takano amp;author S 20Fiore amp;author JF 20Maddox amp;author HR 20Brady amp;author NA 20Petasis amp;volume 185 amp;publication_year 1997 amp;pages 1693-1704 amp;pmid 9151906 amp;doi 10.1084/jem.185.9.1693 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R114\"   cite Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, Hong S, Arita M, Serhan CN. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chemistry  amp; biology. 2006;13:1193 1202. doi: 10.1016/j.chembiol.2006.09.011. /cite  [ a href \"https://doi.org/10.1016/j.chembiol.2006.09.011\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/17114001/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Chemistry 20 amp; 20biology amp;title Resolvin 20E2: 20identification 20and 20anti-inflammatory 20actions: 20pivotal 20role 20of 20human 205-lipoxygenase 20in 20resolvin 20E 20series 20biosynthesis. amp;author E 20Tjonahen amp;author SF 20Oh amp;author J 20Siegelman amp;author S 20Elangovan amp;author KB 20Percarpio amp;volume 13 amp;publication_year 2006 amp;pages 1193-1202 amp;pmid 17114001 amp;doi 10.1016/j.chembiol.2006.09.011 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R115\"   cite Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, Chanez P. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. The Journal of allergy and clinical immunology. 2005;115:55 60. doi: 10.1016/j.jaci.2004.09.038. /cite  [ a href \"https://doi.org/10.1016/j.jaci.2004.09.038\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/15637547/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal The 20Journal 20of 20allergy 20and 20clinical 20immunology amp;title Severe 20asthma 20is 20associated 20with 20a 20loss 20of 20LX4, 20an 20endogenous 20anti-inflammatory 20compound. amp;author I 20Vachier amp;author C 20Bonnans amp;author C 20Chavis amp;author M 20Farce amp;author P 20Godard amp;volume 115 amp;publication_year 2005 amp;pages 55-60 amp;pmid 15637547 amp;doi 10.1016/j.jaci.2004.09.038 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R116\"   cite Wakai K, Ito Y, Kojima M, Tokudome S, Ozasa K, Inaba Y, Yagyu K, Tamakoshi A, Group JS. Intake frequency of fish and serum levels of long-chain n-3 fatty acids: a cross-sectional study within the Japan Collaborative Cohort Study. J Epidemiol. 2005;15:211 218. doi: 10.2188/jea.15.211. /cite  [ a href \"https://doi.org/10.2188/jea.15.211\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC7904379/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/16276030/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal J 20Epidemiol amp;title Intake 20frequency 20of 20fish 20and 20serum 20levels 20of 20long-chain 20n-3 20fatty 20acids: 20a 20cross-sectional 20study 20within 20the 20Japan 20Collaborative 20Cohort 20Study. amp;author K 20Wakai amp;author Y 20Ito amp;author M 20Kojima amp;author S 20Tokudome amp;author K 20Ozasa amp;volume 15 amp;publication_year 2005 amp;pages 211-218 amp;pmid 16276030 amp;doi 10.2188/jea.15.211 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R117\"   cite Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, Min S. Resolvin D1 protects mice from LPS-induced acute lung injury. Pulmonary pharmacology  amp; therapeutics. 2011;24:434 441. doi: 10.1016/j.pupt.2011.04.001. /cite  [ a href \"https://doi.org/10.1016/j.pupt.2011.04.001\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/21501693/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Pulmonary 20pharmacology 20 amp; 20therapeutics amp;title Resolvin 20D1 20protects 20mice 20from 20LPS-induced 20acute 20lung 20injury. amp;author B 20Wang amp;author X 20Gong amp;author JY 20Wan amp;author L 20Zhang amp;author Z 20Zhang amp;volume 24 amp;publication_year 2011 amp;pages 434-441 amp;pmid 21501693 amp;doi 10.1016/j.pupt.2011.04.001 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R118\"   cite Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids in health and disease. 2013;12:89. doi: 10.1186/1476-511X-12-89. /cite  [ a href \"https://doi.org/10.1186/1476-511X-12-89\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3698171/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23767972/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Lipids 20in 20health 20and 20disease amp;title High 20levels 20of 20anti-inflammatory 20and 20pro-resolving 20lipid 20mediators 20lipoxins 20and 20resolvins 20and 20declining 20docosahexaenoic 20acid 20levels 20in 20human 20milk 20during 20the 20first 20month 20of 20lactation. amp;author GA 20Weiss amp;author H 20Troxler amp;author G 20Klinke amp;author D 20Rogler amp;author C 20Braegger amp;volume 12 amp;publication_year 2013 amp;pages 89 amp;pmid 23767972 amp;doi 10.1186/1476-511X-12-89 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R119\"   cite Wu SH, Chen XQ, Liu B, Wu HJ, Dong L. Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema. Br J Dermatol. 2013;168:172 178. doi: 10.1111/j.1365-2133.2012.11177.x. /cite  [ a href \"https://doi.org/10.1111/j.1365-2133.2012.11177.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22834636/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Br 20J 20Dermatol amp;title Efficacy 20and 20safety 20of 2015(R/S)-methyl-lipoxin 20A(4) 20in 20topical 20treatment 20of 20infantile 20eczema. amp;author SH 20Wu amp;author XQ 20Chen amp;author B 20Liu amp;author HJ 20Wu amp;author L 20Dong amp;volume 168 amp;publication_year 2013 amp;pages 172-178 amp;pmid 22834636 amp;doi 10.1111/j.1365-2133.2012.11177.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R120\"   cite Yamaguchi H, Higashi N, Mita H, Ono E, Komase Y, Nakagawa T, Miyazawa T, Akiyama K, Taniguchi M. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2011;41:1711 1718. doi: 10.1111/j.1365-2222.2011.03839.x. /cite  [ a href \"https://doi.org/10.1111/j.1365-2222.2011.03839.x\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22093074/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Clinical 20and 20experimental 20allergy 20: 20journal 20of 20the 20British 20Society 20for 20Allergy 20and 20Clinical 20Immunology amp;title Urinary 20concentrations 20of 2015-epimer 20of 20lipoxin 20A(4) 20are 20lower 20in 20patients 20with 20aspirin-intolerant 20compared 20with 20aspirin-tolerant 20asthma. amp;author H 20Yamaguchi amp;author N 20Higashi amp;author H 20Mita amp;author E 20Ono amp;author Y 20Komase amp;volume 41 amp;publication_year 2011 amp;pages 1711-1718 amp;pmid 22093074 amp;doi 10.1111/j.1365-2222.2011.03839.x amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R121\"   cite Yanes O, Clark J, Wong DM, Patti GJ, Sanchez-Ruiz A, Benton HP, Trauger SA, Desponts C, Ding S, Siuzdak G. Metabolic oxidation regulates embryonic stem cell differentiation. Nature chemical biology. 2010;6:411 417. doi: 10.1038/nchembio.364. /cite  [ a href \"https://doi.org/10.1038/nchembio.364\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC2873061/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/20436487/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature 20chemical 20biology amp;title Metabolic 20oxidation 20regulates 20embryonic 20stem 20cell 20differentiation. amp;author O 20Yanes amp;author J 20Clark amp;author DM 20Wong amp;author GJ 20Patti amp;author A 20Sanchez-Ruiz amp;volume 6 amp;publication_year 2010 amp;pages 411-417 amp;pmid 20436487 amp;doi 10.1038/nchembio.364 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R122\"   cite Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free radical biology  amp; medicine. 2012;53:160 171. doi: 10.1016/j.freeradbiomed.2012.05.001. /cite  [ a href \"https://doi.org/10.1016/j.freeradbiomed.2012.05.001\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3412514/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/22580336/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Free 20radical 20biology 20 amp; 20medicine amp;title Metabolomic 20profiling 20of 20regulatory 20lipid 20mediators 20in 20sputum 20from 20adult 20cystic 20fibrosis 20patients. amp;author J 20Yang amp;author JP 20Eiserich amp;author CE 20Cross amp;author BM 20Morrissey amp;author BD 20Hammock amp;volume 53 amp;publication_year 2012 amp;pages 160-171 amp;pmid 22580336 amp;doi 10.1016/j.freeradbiomed.2012.05.001 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R123\"   cite Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 1997;387:620 624. doi: 10.1038/42506. /cite  [ a href \"https://doi.org/10.1038/42506\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/9177352/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Nature amp;title A 20G-protein-coupled 20receptor 20for 20leukotriene 20B4 20that 20mediates 20chemotaxis. amp;author T 20Yokomizo amp;author T 20Izumi amp;author K 20Chang amp;author Y 20Takuwa amp;author T 20Shimizu amp;volume 387 amp;publication_year 1997 amp;pages 620-624 amp;pmid 9177352 amp;doi 10.1038/42506 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   li id \"R124\"   cite Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O'Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, Hammock BD. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics : Official journal of the Metabolomic Society. 2012;8:1102 1113. doi: 10.1007/s11306-012-0417-5. /cite  [ a href \"https://doi.org/10.1007/s11306-012-0417-5\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" DOI /a ] [ a href \"/articles/PMC3700377/\" class \"usa-link\" PMC free article /a ] [ a href \"https://pubmed.ncbi.nlm.nih.gov/23833568/\" class \"usa-link\" PubMed /a ] [ a href \"https://scholar.google.com/scholar_lookup?journal Metabolomics 20: 20Official 20journal 20of 20the 20Metabolomic 20Society amp;title Serum 20oxylipin 20profiles 20in 20IgA 20nephropathy 20patients 20reflect 20kidney 20functional 20alterations. amp;author AM 20Zivkovic amp;author J 20Yang amp;author K 20Georgi amp;author C 20Hegedus amp;author ML 20Nording amp;volume 8 amp;publication_year 2012 amp;pages 1102-1113 amp;pmid 23833568 amp;doi 10.1007/s11306-012-0417-5 amp;\" class \"usa-link usa-link--external\" data-ga-action \"click_feat_suppl\" target \"_blank\" rel \"noopener noreferrer\" Google Scholar /a ] /li   /ol  /section  /section  /section  /section  /article   /main   /div   /div   /div   !-- Secondary navigation placeholder --   div class \"pmc-sidenav desktop:grid-col-4 display-flex\"   section class \"pmc-sidenav__container\" aria-label \"Article resources and navigation\"   button type \"button\" class \"usa-button pmc-sidenav__container__close usa-button--unstyled\"   img src \"/static/img/usa-icons/close.svg\" role \"img\" alt \"Close\" /   /button   div class \"display-none desktop:display-block\"   section class \"margin-top-4 desktop:margin-top-0\"   h2 class \"margin-top-0\" ACTIONS /h2   ul class \"usa-list usa-list--unstyled usa-list--actions\"   li   a href \"https://doi.org/10.1016/j.ejphar.2015.11.001\" class \"usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1\" target \"_blank\" rel \"noreferrer noopener\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"publisher_link_desktop\"    svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/sprite.svg launch\"  /use   /svg   span class \"display-inline-flex flex-justify-center flex-1 padding-right-2\" View on publisher site /span   /a   /li   li   a href \"pdf/nihms-737995.pdf\" class \"usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"pdf_download_desktop\"    svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/sprite.svg file_download\"  /use   /svg   span class \"display-inline-flex flex-justify-center flex-1\" PDF (1.2 MB) /span   /a   /li   li   button role \"button\" class \"usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1\" aria-label \"Open dialog with citation text in different styles\" data-ga-category \"actions\" data-ga-action \"open\" data-ga-label \"cite_desktop\" data-all-citations-url \"/resources/citations/4854800/\" data-citation-style \"nlm\" data-download-format-link \"/resources/citations/4854800/export/\"    svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/sprite.svg format_quote\"  /use   /svg   span class \"display-inline-flex flex-justify-center flex-1 button-label\" Cite /span   /button   /li   li   button class \"usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty\" aria-label \"Save article in MyNCBI collections.\" data-ga-category \"actions\" data-ga-action \"click\" data-ga-label \"collections_button_desktop\" data-collections-open-dialog-enabled \"false\" data-collections-open-dialog-url \"https://account.ncbi.nlm.nih.gov/?back_url https 3A 2F 2Fpmc.ncbi.nlm.nih.gov 2Farticles 2FPMC4854800 2F 23open-collections-dialog\" data-in-collections \"false\"   svg class \"usa-icon width-3 height-3 usa-icon--bookmark-full\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/action-bookmark-full.svg icon\"  /use   /svg   svg class \"usa-icon width-3 height-3 usa-icon--bookmark-empty\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/action-bookmark-empty.svg icon\"  /use   /svg   span class \"display-inline-flex flex-justify-center flex-1\" Collections /span   /button   /li   li class \"pmc-permalink\"   button type \"button\" class \"usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none\" aria-label \"Show article permalink\" aria-expanded \"false\" aria-haspopup \"true\" data-ga-category \"actions\" data-ga-action \"open\" data-ga-label \"permalink_desktop\"    svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\" hidden   use xlink:href \"/static/img/sprite.svg share\"  /use   /svg   span class \"display-inline-flex flex-justify-center flex-1 button-label\" Permalink /span   /button   div class \"pmc-permalink__dropdown\" hidden   div class \"pmc-permalink__dropdown__container\"   h2 class \"usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs\" PERMALINK /h2   div class \"pmc-permalink__dropdown__content\"   input type \"text\" class \"usa-input\" value \"https://pmc.ncbi.nlm.nih.gov/articles/PMC4854800/\" aria-label \"Article permalink\"   button class \"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title \"Copy article permalink\" data-ga-category \"save_share\" data-ga-action \"link\" data-ga-label \"copy_link\"   svg class \"usa-icon\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg content_copy\"  /use   /svg   span class \"margin-left-1\" Copy /span   /button   /div   /div   /div   /li   /ul   /section   /div   section class \"pmc-resources margin-top-6 desktop:margin-top-4\" data-page-path \"/articles/PMC4854800/\"   h2 class \"margin-top-0\" RESOURCES /h2   div class \"usa-accordion usa-accordion--multiselectable\" data-allow-multiple   h3 class \"usa-accordion__heading\"   button type \"button\" class \"usa-accordion__button\" aria-expanded \"false\" aria-controls \"resources-similar-articles\" data-ga-category \"resources_accordion\" data-ga-action \"open_similar_articles\" data-ga-label \"/articles/PMC4854800/\" data-action-open \"open_similar_articles\" data-action-close \"close_similar_articles\"   Similar articles  /button   /h3   div id \"resources-similar-articles\" class \"usa-accordion__content usa-prose\" data-source-url \"/resources/similar-article-links/26546247/\"    /div   h3 class \"usa-accordion__heading\"   button type \"button\" class \"usa-accordion__button\" aria-expanded \"false\" aria-controls \"resources-cited-by-other-articles\" data-ga-category \"resources_accordion\" data-ga-action \"open_cited_by\" data-ga-label \"/articles/PMC4854800/\" data-action-open \"open_cited_by\" data-action-close \"close_cited_by\"   Cited by other articles  /button   /h3   div id \"resources-cited-by-other-articles\" class \"usa-accordion__content usa-prose\" data-source-url \"/resources/cited-by-links/26546247/\"    /div   h3 class \"usa-accordion__heading\"   button type \"button\" class \"usa-accordion__button\" aria-expanded \"false\" aria-controls \"resources-links-to-ncbi-databases\" data-ga-category \"resources_accordion\" data-ga-action \"open_NCBI_links\" data-ga-label \"/articles/PMC4854800/\" data-action-open \"open_NCBI_links\" data-action-close \"close_NCBI_link\"   Links to NCBI Databases  /button   /h3   div id \"resources-links-to-ncbi-databases\" class \"usa-accordion__content usa-prose\" data-source-url \"/resources/db-links/4854800/\"    /div   /div   /section   section class \"usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4\" data-title-text \"On this page\" data-title-heading-level \"h2\" data-scroll-offset \"0\" data-root-margin \"-10  0px -80  0px\" data-main-content-selector \"main\" data-threshold \"1\" hidden   /section   /section   /div   div class \"overlay\" role \"dialog\" aria-label \"Citation Dialog\" hidden   div class \"dialog citation-dialog\" aria-hidden \"true\"   div class \"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"   h2 class \"usa-modal__heading margin-0\" Cite /h2   button type \"button\" class \"usa-button usa-button--unstyled close-overlay text-black width-auto\" tabindex \"1\"   svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg close\"  /use   /svg   /button   /div   div class \"citation-text-block\"   div class \"citation-text margin-bottom-2\"  /div   ul class \"usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center\"   li   button class \"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus\" data-ga-category \"save_share\" data-ga-action \"cite\" data-ga-label \"copy\" tabindex \"2\"   svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg content_copy\"  /use   /svg   span Copy /span   /button   /li   li   a href \" \" role \"button\" class \"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button\" data-ga-category \"save_share\" data-ga-action \"cite\" data-ga-label \"download\" title \"Download a file for external citation management software\" tabindex \"3\"   svg class \"usa-icon width-3 height-3\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg file_download\"  /use   /svg   span class \"display-none mobile-lg:display-inline\" Download .nbib /span   span class \"display-inline mobile-lg:display-none\" .nbib /span   /a   /li   li   div class \"display-inline-flex flex-align-center\"   label class \"usa-label margin-top-0\" Format: /label   select aria-label \"Format\" class \"usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4\" tabindex \"4\"    option data-style-url-name \"ama\" value \"AMA\"   AMA  /option   option data-style-url-name \"apa\" value \"APA\"   APA  /option   option data-style-url-name \"mla\" value \"MLA\"   MLA  /option   option data-style-url-name \"nlm\" value \"NLM\" selected \"selected\"  NLM  /option   /select   /div   /li   /ul   /div   /div   /div   div class \"overlay\" role \"dialog\" hidden   div id \"collections-action-dialog\" class \"dialog collections-dialog\" aria-hidden \"true\"   div class \"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"   h2 class \"usa-modal__heading margin-0\" Add to Collections /h2   /div   div class \"collections-action-panel action-panel\"   form id \"collections-action-dialog-form\" class \"usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors\" data-existing-collections-url \"/list-existing-collections/\" data-add-to-existing-collection-url \"/add-to-existing-collection/\" data-create-and-add-to-new-collection-url \"/create-and-add-to-new-collection/\" data-myncbi-max-collection-name-length \"100\" data-collections-root-url \"https://www.ncbi.nlm.nih.gov/myncbi/collections/\"   input type \"hidden\" name \"csrfmiddlewaretoken\" value \"gRwZbTGoIUpBfrxcdHwk3L3gX6KrU8wOBl6DR7murS8998QrxLBfTUDRlgYrTeWy\"   fieldset class \"usa-fieldset margin-bottom-2\"   div class \"usa-radio\"   input type \"radio\" id \"collections-action-dialog-new\" class \"usa-radio__input usa-radio__input--tile collections-new margin-top-0\" name \"collections\" value \"new\" data-ga-category \"collections_button\" data-ga-action \"click\" data-ga-label \"collections_radio_new\" /   label class \"usa-radio__label\" for \"collections-action-dialog-new\" Create a new collection /label   /div   div class \"usa-radio\"   input type \"radio\" id \"collections-action-dialog-existing\" class \"usa-radio__input usa-radio__input--tile collections-existing\" name \"collections\" value \"existing\" checked \"true\" data-ga-category \"collections_button\" data-ga-action \"click\" data-ga-label \"collections_radio_existing\" /   label class \"usa-radio__label\" for \"collections-action-dialog-existing\" Add to an existing collection /label   /div   /fieldset   fieldset class \"usa-fieldset margin-bottom-2\"   div class \"action-panel-control-wrap new-collections-controls\"   label for \"collections-action-dialog-add-to-new\" class \"usa-label margin-top-0\"  Name your collection  abbr title \"required\" class \"usa-hint usa-hint--required text-no-underline\"   /abbr   /label   input type \"text\" name \"add-to-new-collection\" id \"collections-action-dialog-add-to-new\" class \"usa-input collections-action-add-to-new\" pattern \"[  quot; amp;  lt; gt;/] \" title \"The following characters are not allowed in the Name field:  quot; amp;  lt; gt;/\" maxlength \"\" data-ga-category \"collections_button\" data-ga-action \"create_collection\" data-ga-label \"non_favorties_collection\" required /   /div   div class \"action-panel-control-wrap existing-collections-controls\"   label for \"collections-action-dialog-add-to-existing\" class \"usa-label margin-top-0\"  Choose a collection  /label   select id \"collections-action-dialog-add-to-existing\" class \"usa-select collections-action-add-to-existing\" data-ga-category \"collections_button\" data-ga-action \"select_collection\" data-ga-label \"( ('.collections-action-add-to-existing').val()     'Favorites') ? 'Favorites' : 'non_favorites_collection'\"   /select   div class \"collections-retry-load-on-error usa-input-error-message selection-validation-message\"  Unable to load your collection due to an error br   a href \" \" Please try again /a   /div   /div   /fieldset   div class \"display-inline-flex\"   button class \"usa-button margin-top-0 action-panel-submit\" type \"submit\" data-loading-label \"Adding...\" data-pinger-ignore data-ga-category \"collections_button\" data-ga-action \"click\" data-ga-label \"add\"  Add  /button   button class \"usa-button usa-button--outline margin-top-0 action-panel-cancel\" aria-label \"Close 'Add to Collections' panel\" ref \"linksrc close_collections_panel\" data-ga-category \"collections_button\" data-ga-action \"click\" data-ga-label \"cancel\"  Cancel  /button   /div   /form   /div   /div   /div   /div   /div   /div   footer class \"ncbi-footer ncbi-dark-background \"    div class \"ncbi-footer__icon-section\"   div class \"ncbi-footer__social-header\"  Follow NCBI  /div   div class \"grid-container ncbi-footer__ncbi-social-icons-container\"   a href \"https://twitter.com/ncbi\" class \"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"40\" height \"40\" viewBox \"0 0 40 40\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"   /path   /svg   span class \"usa-sr-only\" NCBI on X (formerly known as Twitter) /span   /a   a href \"https://www.facebook.com/ncbi.nlm\" class \"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"16\" height \"29\" focusable \"false\" aria-hidden \"true\" viewBox \"0 0 16 29\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\"   path d \"M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z\"   /path   /svg   span class \"usa-sr-only\" NCBI on Facebook /span   /a   a href \"https://www.linkedin.com/company/ncbinlm\" class \"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"25\" height \"23\" viewBox \"0 0 26 24\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z\"   /path   path d \"M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z\"   /path   path d \"M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z\"   /path   /svg   span class \"usa-sr-only\" NCBI on LinkedIn /span   /a   a href \"https://github.com/ncbi\" class \"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"28\" height \"27\" viewBox \"0 0 28 28\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z\"   /path   /svg   span class \"usa-sr-only\" NCBI on GitHub /span   /a   a href \"https://ncbiinsights.ncbi.nlm.nih.gov/\" class \"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"26\" height \"26\" viewBox \"0 0 27 27\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z\"   /path   path d \"M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z\"   /path   path d \"M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z\"   /path   /svg   span class \"usa-sr-only\" NCBI RSS feed /span   /a   /div   /div   div data-testid \"gridContainer\" class \"grid-container ncbi-footer__container\"   div class \"grid-row ncbi-footer__main-content-container\" data-testid \"grid\"   div class \"ncbi-footer__column\"   p class \"ncbi-footer__circled-icons-heading\"  Connect with NLM  /p   div class \"ncbi-footer__circled-icons-list\"   a href https://twitter.com/nlm_nih class \"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"32\" height \"32\" viewBox \"0 0 40 40\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"   /path   /svg   span class \"usa-sr-only\" NLM on X (formerly known as Twitter) /span   /a   a href https://www.facebook.com/nationallibraryofmedicine class \"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"13\" height \"24\" viewBox \"0 0 13 24\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z\"   /path   /svg   span class \"usa-sr-only\" NLM on Facebook /span   /a   a href https://www.youtube.com/user/NLMNIH class \"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" target \"_blank\" rel \"noreferrer noopener\"   svg width \"21\" height \"15\" viewBox \"0 0 21 15\" fill \"none\" xmlns \"http://www.w3.org/2000/svg\" focusable \"false\" aria-hidden \"true\"   path d \"M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z\" fill \"white\" /   /svg   span class \"usa-sr-only\" NLM on YouTube /span   /a   /div   /div   address class \"ncbi-footer__address ncbi-footer__column\"   p   a class \"usa-link usa-link--external\" href \"https://www.google.com/maps/place/8600 Rockville Pike, Bethesda, MD 20894/ 4038.9959508, -77.101021,17z/data 3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb 3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323\" rel \"noopener noreferrer\" target \"_blank\" National Library of Medicine  br/  8600 Rockville Pike br/  Bethesda, MD 20894 /a   /p   /address   ul class \"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"   li class \"ncbi-footer__vertical-list-item\"   a href \"https://www.nlm.nih.gov/web_policies.html\" class \"usa-link usa-link--alt ncbi-footer__link\"   Web Policies  /a   /li   li class \"ncbi-footer__vertical-list-item\"   a href \"https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office\" class \"usa-link usa-link--alt ncbi-footer__link\"   FOIA  /a   /li   li class \"ncbi-footer__vertical-list-item\"   a href \"https://www.hhs.gov/vulnerability-disclosure-policy/index.html\" class \"usa-link usa-link--external usa-link--alt ncbi-footer__link\" rel \"noreferrer noopener\" target '_blank'   HHS Vulnerability Disclosure  /a   /li   /ul   ul class \"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"   li class \"ncbi-footer__vertical-list-item\"   a href \"https://support.nlm.nih.gov/\" class \"usa-link usa-link--alt ncbi-footer__link\"   Help  /a   /li   li class \"ncbi-footer__vertical-list-item\"   a href \"https://www.nlm.nih.gov/accessibility.html\" class \"usa-link usa-link--alt ncbi-footer__link\"   Accessibility  /a   /li   li class \"ncbi-footer__vertical-list-item\"   a href \"https://www.nlm.nih.gov/careers/careers.html\" class \"usa-link usa-link--alt ncbi-footer__link\"   Careers  /a   /li   /ul   /div   div class \"grid-row grid-col-12\" data-testid \"grid\"   ul class \"ncbi-footer__bottom-links-list\"   li class \"ncbi-footer__bottom-list-item\"   a href \"https://www.nlm.nih.gov/\" class \"usa-link usa-link--alt ncbi-footer__link\"   NLM  /a   /li   li class \"ncbi-footer__bottom-list-item\"   a href \"https://www.nih.gov/\" class \"usa-link usa-link--alt ncbi-footer__link\"   NIH  /a   /li   li class \"ncbi-footer__bottom-list-item\"   a href \"https://www.hhs.gov/\" class \"usa-link usa-link--external usa-link--alt ncbi-footer__link\" rel \"noreferrer noopener\" target '_blank'   HHS  /a   /li   li class \"ncbi-footer__bottom-list-item\"   a href \"https://www.usa.gov/\" class \"usa-link usa-link--external usa-link--alt ncbi-footer__link\" rel \"noreferrer noopener\" target '_blank'   USA.gov  /a   /li   /ul   /div   /div   /footer   script type \"text/javascript\" src \"https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js\"   /script   button class \"back-to-top\" data-ga-category \"pagination\" data-ga-action \"back_to_top\"   label Back to Top /label   svg class \"usa-icon order-0\" aria-hidden \"true\" focusable \"false\" role \"img\"   use xlink:href \"/static/img/sprite.svg arrow_upward\"  /use   /svg   /button   script type \"application/javascript\"  window.ncbi   window.ncbi    {}; window.ncbi.pmc   window.ncbi.pmc    {}; window.ncbi.pmc.options   { logLevel: 'INFO', staticEndpoint: '/static/', citeCookieName: 'pmc-cf', };  /script   script type \"module\" crossorigin \"\" src \"/static/assets/base-370d5dd6.js\"  /script   script type \"text/javascript\" src \"https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js\"   xA0; /script   script type \"text/javascript\"  jQuery.getScript(\"https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js\", function () { galert(['div.nav_and_browser', 'div.header', ' universal_header', '.usa-banner', 'body    :nth-child(1)']) });  /script   script type \"text/javascript\" var exports   {}; /script   script src \"/static/CACHE/js/output.13b077bc3ffd.js\"  /script   script type \"module\" crossorigin \"\" src \"/static/assets/article-917ba005.js\"  /script   /body   /html",
  "url": "file:///Users/matejlukasik/Projects/chatbot/data/raw/pdfs/pmc_4854800.pdf",
  "source": "pdf",
  "filename": "pmc_4854800.pdf",
  "metadata": {
    "filename": "pmc_4854800.pdf",
    "file_size": 323381,
    "error": "EOF marker not found"
  },
  "scraped_at": "2025-07-03T19:36:41.642701",
  "word_count": 36851,
  "char_count": 296134
}